dantrolene has been researched along with Anesthesia Related Hyperthermia in 522 studies
Dantrolene: Skeletal muscle relaxant that acts by interfering with excitation-contraction coupling in the muscle fiber. It is used in spasticity and other neuromuscular abnormalities. Although the mechanism of action is probably not central, dantrolene is usually grouped with the central muscle relaxants.
dantrolene : The hydrazone resulting from the formal condensation of 5-(4-nitrophenyl)furfural with 1-aminohydantoin. A ryanodine receptor antagonist used for the relief of chronic severe spasticity and malignant hyperthermia.
| Excerpt | Relevance | Reference |
|---|---|---|
| " A diagnosis of neuroleptic malignant syndrome was made, and the patient was given dantrolene with prompt and complete resolution of all signs and symptoms." | 7.68 | Neuroleptic malignant syndrome induced by domperidone. ( Chan, W; Sachar, DB; Spirt, MJ; Thieberg, M, 1992) |
| "Dantrolene has also been used successfully in the treatment of a few cases of heat stroke and the neuroleptic malignant syndrome--both of which have many similarities to malignant hyperthermia." | 6.37 | Dantrolene. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity. ( Chaffman, MO; Sorkin, EM; Ward, A, 1986) |
| "Dantrolene is a ryanodine receptor antagonist and is used as an anti-inflammatory agent." | 5.62 | Beneficial effects of dantrolene in the treatment of rhabdomyolysis as a potential late complication associated with COVID-19: a case report. ( Chiba, N; Kinoshita, K; Matsuzaki, M; Mawatari, T; Mizuochi, M; Sakurai, A, 2021) |
| "On retrospective evaluation using the malignant hyperthermia scale, the present case was almost certainly that of a patient with MH." | 5.62 | Postoperative malignant hyperthermia confirmed by calcium-induced calcium release rate after breast cancer surgery, in which prompt recognition and immediate dantrolene administration were life-saving: a case report. ( Fukui, H; Ishida, Y; Kobayashi, T; Komiya, T; Miyazaki, N; Ogihara, Y; Okada, T; Uchino, H, 2021) |
| "Malignant syndrome is a disease characterized by high fever, extrapyramidal syndrome and dysautonomia recognized during or at the time of stopping administration of antipsychotic medication and it is the most severe and lethal side effect of antipsychotic medication." | 5.30 | [A case of malignant syndrome triggered by the use of haloperidol and chrorpromazine]. ( Fujimoto, K; Konishi, K; Kubota, M; Ogawa, H, 1997) |
| " No adverse effect of dantrolene sodium was detected by extensive testing of the fetus and neonate." | 5.27 | Dantrolene in pregnancy: lack of adverse effects on the fetus and newborn infant. ( Andrews, J; Britt, B; Gare, D; Shime, J, 1988) |
| "Oral dantrolene was given during the first nine postoperative days." | 5.27 | [Oral dantrolene in a parturient with myotonic dystrophy and susceptibility to malignant hyperthermia]. ( Achilli-Cornesse, E; Houvenaeghel, M; Jullian-Papouin, H; Manelli, JC; Martin-Meyssonier, A, 1988) |
| "Herein, the authors report a two-month-old infant who underwent holmium laser epiglottis retrofitting through a bronchoscope, but developed limb muscular stiffness, tachypnea, tachycardia, and hyperthermia after sevoflurane exposure." | 4.02 | The Use of Continuous Blood Purification for the Treatment of Malignant Hyperthermia in an Infant. ( Jing, Z; Li, Y; Sheng, C; Yang, C, 2021) |
| "Malignant hyperthermia (MH) is a severe hypermetabolic disorder associated with dysregulation of calcium homeostasis and is triggered by inhalational anesthetics (isoflurane, sevoflurane, desflurane) and a depolarizing muscle relaxant (succinylcholine)." | 4.02 | Malignant hyperthermia in a 16-day-old infant with congenital diaphragmatic hernia: a case report. ( Kakuta, N; Kanzaki, R; Kawanishi, R; Kondo, T; Miyoshi, H; Morio, A; Mukaida, K; Noda, Y; Tanaka, K; Tsutsumi, YM, 2021) |
| " They include: (1) How much dantrolene should be available in facilities where volatile agents are not available or administered, and succinylcholine is only stocked on site for emergency purposes? (2) What defines masseter muscle rigidity? What is its relationship to MH, and how should it be managed when it occurs? (3) What is the relationship between MH susceptibility and heat- or exercise-related rhabdomyolysis? (4) What evidence-based interventions should be recommended to alleviate hyperthermia associated with MH? (5) After treatment of acute MH, how much dantrolene should be administered and for how long? What criteria should be used to determine stopping treatment with dantrolene? (6) Can patients with a suspected personal or family history of MH be safely anesthetized before diagnostic testing? This report describes the consensus process and the outcomes for each of the foregoing unanswered clinical questions." | 3.91 | Consensus Statement of the Malignant Hyperthermia Association of the United States on Unresolved Clinical Questions Concerning the Management of Patients With Malignant Hyperthermia. ( Larach, MG; Litman, RS; Mayes, L; Shukry, M; Smith, VI; Theroux, MC; Watt, S; Wong, CA, 2019) |
| " Exposure of CASQ1-null mice to either 2% halothane or heat stress triggers lethal episodes characterized by whole-body contractures, elevated core temperature, and severe rhabdomyolysis, which are prevented by prior dantrolene administration." | 3.75 | Anesthetic- and heat-induced sudden death in calsequestrin-1-knockout mice. ( Canato, M; Dainese, M; Dirksen, RT; Lyfenko, AD; Paolini, C; Protasi, F; Quarta, M; Reggiani, C, 2009) |
| " The initial reaction was successfully treated with dantrolene, but during the following days the patient developed several compartment syndromes requiring fasciotomies." | 3.72 | A fatal case of malignant hyperthermia complicated by generalized compartment syndrome and rhabdomyolysis. ( Green, G, 2003) |
| " Eight days later, he presented with a neuroleptic malignant syndrome following an injection of droperidol." | 3.70 | Malignant hyperthermia and neuroleptic malignant syndrome in a patient during treatment for acute asthma. ( Cardinaud, JP; Favier, JC; Gbikpi-Benissan, G; Gruson, D; Hilbert, G; Portel, L, 1999) |
| " The halothane/caffeine contracture test was performed on the biopsied muscle." | 3.69 | Incidence of malignant hyperthermia reactions in 2,214 patients undergoing muscle biopsy. ( Britt, BA; Carr, AS; Cunliffe, M; Lerman, J; McLeod, ME, 1995) |
| " Hypotension was treated with ephedrine." | 3.69 | Anaesthesia for caesarean delivery of a malignant hyperthermia susceptible parturient. ( Lucy, SJ, 1994) |
| "Muscle metabolism was studied in pigs of different halothane genotypes by taking blood and muscle biopsy samples during a 45-min preslaughter period of anesthesia." | 3.69 | Effect of dantrolene treatment on muscle metabolism and meat quality of anesthetized pigs of different halothane genotypes. ( Klont, RE; Lambooy, E; van Logtestijn, JG, 1994) |
| " A diagnosis of neuroleptic malignant syndrome was made, and the patient was given dantrolene with prompt and complete resolution of all signs and symptoms." | 3.68 | Neuroleptic malignant syndrome induced by domperidone. ( Chan, W; Sachar, DB; Spirt, MJ; Thieberg, M, 1992) |
| " Discussion centres around the problems of diagnosis of malignant hyperthermia susceptibility in pregnancy, the differential diagnosis and management of fever and tachycardia in a MHS parturient during labour and the use of dantrolene prophylaxis." | 3.67 | The anaesthetic management of the malignant hyperthermia susceptible parturient. ( Douglas, MJ; McMorland, GH, 1986) |
| "We present the case of a 35-year-old man who developed symptoms of the neuroleptic malignant syndrome (NMS) after taking prescribed, moderately high, therapeutic doses of haloperidol." | 3.67 | Neuroleptic malignant syndrome. ( Lucid, EJ; Martin, ML; Walker, RW, 1985) |
| "The authors examined the thesis that a dose of dantrolene producing 95 per cent of maximal muscle relaxation (ED95) would effectively prevent or treat malignant hyperthermia (MH)." | 3.66 | Dantrolene dose response in malignant hyperthermia-susceptible (MHS) swine: method to obtain prophylaxis and therapeusis. ( Flewellen, EH; Nelson, TE, 1980) |
| "Halothane-induced contractures in isolated muscle fibers from swine susceptible to malignant hyperthermia (MHS) were significantly less when fibers were incubated in KRB plus 6." | 3.65 | Porcine malignant hyperthermia: effect of dantrolene sodium on in-vitro halothane-induced contraction of susceptible muscle. ( Anderson, IL; Jones, EW, 1976) |
| "Dantrolene was administered in 24 cases." | 3.01 | Malignant hyperthermia in maxillofacial surgery: Literature review supported by case presentation. ( Aires, CCG; Amorim, JA; Carneiro, SCAS; de Souza, RRL; Diniz, DA; Santos, FG; Vasconcellos, RJH, 2023) |
| "Exertional heat stroke (EHS) and malignant hyperthermia (MH) are life-threatening conditions, triggered by different environmental stimuli that share several clinical symptoms and pathophysiological features." | 2.66 | Overlapping Mechanisms of Exertional Heat Stroke and Malignant Hyperthermia: Evidence vs. Conjecture. ( Laitano, O; Leon, LR; Murray, KO, 2020) |
| "Succinylcholine was used in 46% (n = 710) of grade IV mask ventilation cases (median dose, 100 mg, 1." | 2.61 | Succinylcholine Use and Dantrolene Availability for Malignant Hyperthermia Treatment: Database Analyses and Systematic Review. ( Adelman, BT; Aziz, MF; Belani, KG; Berman, MF; Berris, J; Biggs, DA; Brandom, BW; Capacchione, J; Coffman, T; Coles, P; Craft, RM; Cummings, KC; Durieux, ME; Ellis, TA; Ginde, AA; Harris, JM; Helsten, DL; Herlich, A; Kheterpal, S; Kim, TW; Klumpner, TT; Kooij, F; LaGorio, J; Larach, MG; Limoncelli, J; Lins, S; Mackey, SC; Mashman, D; McCormick, PJ; Miller, SA; Molina, S; Nair, BJ; Nanamori, M; Neuman, MD; Pace, NL; Paganelli, WC; Peterson, W; Price, Z; Riazi, S; Schonberger, RB; Sivak, EL; Soto, R; Tom, S; Turnbull, ZA; van Klei, WA; Vaughn, MT; Wanderer, JP; Wedeven, C; Wilczak, J, 2019) |
| "We report a case of almost-certain malignant hyperthermia, according to the clinical grading scale, in a patient undergoing on-pump coronary artery bypass grafting surgery." | 2.61 | Almost-certain malignant hyperthermia during cardiopulmonary bypass: a case report and literature review. ( Zhang, Y; Zhou, R, 2019) |
| "Malignant hyperthermia is a pharmacogenetic disorder, which is an uncommon but frequently fatal intricacy of inhalation anesthesia in man." | 2.61 | Overactivation of the sodium-calcium exchanger and transient receptor potential in anesthesia-induced malignant hyperthermia. ( Cui, YF; Liu, XM; Sun, QC; Zhao, P, 2019) |
| "The prevalence of malignant hyperthermia (MH) in Germany is 1:2000-1:3000 and therefore more common than previously assumed, so that anesthesia personnel will more often be confronted with susceptible patients in the clinical setting." | 2.58 | [S1 guidelines on malignant hyperthermia : Update 2018]. ( Wappler, F, 2018) |
| "Malignant hyperthermia is a hypermetabolic syndrome that appears in susceptible patients after exposure to certain anaesthetic drugs (succinylcholine, inhalation anaesthetics)." | 2.55 | Clinical protocol for the management of malignant hyperthermia. ( Alsina, E; Del Blanco, B; Domínguez, A; García, A; Guerrero, JL; Kollmann-Camaiora, A; Yepes, MJ, 2017) |
| "Dantrolene sodium is a specific antagonist of the pathophysiologic changes of MH and should be available wherever general anesthesia is administered." | 2.47 | Malignant hyperthermia in the oral and maxillofacial surgery patient: an update. ( Patil, PM, 2011) |
| "Dantrolene is a skeletal muscle relaxant that depresses the excitation-contraction coupling,however, the specificity of action remains unknown." | 2.42 | [Dantrolene. Pharmacological and therapeutic aspects]. ( Agarwal, K; Fiege, M; Gerbershagen, MU; Krause, T; Wappler, F, 2003) |
| "In this article the pathophysiology of malignant hyperthermia, its signs, symptoms and treatment as well as safe anesthetic agents for individuals susceptible to malignant hyperthermia are discussed." | 2.42 | [Malignant hyperthermia]. ( Glahn, KP, 2003) |
| "The association of malignant hyperthermia-like reactions with other neuromuscular disorders requires the collaboration of several clinical disciplines to achieve a timely recognition of this still life-threatening disorder." | 2.42 | [Malignant hyperthermia]. ( Kress, HG; Zeitlhofer, J; Zimprich, F, 2003) |
| "Human malignant hyperthermia is a life-threatening genetic sensitivity of skeletal muscles to volatile anaesthetics and depolarizing neuromuscular blocking drugs occurring during or after anaesthesia." | 2.42 | Dantrolene--a review of its pharmacology, therapeutic use and new developments. ( Fiege, M; Gerbershagen, MU; Krause, T; Wappler, F; Weisshorn, R, 2004) |
| "Malignant hyperthermia is a potentially fatal genetic myopathy that presents when the patient is under anesthesia." | 2.41 | Malignant hyperthermia: considerations for the general surgeon. ( Heggie, JE, 2002) |
| " The successful treatment is based on an early diagnosis, immediately interruption of triggering agents, intravenous administration of Dantrolene in sufficient dosage and starting of adequate symptomatic treatment." | 2.41 | [Malignant hyperthermia]. ( Ben Ammar, MS; Bouhajja, B; Haddad, F, 2002) |
| "When malignant hyperthermia-does occur in the operating room, prompt recognition and treatment usually prevent a potentially fatal outcome." | 2.40 | Malignant hyperthermia. ( Adnet, P; Ben Abraham, R; Glauber, V; Perel, A, 1998) |
| "The most common is malignant hyperthermia (MH), a dangerous hypermetabolic state after anaesthesia with suxamethonium and/or volatile halogenated anaesthetic agents." | 2.40 | Malignant hyperthermia. ( Denborough, M, 1998) |
| "Malignant hyperthermia is a serious anesthetic complication, presenting with various manifestations, with high mortality and morbidity." | 2.40 | [Malignant hyperthermia]. ( Bracco, D; Chastonay, P; Freymond, D; Ravussin, P, 1999) |
| "Neuroleptic malignant syndrome and malignant hyperthermia share two cardinal clinical features: hypothermia and rigidity." | 2.38 | Neuroleptic malignant syndrome and malignant hyperthermia. Important issues for the medical consultant. ( Heiman-Patterson, TD, 1993) |
| "Malignant hyperthermia is usually triggered by halogenated anesthetic agents with or without depolarizing muscle relaxants." | 2.38 | Malignant hyperthermia: a review. ( Edleman, KJ; Johnson, C, 1992) |
| "Signs of malignant hyperthermia include hypercarbia, muscle rigidity and tachycardia." | 2.38 | Malignant hyperthermia. ( Moore, JL; Rice, EL, 1992) |
| "Two of the persisting controversies concerning malignant hyperthermia (MH) are discussed: storing and dosage of dantrolene and preoperative tactics to be followed with patients who are MH-susceptible." | 2.38 | [An attempt to reconcile differences of opinion in the field of malignant hyperthermia]. ( Eberlein, HJ; Schulte-Sasse, U, 1991) |
| "Death from malignant hyperthermia (MH) still occurs in France." | 2.38 | [Management of a patient with malignant hyperthermia susceptibility during anesthesia and daily living]. ( Jacquot, C; Stieglitz, P, 1989) |
| "Neuroleptic malignant syndrome is a rare but serious adverse effect of antipsychotic medication." | 2.37 | Neuroleptic malignant syndrome. ( Levenson, JL, 1985) |
| "New publications on malignant hyperthermia (MH), with direct clinical importance, are reported." | 2.37 | [New findings and experiences in the field of malignant hyperthermia]. ( Eberlein, HJ; Schulte-Sasse, U, 1986) |
| " These results were likely due to the relatively high bioavailability of oral dantrolene and, possibly, to continued absorption of dantrolene in the postoperative period." | 2.37 | Plasma levels of dantrolene following oral administration in malignant hyperthermia-susceptible patients. ( Allen, GC; Cattran, CB; Lalande, M; Peterson, RG, 1988) |
| "Malignant hyperthermia is a hereditary trait characterized by hypercatabolic reactions induced by anesthetic drugs, or physical or emotional stress." | 2.37 | Malignant hyperthermia. ( Britt, BA; Tomarken, JL, 1987) |
| "Dantrolene has also been used successfully in the treatment of a few cases of heat stroke and the neuroleptic malignant syndrome--both of which have many similarities to malignant hyperthermia." | 2.37 | Dantrolene. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity. ( Chaffman, MO; Sorkin, EM; Ward, A, 1986) |
| "Anesthetic-induced malignant hyperthermia (MH) originally attracted scientific interest because of the associated high fatality rate." | 2.36 | Malignant hyperthermia: responses of skeletal muscles to general anesthetics. ( Ahern, CP; Gallant, EM, 1983) |
| "Malignant hyperthermia has been an iatrogenic syndrome which was usually fatal." | 2.36 | Malignant hyperthermia following intravenous iodinated contrast media. Report of a fatal case. ( Mozley, PD, 1981) |
| "Two clinical myopathies are known to be associated with this membrane defect." | 2.36 | Etiology and pathophysiology of malignant hyperthermia. ( Denborough, MA, 1979) |
| "Dantrolene median dose was 50 (25-400) and 200 (25-400) mg·day -1 in responders and nonresponders, respectively." | 1.91 | Oral Dantrolene for Myopathic Symptoms in Malignant Hyperthermia-Susceptible Patients: A 25-Year Retrospective Cohort Study of Adverse Effects and Tolerability. ( Ibarra Moreno, CA; Jungbluth, H; Kraeva, N; Riazi, S; Voermans, NC; Zvaritch, E, 2023) |
| "Dantrolene is an intra-cellularly acting skeletal muscle relaxant used for the treatment of the rare genetic disorder, malignant hyperthermia (MH)." | 1.91 | Molecular Aspects Implicated in Dantrolene Selectivity with Respect to Ryanodine Receptor Isoforms. ( Gaburjakova, J; Gaburjakova, M, 2023) |
| "Malignant hyperthermia is an extremely dangerous condition that can occur with exposure to volatile inhalant anesthetics and depolarizing muscle relaxants, and that requires immediate intervention." | 1.91 | Pediatric fulminant malignant hyperthermia with severe electroencephalographic abnormality and brain damage: a case report. ( Ikeda, A; Kajihama, A; Minami, S; Nagafuchi, H; Shimizu, H; Yamada, K, 2023) |
| "Dantrolene was administered to 304 inpatients." | 1.72 | Intravenous dantrolene in hypermetabolic syndromes: a survey of the U.S. Veterans Health Administration database. ( Berkowitz, RM; Caroff, SN; Mashman, D; Riazi, S; Roberts, CB; Rosenberg, H; Tobin, JR; Watt, S, 2022) |
| "Malignant hyperthermia is defined in the International Classification of Diseases as a progressive life-threatening hyperthermic reaction occurring during general anaesthesia." | 1.62 | Malignant hyperthermia 2020: Guideline from the Association of Anaesthetists. ( Dalay, S; Girard, T; Hopkins, PM; Jenkins, B; McGrady, E; Patteril, M; Thacker, A, 2021) |
| "Dantrolene is a ryanodine receptor antagonist and is used as an anti-inflammatory agent." | 1.62 | Beneficial effects of dantrolene in the treatment of rhabdomyolysis as a potential late complication associated with COVID-19: a case report. ( Chiba, N; Kinoshita, K; Matsuzaki, M; Mawatari, T; Mizuochi, M; Sakurai, A, 2021) |
| "The cases of malignant hyperthermia reported on the most commonly used databases in China from 1985 to 2020 were analyzed." | 1.62 | Malignant hyperthermia when dantrolene is not readily available. ( Gong, X, 2021) |
| "On retrospective evaluation using the malignant hyperthermia scale, the present case was almost certainly that of a patient with MH." | 1.62 | Postoperative malignant hyperthermia confirmed by calcium-induced calcium release rate after breast cancer surgery, in which prompt recognition and immediate dantrolene administration were life-saving: a case report. ( Fukui, H; Ishida, Y; Kobayashi, T; Komiya, T; Miyazaki, N; Ogihara, Y; Okada, T; Uchino, H, 2021) |
| "Dantrolene was administered to treat the hypermetabolic manifestations in 20 minutes after the identification of MH." | 1.62 | A case report of malignant hyperthermia in a patient with myotonic dystrophy type I: A CARE-compliant article. ( Baek, SJ; Doo, AR; Kim, DC; Yoo, SW, 2021) |
| "To report on a case of malignant hyperthermia in a child after a magnetic resonance imaging of the skull was performed using sevoflurane anesthesia." | 1.56 | MALIGNANT HYPERTHERMIA IN A CHILD AFTER MAGNETIC RESONANCE IMAGING: A CASE REPORT. ( Almeida, CG; Colleti Junior, J, 2020) |
| " The consensus process used a modified web-based Delphi exercise, in which participants rated the appropriateness of statements that covered the dosing regimen for dantrolene in a malignant hyperthermia crisis, the types of facility that should stock dantrolene, and the amount of dantrolene that should be stocked." | 1.56 | Availability of dantrolene for the management of malignant hyperthermia crises: European Malignant Hyperthermia Group guidelines. ( Bendixen, D; Girard, T; Glahn, KPE; Hopkins, PM; Johannsen, S; Rüffert, H; Snoeck, MM; Urwyler, A, 2020) |
| "We report a case of malignant hyperthermia related to exposure to sevoflurane during adenoidectomy surgery in a 6-year-old female." | 1.56 | Malignant hyperthermia syndrome: A rare entity. ( Esteban-Zubero, E; García-Muro, C; Gutiérrez-Delgado, JM; Riaño-Méndez, B; Sáenz-Moreno, I; Valencia-Ramos, J, 2020) |
| "Malignant hyperthermia is a rare condition that occurs in susceptible patients exposed to triggering anesthetic agents." | 1.51 | Malignant Hyperthermia: A Case Report in a Trauma Patient. ( Bonnick, AM; Fadahunsi, O; Gibbs, IC; Reid, N, 2019) |
| "There are no case reports of malignant hyperthermia in pediatric patients treated on cardiopulmonary bypass (CPB)." | 1.51 | Presumed Malignant Hyperthermia Treated During Cardiopulmonary Bypass in a Pediatric Patient Undergoing Aortic Valve Replacement: A Case Report. ( Kuntz, MT; Saab, AD, 2019) |
| "Schizencephaly is a rare congenital central nervous system malformation characterized by linear, thickened clefts of the cerebral mantle." | 1.51 | Malignant Hyperthermia and Cerebral Venous Sinus Thrombosis After Ventriculoperitoneal Shunt in Infant with Schizencephaly and COL4A1 Mutation. ( Fujii, Y; Hasegawa, H; Matsumoto, N; Miyatake, S; Natsumeda, M; Ohashi, T; Oishi, M; Okamoto, K; Watanabe, J, 2019) |
| "The diagnosis of malignant hyperthermia (MH) susceptibility could be confirmed in the patient 4 months after the acute event by the in vitro contracture test and detection of the MH causative mutation p." | 1.48 | [Abortive course of malignant hyperthermia following preclinical induction of general anesthesia using succinylcholine]. ( Helf, D; Johannsen, S; Markus, CK; Schneiderbanger, D; Schuster, F, 2018) |
| "We found that maintaining a malignant hyperthermia cart in every maternity unit in the United States would reduce morbidity and mortality costs by $3,304,641 per year nationally but would cost $5,927,040 annually." | 1.48 | Cost-benefit Analysis of Maintaining a Fully Stocked Malignant Hyperthermia Cart versus an Initial Dantrolene Treatment Dose for Maternity Units. ( Carvalho, B; Ho, PT; Macario, A; Riley, ET; Sun, EC, 2018) |
| " Current dantrolene dosing recommendations are based on actual body weight despite a paucity of literature in obese patients." | 1.46 | Malignant Hyperthermia in a Morbidly Obese Patient Depletes Community Dantrolene Resources: A Case Report. ( Gamble, J; Magistris, F, 2017) |
| "Sporadic clinical episodes of malignant hyperthermia (MH) that develop during general anaesthesia (GA) have been reported in Singapore." | 1.46 | Malignant Hyperthermia and Ryanodine Receptor Type 1 Gene (RyR1) Mutation in a Family in Singapore. ( Lai, PS; Lee, DW; Lee, TL; Li, DW; Yong, RY, 2017) |
| "Type A aortic dissections are surgical emergencies requiring cardiopulmonary bypass and frequently deep hypothermic circulatory arrest." | 1.46 | Suspected Malignant Hyperthermia in the Setting of Hypothermic Circulatory Arrest for Type A Aortic Dissection Repair: A Case Report. ( Bunting, B; Knight, J; McHugh, SM, 2017) |
| " With the approval of the health system's pharmacy and therapeutics committee, the new product was added to the formulary as the preferred dosage form of dantrolene, and existing dantrolene product stock was converted to the new formulation." | 1.43 | Implementation of a new dantrolene formulation across a multifacility health system. ( Gross, C; Lang, MB; Skledar, S; Zavilla, CM, 2016) |
| "Knock-in mice with the malignant hyperthermia susceptibility RYR1 mutation Y522S (MHS RYR1Y522S) had longer bleeding times than their wild-type littermates." | 1.43 | An RYR1 mutation associated with malignant hyperthermia is also associated with bleeding abnormalities. ( Alamelu, J; Brink, M; Byrne, S; Clement, E; Jungbluth, H; Lopez, RJ; Mohammed, S; Muntoni, F; Radunovic, A; Sekulic-Jablanovic, M; Snoeck, M; Treves, S; Voermans, N; Vukcevic, M; Wraige, E; Xu, L; Zhou, H; Zorzato, F, 2016) |
| "Dantrolene was given in 81% of the MH events." | 1.42 | Accuracy of malignant hyperthermia diagnoses in hospital discharge records. ( Brady, JE; Lang, BH; Li, G; Pinyavat, T; Riazi, S; Rosenberg, H; Sun, LS; Wong, CA, 2015) |
| "Dantrolene is the first line therapy of malignant hyperthermia." | 1.42 | Essential Role of Calmodulin in RyR Inhibition by Dantrolene. ( Gomez-Hurtado, N; Imtiaz, MS; Knollmann, BC; Laver, DR; Oo, YW; van Helden, DF; Walweel, K, 2015) |
| "Postoperative malignant hyperthermia can sometimes be difficult to distinguish from central hyperthermia, especially after neurosurgery." | 1.40 | [Suspected case of postoperative malignant hyperthermia treated with dantrolene one week after neurosurgery]. ( Itoh, K; Kitamura, A; Nishibe, S; Usuda, Y, 2014) |
| "We report a case of malignant hyperthermialike syndrome in a living-donor liver transplant recipient with no familial history of malignant hyperthermia or exposure to known triggering drugs." | 1.39 | A malignant hyperthermialike episode in a liver transplant recipient. ( Fukuda, K; Segawa, H; Tsujikawa, H, 2013) |
| "After achieving predefined malignant hyperthermia criteria, standardised therapy was initiated; dantrolene sodium suspension (5 mg kg(-1)) was administered and the injection was repeated after 24 min." | 1.39 | 3,4-Methylenedioxymethamphetamine induces a hyperthermic and hypermetabolic crisis in pigs with and without a genetic disposition for malignant hyperthermia. ( Becker, S; Gerbershagen, MU; Oldewurtel, C; Richard, A; Schäfer, U; Schütte, JK; Singler, P; Starosse, A; Wappler, F, 2013) |
| "Halothane was discontinued after the administration of 0." | 1.37 | Comparison of the therapeutic effectiveness of a dantrolene sodium solution and a novel nanocrystalline suspension of dantrolene sodium in malignant hyperthermia normal and susceptible pigs. ( Becker, S; Burmester, S; Gerbershagen, MU; Kröner, L; Lenz, D; Schütte, JK; Starosse, A; Wappler, F, 2011) |
| "Sevoflurane was discontinued and body surface cooling, hyperventilation with 100% oxygen, and administration of dantrolene sodium 2 mg x kg(-1), furosemide 4 mg, and 7% NaHCO3 solution 10 ml were started on a suspicion of malignant hyperthermia." | 1.37 | [Case of fulminant-malignant hyperthermia occurring on sixth sevoflurane anesthesia]. ( Kohjitani, A; Manabe, Y; Saitoh, Y; Shimomatsu, K; Sugiyama, K; Toya, A, 2011) |
| "We analyzed cases of malignant hyperthermia (MH) reported to the North American MH Registry for clinical characteristics, treatment, and complications." | 1.36 | Clinical presentation, treatment, and complications of malignant hyperthermia in North America from 1987 to 2006. ( Allen, GC; Brandom, BW; Gronert, GA; Larach, MG; Lehman, EB, 2010) |
| "Malignant hyperthermia was suspected early, and resuscitative measures, including supportive and specific treatment, were successfully implemented." | 1.36 | A report of fulminant malignant hyperthermia in a patient with a novel mutation of the CACNA1S gene. ( Beattie, WS; Chandy, TT; Ghanekar, A; Kraeva, N; Riazi, S; Toppin, PJ, 2010) |
| "Pre-treatment with dantrolene (for 7-10 days) significantly inhibited the inducible VT (P<0." | 1.36 | Dantrolene, a therapeutic agent for malignant hyperthermia, inhibits catecholaminergic polymorphic ventricular tachycardia in a RyR2(R2474S/+) knock-in mouse model. ( Doi, M; Kobayashi, S; Matsuzaki, M; Oda, T; Okuda, S; Ono, M; Suetomi, T; Susa, T; Tateishi, H; Uchinoumi, H; Xu, X; Yamamoto, T; Yano, M, 2010) |
| "We describe a case of malignant hyperthermia encountered and treated during surgical operations concurrent with an overseas humanitarian assistance mission." | 1.35 | A case of malignant hyperthermia in a child encountered during a humanitarian assistance mission to the Philippines. ( Blaschke, G; Jones, S; Pfeiffer, J; Plurad, D, 2008) |
| "Dantrolene was administered prior to the Hotline call in 32 cases." | 1.35 | Hyperthermia in the pediatric intensive care unit--is it malignant hyperthermia? ( Litman, RS; Schleelein, LE, 2009) |
| "Malignant hyperthermia is a pharmacogenetic disease of skeletal muscle in which a life-threatening, hypermetabolic syndrome is induced by exposure of susceptible patients to halogenated general anaesthetics and/or succinylcholine." | 1.35 | Effects of azumolene on normal and malignant hyperthermia-susceptible skeletal muscle. ( Carmo, PL; Sudo, RT; Trachez, MM; Zapata-Sudo, G, 2008) |
| "Some patients develop recrudescence after a malignant hyperthermia (MH) reaction, but it is not clear which patients are at risk." | 1.34 | Analysis of the clinical variables associated with recrudescence after malignant hyperthermia reactions. ( Burkman, JM; Domino, KB; Posner, KL, 2007) |
| "As sevoflurane, promotes the CICR (calcium-induced calcium release) mechanism, the trigger of this case is probably sevoflurane." | 1.34 | [Case of malignant hyperthermia in which treatment was carried out smoothly]. ( Endo, K; Furuta, S; Kaneko, T; Morota, T; Obara, S; Ohmuzo, H; Onuma, T; Watanabe, K, 2007) |
| "We describe a case of malignant hyperthermia during orthotopic liver transplantation." | 1.34 | Malignant hyperthermia in a liver transplant patient: a case report. ( Azevedo, DM; Coelho, GR; Fernandes, CR; Garcia, JH; Gomes, JM; Gonçalves, BP; Vasconcelos, JB, 2007) |
| "According to the diagnostic criteria for malignant hyperthermia by Larach and his colleague, malignant hyperthermia was somewhat less than likely in our case." | 1.33 | [Central hyperthermia suspected of malignant hyperthermia in a patient undergoing radical neck clipping for cerebral aneurysm]. ( Matsuki, A; Murakawa, T; Sakai, I, 2005) |
| "Susceptibility to malignant hyperthermia is inherited as an autosomal dominant disorder and is associated with myopathies." | 1.33 | [Malignant hyperthermia--a hereditary and potentially life-threatening condition]. ( Aasly, J; Haugen, T; Müller, CR; Toft, M, 2005) |
| " Current dosing recommendations are based on noncompartmental analyses and are largely empiric." | 1.33 | Compartmental pharmacokinetics of dantrolene in adults: do malignant hyperthermia association dosing guidelines work? ( Bouillon, T; Kurz, A; Podranski, T; Schumacher, PM; Sessler, DI; Taguchi, A, 2005) |
| "However, a fatal malignant hyperthermia-like syndrome (MHLS) with rhabdomyolysis associated with new-onset diabetes mellitus and HHNS in adolescents has been described." | 1.33 | Approach to management of malignant hyperthermia-like syndrome in pediatric diabetes mellitus. ( Backeljauw, PF; Crimmins, NA; Kilbane, BJ; Mehta, S; Shanley, TP, 2006) |
| "A 38-year-old man diagnosed as esophageal achalasia developed masseter muscle rigidity after intravenous suxamethonium during anesthetic induction." | 1.32 | [Masseter muscle rigidity after suxamethonium during induction and postoperative abortive malignant hyperthermia in a patient with esophageal achalasia]. ( Anzai, T; Arakawa, Y; Hoka, S; Kanai, A; Kuroiwa, M; Okamoto, H, 2004) |
| "Exertional heat illness (EHI) and malignant hyperthermia (MH) are two potentially lethal conditions." | 1.32 | Is there a link between malignant hyperthermia and exertional heat illness? ( Brandom, B; Bunger, R; Deuster, P; Muldoon, S, 2004) |
| "Malignant hyperthermia is a rare but potentially fatal metabolic syndrome triggered in susceptible patients by certain inhalational anesthetics and depolarizing muscle relaxants." | 1.31 | Malignant hyperthermia: how to spot it early. ( Haslego, SS, 2002) |
| "We present a case of malignant hyperthermia in an African-American patient during desflurane anesthesia." | 1.31 | An unusual case of malignant hyperthermia during desflurane anesthesia in an African-American patient. ( Brooks, AG; Castresana, MR; Lane, JE; Logan, MS; Newman, WH, 2000) |
| "He previously had an episode suggesting malignant hyperthermia susceptibility during anesthesia managed with suxamethonium and isoflurane." | 1.31 | [A case of high dose administration of propofol]. ( Kinuwaki, H; Nishioka, H; Shimoda, O; Terasaki, H, 2000) |
| "Sevoflurane was discontinued and dantrolene was given by intravenous bolus." | 1.31 | Malignant hyperthermia in a patient with Graves' disease during subtotal thyroidectomy. ( Genma, R; Kitahara, A; Matsushita, A; Nakamura, H; Nakano, K; Natsume, H; Nishiyama, K; Sasaki, S; Yamamoto, Y, 2001) |
| "We experienced two cases of malignant hyperthermia (MH) triggered by sevoflurane." | 1.31 | [Two pediatric cases of malignant hyperthermia caused by sevoflurane]. ( Fukumitsu, K; Kinouchi, K; Kitamura, S; Okawa, M; Tachibana, K; Taniguchi, A, 2001) |
| "Malignant syndrome is a disease characterized by high fever, extrapyramidal syndrome and dysautonomia recognized during or at the time of stopping administration of antipsychotic medication and it is the most severe and lethal side effect of antipsychotic medication." | 1.30 | [A case of malignant syndrome triggered by the use of haloperidol and chrorpromazine]. ( Fujimoto, K; Konishi, K; Kubota, M; Ogawa, H, 1997) |
| "A case of suspected malignant hyperthermia in a 13-month-old female, to whom succinylcholine was not administered, is presented." | 1.30 | Suspected malignant hyperthermia in a 13-month-old: today's "typical" episode--a case report. ( Carvill, KA; Eckert, T; Smith, CA, 1997) |
| "Dantrolene is used to treat malignant hyperthermia (MH), a genetic predisposition to excessive intracellular Ca2+ release upon exposure to volatile anaesthetics." | 1.30 | Pharmacological distinction between dantrolene and ryanodine binding sites: evidence from normal and malignant hyperthermia-susceptible porcine skeletal muscle. ( Louis, CF; Mickelson, JR; Palnitkar, SS; Parness, J, 1997) |
| "Pretreatment with dantrolene completely abolished serotonin-induced MH." | 1.30 | Attenuation of serotonin-induced contractures in skeletal muscle from malignant hyperthermia-susceptible patients with dantrolene. ( Fiege, M; Köchling, A; Lambrecht, W; Scholz, J; Schulte am Esch, J; von Richthofen, V; Wappler, F, 1997) |
| "Dantrolene is the treatment of choice and prognosis depends on the early administration of this agent." | 1.30 | [Intraoperative malignant hyperthermia: apropos of a case]. ( Antakly, MC; Bou-Khalil, M; Cherfane, A; Madi-Jebara, S; Yazbeck, P, 1997) |
| "Malignant hyperthermia is a rare complication in clinical anesthesia, especially associated with the administration of succinylcholine or inhalation anesthetics." | 1.30 | Elimination of hypercapnia may postpone the clinical presentation of malignant hyperthermia: a case report. ( Chia, YY; Lee, MC; Liu, K; Liu, YC; Lo, Y, 1998) |
| "If unrecognized and/or untreated, malignant hyperthermia can be fatal." | 1.29 | Malignant hyperthermia: not just an operating room emergency. ( Kindred, D; Young, MS, 1993) |
| "During halothane-induced malignant hyperthermia (MH), plasma levels of serotonin (5-hydroxytryptamine, 5-HT) increase in pigs." | 1.29 | Lack of prophylactic or therapeutic efficacy of 5-HT2A receptor antagonists in halothane-induced porcine malignant hyperthermia. ( Gerdes, C; Löscher, W; Richter, A, 1994) |
| "Two cases of possible clinical malignant hyperthermia are described." | 1.29 | Clinical variability of possible malignant hyperthermia as revealed by two cases. ( Bendixen, D; Knudsen, F; Nielsen, J; Ording, H; Poulsen, TD, 1994) |
| "Dantrolene (3 mg/kg) was administered slowly into an antecubital vein, and blood samples were withdrawn from the other arm at 5 and 25 minutes after infusion." | 1.29 | Clinical effects of intravenously administered dantrolene. ( Iaizzo, PA; Quinlan, JG; Wedel, DJ, 1995) |
| "A case of porcine malignant hyperthermia (MH) is reported, which occurred during a cardiological animal experiment under general anaesthesia using isoflurane as inhalational anaesthetic." | 1.29 | [Malignant hyperthermia in swine during isoflurane anesthesia]. ( Bötel, C; Krohn, S; Paul, T; Strauss, JM; Sümpelmann, R; Zimmermann, M, 1994) |
| "In dantrolene-treated animals, EEG total power and median frequency increased within 5 min." | 1.29 | Improvement of brain electrical activity during treatment of porcine malignant hyperthermia with dantrolene. ( Hoffman, WE; Kochs, E; Schulte am Esch, J, 1993) |
| "The authors report a case of malignant hyperthermia in susceptible woman undergoing safenectomy." | 1.29 | [The use of subarachnoid bupivacaine analgesia in malignant hyperthermia-susceptible subjects. A clinical case report]. ( Abballe, C; De Cosmo, G; Primieri, P, 1993) |
| "Malignant hyperthermia is a seemingly rare genetic myopathy." | 1.29 | Malignant hyperthermia in the otology patient: the UCLA experience. ( Blackwell, KE; Wackym, PA, 1994) |
| "Dantrolene effectively treats malignant hyperthermia (MH) hut the current form, Dantrium, must be dissolved to a 0." | 1.29 | Intravenous lecithin-coated microcrystals of dantrolene are effective in the treatment of malignant hyperthermia: an investigation in rats, dogs, and swine. ( Bina, S; Boedeker, BH; Haynes, DH; Karan, SM; Lojeski, EW; Muldoon, SM; Wesche, DL, 1996) |
| "In this report, we describe a case of malignant hyperthermia, its clinical course, and the measures taken to successfully treat it and preserve the function of a kidney allograft." | 1.29 | Successful treatment of intraoperative malignant hyperthermia during renal transplantation. ( Brennan, DC; Flye, MW; Goss, JA; Howard, TK; McClure, S; Miller, BT; Shenoy, S, 1996) |
| "Dantrolene sodium (DS) is a direct-acting skeletal muscle relaxant whose only known action is to block calcium release from intracellular storage sites." | 1.29 | Dantrolene sodium can increase or attenuate activity of skeletal muscle ryanodine receptor calcium release channel. Clinical implications. ( Lin, M; Nelson, TE; Sudo, RT; Zapata-Sudo, G, 1996) |
| "treatment with dantrolene." | 1.29 | The reduction of skeletal muscle lesions after experimental stress in stress-susceptible pigs protected with dantrolene. ( Bjurström, S; Carlsten, J; Jönsson, L, 1995) |
| "1." | 1.28 | W-7, a calmodulin antagonist, and contracture of malignant hyperthermia susceptible skeletal muscle. ( Holland, M; Lee, JC; Williams, JH, 1992) |
| "These episodes were not considered to be malignant hyperthermia and were not treated with dantrolene." | 1.28 | Should all children with suspected or confirmed malignant hyperthermia susceptibility be admitted after surgery? A 10-year review. ( Hartley, EJ; Levine, MF; Yentis, SM, 1992) |
| "These results suggest that (i) the malignant hyperthermia syndrome is not directly related to the polar heads of phospholipids and (ii) dantrolene counteracts unspecifically the disturbing effect of halothane at the lipid level." | 1.28 | 31P NMR and freeze fracture studies of sarcoplasmic reticulum membranes from normal and malignant hyperthermic pigs: effect of halothane and dantrolene. ( Dufourc, EJ; Gaillard, S; Renou, JP; Rock, E; Vignon, X, 1992) |
| "An acute episode of a malignant hyperthermia-like syndrome is described which occurred after suxamethonium and isoflurane anaesthesia in a 41-year-old healthy male patient undergoing a minor elective hand operation." | 1.28 | A case of malignant hyperthermia? ( Boersma, GA; Broekema, AA; Hennis, PJ, 1991) |
| "We report on the fulminant crisis of malignant hyperthermia occurring in a 30-year-old female during kidney transplantation." | 1.28 | [Fulminant malignant hyperthermia during the 6th general anesthesia using volatile anesthetics]. ( Hartung, E; Lechner, J; Striebel, HW; Wiegand, C, 1991) |
| "Until our malignant hyperthermia diagnostic center was opened, such tests could not be performed in Israel." | 1.28 | [In vitro diagnosis of malignant hyperpyrexia syndrome]. ( Eldar, I; Glauber, V; Goldberg, G; Perel, A, 1991) |
| "Dantrolene was administered intravenously over a period of 15 min at doses of 1." | 1.28 | Intravenous dantrolene does not exhibit calcium channel blocking effects on the cardiac conduction system in humans. ( Kentsch, M; Kuck, KH; Kunze, KP; Roewer, N, 1991) |
| "Dantrolene has been recommended for use in horses at risk of developing postanesthetic myopathy." | 1.28 | Prophylactic use of dantrolene associated with prolonged postanesthetic recumbency in a horse. ( Boyd, CJ; Dyson, DH; Pascoe, PJ; Valverde, A, 1990) |
| "This article pertains to malignant hyperthermia (MH)." | 1.28 | Malignant hyperthermia: a potential crisis in the postanesthesia care unit. ( Ashby, D, 1990) |
| "In this article a case report of malignant hyperthermia occurring in an office surgery suite is presented." | 1.28 | Malignant hyperthermia in an office surgery suite: a case report. ( Manino, J; Turpin, IM, 1989) |
| "A case of susceptibility to malignant hyperthermia, diagnosed by muscle biopsy during the first trimester of pregnancy, is presented." | 1.28 | Diagnosis and management of susceptibility to malignant hyperthermia in pregnancy. ( Botti, JJ; Ingardia, CJ; Sorosky, JI, 1989) |
| "A 55-year-old, malignant hyperthermia-susceptible patient underwent myocardial revascularization without incident." | 1.28 | Rewarming following hypothermic cardiopulmonary bypass in the malignant hyperthermia-susceptible patient: implications for diagnosis and perioperative management. ( Allen, GC; Cattran, CB, 1989) |
| " We suggest the same dosage regimen as is used in the treatment of malignant hyperthermia." | 1.28 | Acute thyroid crisis on induction of anaesthesia. ( Bennett, MH; Wainwright, AP, 1989) |
| " Thereafter, the concentration of dantrolene decreased slowly with an elimination half-life (mean +/- SD) of 10." | 1.28 | Pharmacokinetics of intravenous dantrolene in children. ( Lerman, J; McLeod, ME; Strong, HA, 1989) |
| "Two cases of malignant hyperthermia are described where the earliest sign was a rise in the end-tidal CO2 concentration." | 1.27 | End-tidal CO2 monitoring. Its use in the diagnosis and management of malignant hyperthermia. ( Baudendistel, L; Cote', C; Goudsouzian, N; Strafford, M, 1984) |
| "Malignant hyperthermia is a hypermetabolic, frequently fatal syndrome triggered by anesthetic drugs that occurs in genetically susceptible persons." | 1.27 | Malignant hyperthermia in dental patients. ( Adriani, J; Sundin, R, 1984) |
| "A case of malignant hyperthermia (MH) in a three-year eight-month-old girl is presented." | 1.27 | Postoperative malignant hyperthermia and dantrolene therapy. ( Eberlein, HJ; Hess, W; Schulte-Sasse, U, 1983) |
| "The effects of an induced malignant hyperthermia (MH) crisis have been studied in the intact pig." | 1.27 | In vivo induced malignant hyperthermia in pigs. I. Physiological and biochemical changes and the influence of dantrolene sodium. ( Crul, JF; de Bruyn, CH; Gielen, MJ; Oerlemans, FT; van Bennekom, CA; Verburg, MP, 1984) |
| "Biceps femoris muscle biopsies of malignant hyperthermia susceptible (MH+) and non-susceptible (MH-) Dutch Landrace pigs were studied ultrastructurally, and exchangeable calcium was demonstrated, using the antimonate precipitation technique in combination with electron probe x-ray microanalysis." | 1.27 | In vivo induced malignant hyperthermia in pigs. III. Localization of calcium in skeletal muscle mitochondria by means of electronmicroscopy and microprobe analysis. ( Ruitenbeek, W; Sengers, RC; Stadhouders, AM; Verburg, MP; Viering, WA, 1984) |
| "Dantrolene was shown to inhibit the halothane-induced calcium release." | 1.27 | Calcium-induced Ca2+ release from sarcoplasmic reticulum of pigs susceptible to malignant hyperthermia. The effects of halothane and dantrolene. ( Gronert, GA; Ohnishi, ST; Taylor, S, 1983) |
| "Dantrolene sodium is a drug used in the treatment of spasticity and malignant hyperthermia." | 1.27 | [In vitro electrophysiological effects of sodium dantrolene on isolated preparations of Purkinje fibers and ventricular myocardium of sheep]. ( Grosgogeat, Y; Lascault, G; Waxman, MB, 1985) |
| "Malignant Hyperthermia is a specific potentially fatal condition which occurs in susceptible individuals in response to various triggering mechanisms, of which anesthetic agents have been found to be the most common offenders." | 1.27 | [Malignant neuroleptic syndrome and malignant hyperthermia--a comparison]. ( Hippius, H; Spiess-Kiefer, C, 1986) |
| "This is the first report of a case of malignant hyperthermia (MH) from Saudi Arabia." | 1.27 | Malignant hyperthermia in a Saudi child. ( Joseph, M; Juneja, M; Radwan, HE, 1985) |
| " No adverse effect of dantrolene sodium was detected by extensive testing of the fetus and neonate." | 1.27 | Dantrolene in pregnancy: lack of adverse effects on the fetus and newborn infant. ( Andrews, J; Britt, B; Gare, D; Shime, J, 1988) |
| "Oral dantrolene was given during the first nine postoperative days." | 1.27 | [Oral dantrolene in a parturient with myotonic dystrophy and susceptibility to malignant hyperthermia]. ( Achilli-Cornesse, E; Houvenaeghel, M; Jullian-Papouin, H; Manelli, JC; Martin-Meyssonier, A, 1988) |
| "Dantrolene was only used in 32% of cases, and then at inadequate doses and very often too late; this probably explains the large number of treatment failures." | 1.27 | [Registration of peranesthetic cases of malignant hyperthermia in France. An update]. ( Jacquot, C; Kozak-Reiss, G; Krivosic-Horber, R; Laxenaire, MC; Lienhart, A; Nivoche, Y; Stieglitz, P, 1988) |
| "Malignant hyperthermia is an inherited disease of skeletal muscle characterized by acute elevations of body temperature." | 1.27 | Malignant hyperthermia: a dilemma for the cardiac surgeon. ( Allen, C; Johnstone, D; Landymore, RW; Wood, J, 1987) |
| "We describe a young man who experienced malignant hyperpyrexia, probably triggered by suxamethonium and/or enflurane during his second operation for an epigastric hernia." | 1.27 | Spinal block, after dantrolene pretreatment, for resection of a thigh muscle herniation in a young malignant hyperthermia susceptible man. ( Björkenheim, JM; Huopaniemi, T; Oikkonen, M; Paetau, A; Rosenberg, PH, 1987) |
| "The pathogenesis of the malignant hyperthermia syndrome is not yet completely understood." | 1.27 | Malignant hyperthermia susceptibility--successful management with a "stressfree" technique. ( Erdmann, K; Jantzen, JP; Kleemann, PP, 1987) |
| "Two cases of malignant hyperthermia (MH) are presented." | 1.27 | Malignant hyperthermia: clinical course and metabolic changes in two patients. ( Håkanson, E; Rutberg, H, 1986) |
| "An episode of malignant hyperthermia occurring in a two-year-old child undergoing cardiac surgery is reported." | 1.27 | Development of malignant hyperthermia obscured by cardiopulmonary bypass. ( Gemmell, L; Jann, H; MacGillivray, RG; Mahomedy, AE; Vanker, E, 1986) |
| "The family history was positive for malignant hyperthermia." | 1.27 | Dantrolene plasma and urine concentrations after oral pretreatment for malignant hyperthermia: report of a case. ( Driessen, JJ; Evers, J; van der Kleyn, E; Vree, TB; Wuis, EW, 1986) |
| "A patient who had malignant hyperthermia that apparently was triggered by nitrous oxide anesthesia even though he was premedicated with dantrolene sodium was successfully managed on a separate occasion using dantrolene without nitrous oxide." | 1.27 | Malignant hyperthermia in a patient receiving nitrous oxide. ( Ballard, JB; Waite, PD; Yonfa, A, 1985) |
| "The true incidence of malignant hyperthermia is unknown, but the frequency has been estimated as high as 1/14,000 anesthetic events." | 1.26 | Malignant hyperthermia. ( Nissen, RL; Yonkers, AJ, 1982) |
| "A case of malignant hyperthermia in a young girl with vesicoureteral reflux and multiple congenital abnormalities is discussed." | 1.26 | Management of malignant hyperthermia. ( Bloom, DA; Ehrlich, RM; Iwamoto, K; Reynolds, RC, 1981) |
| "Malignant hyperthermia is a pharmacogenetic disease involving uninhibited flow of calcium ion into the muscle substance." | 1.26 | Malignant hyperthermia syndrome. ( Waterman, PM, 1981) |
| "The pharmacogenetic syndrome of malignant hyperthermia (MH) in response to general anaesthesia, though rare, is usually fatal when it does occur." | 1.26 | Dantrolene sodium in the treatment of malignant hyperthermia. A case report. ( Harrison, GG, 1981) |
| "Malignant Hyperthermia is a life-threatening crisis frequently triggered by the use of various anesthetic agents." | 1.26 | Malignant hyperthermia in myelomeningocele: a previously unreported association. ( Anderson, TE; Breed, AL; Drummond, DS; Taylor, CA, 1981) |
| "Dantrolene dose response was determined twice in each anaesthetized subject, once with thiopentone and subsequently with thiopentone and halothane." | 1.26 | Porcine malignant hyperthermia--failure of dantrolene dose response to diagnose susceptibility (halothane effect). ( Bee, DE; Flewellen, EH; Nelson, TE, 1980) |
| "This situation may be similar to that in malignant hyperpyrexia (MH) occurring in mammals." | 1.26 | The chick as a model for malignant hyperpyrexia. ( Korczyn, AD; Shavit, S; Shlosberg, I, 1980) |
| "In connection with malignant hyperthermia the afflicted girl and her blood relations from 4 generations were investigated." | 1.26 | [Malignant hyperthermia. II. Investigation of the patient's family (author's transl)]. ( Plötz, J, 1980) |
| "The key factor in malignant hyperthermia does not seem to be a defect in the calcium-storing membrane of the skeletal and cardiac muscle cells." | 1.26 | [New aspects in the clinical picture of malignant hyperthermia (author's transl)]. ( Junger, H; Kuhnle, P; Schorer, R, 1980) |
| " Modification of the dosage scheme may be advisable." | 1.26 | Pre-anaesthetic administration of dantrolene sodium to a patient at risk from malignant hyperthermia: case report. ( Free, CW; Jaimon, MP, 1978) |
| "Malignant hyperthermia is a dominantly inherited, usually subclinical, disease that occurs in individuals who have an underlying muscular disorder and connotes the gravest possible consequences." | 1.26 | Dantrolene sodium in the management of patients at risk from malignant hyperthermia. ( Bronstein, SL; Mahowald, MC; Ryan, DE; Solomons, CC, 1979) |
| "Malignant hyperthermia is an inherited muscular disorder and a cause of sudden death in afflicted patients." | 1.26 | Malignant hyperthermia. A potentially fatal syndrome in orthopaedic patients. ( Barak, AJ; Connolly, JF; Jardon, OM; Wingard, DW, 1979) |
| "Two patients with successfully treated malignant hyperpyrexia are reported." | 1.26 | Increased carbon dioxide production in two patients with malignant hyperpyrexia and its control by dantolene. ( Liebenschütz, F; Mai, C; Pickerodt, VW, 1979) |
| "We present a case of malignant hyperthermia in which successful management included the intravenous use of dantrolene sodium." | 1.26 | Successful use of dantrolene sodium in human malignant hyperthermia syndrome: a case report. ( Brodsky, JB; Dillingham, MF; Friesen, CM, 1979) |
| "The effect of dantrolene on porcine malignant hyperthermia in the Pietrain pig was studied." | 1.26 | Treatment of porcine malignant hyperpyrexia. The successful use of dantrolene in the Pietrain pig. ( Hall, GM; Lister, D; Lucke, JN, 1977) |
| "When dantrolene was added to supportive therapy, Vo2, lactate, K+, catecholamines, and temperature decreased, and the course of MH was dramatically slowed and, apparently, reversed." | 1.26 | Dantrolene in porcine malignant hyperthermia. ( Gronert, GA; Milde, JH; Theye, RA, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 225 (43.10) | 18.7374 |
| 1990's | 111 (21.26) | 18.2507 |
| 2000's | 70 (13.41) | 29.6817 |
| 2010's | 85 (16.28) | 24.3611 |
| 2020's | 31 (5.94) | 2.80 |
| Authors | Studies |
|---|---|
| Min, JY | 1 |
| Hong, SH | 1 |
| Kim, SJ | 1 |
| Chung, MY | 1 |
| Noda, Y | 2 |
| Mukaida, K | 7 |
| Miyoshi, H | 4 |
| Nakamura, R | 1 |
| Yasuda, T | 3 |
| Saeki, N | 1 |
| Nishino, I | 1 |
| Tsutsumi, YM | 3 |
| Cieniewicz, A | 2 |
| Trzebicki, J | 2 |
| Aires, CCG | 1 |
| de Souza, RRL | 1 |
| Amorim, JA | 1 |
| Santos, FG | 1 |
| Diniz, DA | 1 |
| Carneiro, SCAS | 1 |
| Vasconcellos, RJH | 1 |
| Smith, A | 1 |
| Brandom, B | 2 |
| Miner, L | 1 |
| Henker, R | 1 |
| Caroff, SN | 1 |
| Roberts, CB | 1 |
| Rosenberg, H | 14 |
| Tobin, JR | 1 |
| Watt, S | 2 |
| Mashman, D | 3 |
| Riazi, S | 10 |
| Berkowitz, RM | 1 |
| Ibarra Moreno, CA | 1 |
| Kraeva, N | 5 |
| Zvaritch, E | 1 |
| Jungbluth, H | 2 |
| Voermans, NC | 1 |
| Moon, YJ | 1 |
| Park, J | 1 |
| Kim, JR | 1 |
| Lee, SY | 1 |
| Lee, J | 1 |
| Cho, YG | 1 |
| Kim, DS | 1 |
| Fu, PH | 1 |
| Ho, CN | 1 |
| Toyota, Y | 1 |
| Kondo, T | 2 |
| Shorin, D | 1 |
| Sumii, A | 1 |
| Kido, K | 1 |
| Watanabe, T | 1 |
| Otsuki, S | 1 |
| Kanzaki, R | 2 |
| Horikawa, YT | 1 |
| Xu, H | 1 |
| Wang, Z | 1 |
| Peng, Z | 1 |
| Zhang, J | 1 |
| Li, X | 1 |
| Liu, D | 1 |
| Qi, J | 1 |
| Li, J | 1 |
| Gaburjakova, J | 1 |
| Gaburjakova, M | 1 |
| Minami, S | 1 |
| Ikeda, A | 1 |
| Yamada, K | 1 |
| Kajihama, A | 1 |
| Shimizu, H | 1 |
| Nagafuchi, H | 1 |
| Jung, H | 1 |
| Kim, H | 1 |
| Yu, T | 1 |
| Yeo, J | 1 |
| Shin, WJ | 1 |
| Ri, HS | 1 |
| Kwak, KH | 1 |
| Lim, DG | 1 |
| Kim, S | 1 |
| Larach, MG | 10 |
| Klumpner, TT | 2 |
| Brandom, BW | 7 |
| Vaughn, MT | 2 |
| Belani, KG | 3 |
| Herlich, A | 2 |
| Kim, TW | 2 |
| Limoncelli, J | 2 |
| Sivak, EL | 2 |
| Capacchione, J | 2 |
| Johannsen, S | 5 |
| Schuster, F | 5 |
| Kim, KSM | 1 |
| Kriss, RS | 1 |
| Tautz, TJ | 1 |
| McAvoy, JC | 1 |
| Brodsky, JB | 2 |
| Brock-Utne, J | 1 |
| Bolognino, I | 1 |
| Giangregorio, N | 1 |
| Pisani, L | 1 |
| de Candia, M | 1 |
| Purgatorio, R | 1 |
| Tonazzi, A | 1 |
| Altomare, CD | 1 |
| Cellamare, S | 1 |
| Catto, M | 1 |
| Bongetta, D | 1 |
| De Pirro, A | 1 |
| Iotti, GA | 1 |
| Assietti, R | 1 |
| Almeida, CG | 1 |
| Colleti Junior, J | 1 |
| Storey, M | 1 |
| Hardy, R | 1 |
| Kelly, FE | 1 |
| Glahn, KPE | 1 |
| Bendixen, D | 3 |
| Girard, T | 2 |
| Hopkins, PM | 4 |
| Rüffert, H | 2 |
| Snoeck, MM | 2 |
| Urwyler, A | 2 |
| Laitano, O | 1 |
| Murray, KO | 1 |
| Leon, LR | 1 |
| Bastian, B | 1 |
| Heiderich, S | 1 |
| Klingler, W | 2 |
| García-Muro, C | 1 |
| Sáenz-Moreno, I | 1 |
| Riaño-Méndez, B | 1 |
| Gutiérrez-Delgado, JM | 1 |
| Valencia-Ramos, J | 1 |
| Esteban-Zubero, E | 1 |
| Sheng, C | 1 |
| Yang, C | 1 |
| Jing, Z | 1 |
| Li, Y | 1 |
| Nakashima, K | 1 |
| Matsunaga, Y | 1 |
| Ohara, K | 1 |
| Nie, M | 1 |
| Dalay, S | 1 |
| Jenkins, B | 1 |
| Thacker, A | 1 |
| Patteril, M | 1 |
| McGrady, E | 1 |
| Chiba, N | 1 |
| Matsuzaki, M | 3 |
| Mawatari, T | 1 |
| Mizuochi, M | 1 |
| Sakurai, A | 1 |
| Kinoshita, K | 1 |
| Kakuta, N | 1 |
| Kawanishi, R | 1 |
| Tanaka, K | 1 |
| Morio, A | 1 |
| Gong, X | 1 |
| Miyazaki, N | 1 |
| Kobayashi, T | 1 |
| Komiya, T | 1 |
| Okada, T | 1 |
| Ishida, Y | 1 |
| Fukui, H | 1 |
| Ogihara, Y | 1 |
| Uchino, H | 1 |
| Yoo, SW | 1 |
| Baek, SJ | 1 |
| Kim, DC | 1 |
| Doo, AR | 1 |
| Choi, RH | 1 |
| Koenig, X | 1 |
| Launikonis, BS | 1 |
| Cannon, SC | 1 |
| Chen, W | 2 |
| Koop, A | 1 |
| Liu, Y | 1 |
| Guo, W | 1 |
| Wei, J | 1 |
| Wang, R | 2 |
| MacLennan, DH | 1 |
| Dirksen, RT | 2 |
| Chen, SRW | 1 |
| Magistris, F | 1 |
| Gamble, J | 1 |
| Sams, SH | 1 |
| Revilla, S | 1 |
| Stahl, DL | 1 |
| Li, DW | 1 |
| Lai, PS | 1 |
| Lee, DW | 1 |
| Yong, RY | 1 |
| Lee, TL | 1 |
| Nathan, N | 1 |
| Helf, D | 1 |
| Schneiderbanger, D | 1 |
| Markus, CK | 1 |
| Nelson, EP | 1 |
| Dorlon, ME | 1 |
| Szabo, TA | 1 |
| Trollinger, JB | 1 |
| Johnson-Mann, C | 1 |
| Broderick, G | 1 |
| Warters, RD | 1 |
| Ho, PT | 1 |
| Carvalho, B | 1 |
| Sun, EC | 1 |
| Macario, A | 1 |
| Riley, ET | 1 |
| Wong, CA | 4 |
| Kim, HJ | 1 |
| Koh, WU | 1 |
| Choi, JM | 1 |
| Ro, YJ | 1 |
| Yang, HS | 1 |
| Shi, Y | 2 |
| Wang, Y | 1 |
| Wei, H | 1 |
| Wappler, F | 11 |
| Pfenninger, E | 1 |
| Nelson, TE | 11 |
| Gibbs, IC | 1 |
| Fadahunsi, O | 1 |
| Reid, N | 1 |
| Bonnick, AM | 1 |
| Kuntz, MT | 1 |
| Saab, AD | 1 |
| Kheterpal, S | 1 |
| Kooij, F | 1 |
| Wilczak, J | 1 |
| Soto, R | 1 |
| Berris, J | 1 |
| Price, Z | 1 |
| Lins, S | 1 |
| Coles, P | 1 |
| Harris, JM | 1 |
| Cummings, KC | 1 |
| Berman, MF | 1 |
| Nanamori, M | 1 |
| Adelman, BT | 1 |
| Wedeven, C | 1 |
| LaGorio, J | 1 |
| McCormick, PJ | 1 |
| Tom, S | 1 |
| Aziz, MF | 1 |
| Coffman, T | 1 |
| Ellis, TA | 1 |
| Molina, S | 1 |
| Peterson, W | 1 |
| Mackey, SC | 1 |
| van Klei, WA | 1 |
| Ginde, AA | 1 |
| Biggs, DA | 1 |
| Neuman, MD | 1 |
| Craft, RM | 1 |
| Pace, NL | 1 |
| Paganelli, WC | 1 |
| Durieux, ME | 1 |
| Nair, BJ | 1 |
| Wanderer, JP | 1 |
| Miller, SA | 1 |
| Helsten, DL | 1 |
| Turnbull, ZA | 1 |
| Schonberger, RB | 1 |
| Rosen, GP | 1 |
| Escobar, M | 1 |
| Fumero, P | 1 |
| Viswanath, O | 1 |
| Wright, J | 1 |
| Litman, RS | 3 |
| Smith, VI | 1 |
| Mayes, L | 1 |
| Shukry, M | 2 |
| Theroux, MC | 1 |
| Xu, X | 3 |
| Zhang, Y | 1 |
| Zhou, R | 1 |
| Watanabe, J | 1 |
| Okamoto, K | 1 |
| Ohashi, T | 1 |
| Natsumeda, M | 1 |
| Hasegawa, H | 1 |
| Oishi, M | 1 |
| Miyatake, S | 1 |
| Matsumoto, N | 1 |
| Fujii, Y | 1 |
| Urman, RD | 1 |
| Rajan, N | 1 |
| Belani, K | 1 |
| Gayer, S | 2 |
| Joshi, GP | 3 |
| Zhao, P | 1 |
| Liu, XM | 1 |
| Sun, QC | 1 |
| Cui, YF | 1 |
| Grodofsky, S | 1 |
| Levitt, C | 1 |
| Schlichter, RA | 1 |
| Stanton, DC | 1 |
| Liu, R | 1 |
| Chen, L | 1 |
| Hu, C | 1 |
| Wijeysundera, D | 1 |
| Massey, C | 1 |
| Tsujikawa, H | 1 |
| Segawa, H | 1 |
| Fukuda, K | 1 |
| Aderibigbe, T | 1 |
| Lang, BH | 2 |
| Chen, Q | 1 |
| Li, G | 2 |
| Boet, S | 1 |
| Pinyavat, T | 1 |
| Brady, JE | 1 |
| Sun, LS | 1 |
| Metterlein, T | 1 |
| Graf, BM | 1 |
| Anetseder, M | 1 |
| Itoh, K | 1 |
| Nishibe, S | 1 |
| Usuda, Y | 1 |
| Kitamura, A | 1 |
| Taffarel, P | 1 |
| Koffman, F | 1 |
| Zifferman, A | 1 |
| Degiuseppe, S | 1 |
| Mansilla, A | 1 |
| Darduin, M | 1 |
| Acerenza, M | 1 |
| Just, KS | 1 |
| Gerbershagen, MU | 6 |
| Grensemann, J | 1 |
| Oo, YW | 1 |
| Gomez-Hurtado, N | 1 |
| Walweel, K | 1 |
| van Helden, DF | 1 |
| Imtiaz, MS | 1 |
| Knollmann, BC | 1 |
| Laver, DR | 1 |
| Timmins, MA | 1 |
| Sterling, C | 1 |
| Galgano, M | 1 |
| Briggs, D | 1 |
| Marawar, S | 1 |
| Calancie, B | 1 |
| Bamaga, AK | 1 |
| Amburgey, K | 1 |
| Ong, S | 1 |
| Halliday, W | 1 |
| Diamandis, P | 1 |
| Guerguerian, AM | 1 |
| Dowling, JJ | 1 |
| Yoon, G | 1 |
| Zavilla, CM | 1 |
| Skledar, S | 1 |
| Lang, MB | 1 |
| Gross, C | 1 |
| Traynor, K | 1 |
| Lopez, RJ | 1 |
| Byrne, S | 1 |
| Vukcevic, M | 1 |
| Sekulic-Jablanovic, M | 1 |
| Xu, L | 1 |
| Brink, M | 1 |
| Alamelu, J | 1 |
| Voermans, N | 1 |
| Snoeck, M | 1 |
| Clement, E | 1 |
| Muntoni, F | 1 |
| Zhou, H | 1 |
| Radunovic, A | 1 |
| Mohammed, S | 1 |
| Wraige, E | 1 |
| Zorzato, F | 1 |
| Treves, S | 1 |
| MacKay, EJ | 1 |
| Wilkerson, C | 1 |
| Kennedy, T | 1 |
| Cummings, T | 1 |
| Der, T | 1 |
| Karsli, C | 1 |
| Kollmann-Camaiora, A | 1 |
| Alsina, E | 1 |
| Domínguez, A | 1 |
| Del Blanco, B | 1 |
| Yepes, MJ | 1 |
| Guerrero, JL | 1 |
| García, A | 1 |
| Butala, BN | 1 |
| Kang, A | 1 |
| Guron, J | 1 |
| Desai, MS | 1 |
| Vila, H | 1 |
| Bunting, B | 1 |
| Knight, J | 1 |
| McHugh, SM | 1 |
| Liu, ST | 1 |
| Liu, LF | 1 |
| Wang, SY | 1 |
| Laureano Filho, JR | 1 |
| de Oliveira Neto, PJ | 1 |
| Duarte, N | 1 |
| Caetana, A | 1 |
| Chagas, Ada S | 1 |
| DeJohn, P | 1 |
| Plurad, D | 1 |
| Blaschke, G | 1 |
| Jones, S | 1 |
| Pfeiffer, J | 1 |
| Nakamura, N | 1 |
| Ueda, T | 1 |
| Ishikawa, R | 1 |
| Tasaka, Y | 1 |
| Fukuuchi, K | 1 |
| Sato, N | 2 |
| Martin, Y | 1 |
| Smith-Erichsen, N | 1 |
| Dainese, M | 1 |
| Quarta, M | 1 |
| Lyfenko, AD | 1 |
| Paolini, C | 1 |
| Canato, M | 1 |
| Reggiani, C | 1 |
| Protasi, F | 1 |
| Kobayashi, S | 3 |
| Yano, M | 2 |
| Suetomi, T | 2 |
| Ono, M | 2 |
| Tateishi, H | 2 |
| Mochizuki, M | 1 |
| Uchinoumi, H | 2 |
| Okuda, S | 2 |
| Yamamoto, T | 2 |
| Koseki, N | 1 |
| Kyushiki, H | 1 |
| Ikemoto, N | 2 |
| Schleelein, LE | 1 |
| Stratman, RC | 1 |
| Flynn, JD | 1 |
| Hatton, KW | 1 |
| Gronert, GA | 11 |
| Allen, GC | 5 |
| Lehman, EB | 1 |
| Shih, TH | 1 |
| Chen, KH | 1 |
| Pao, YY | 1 |
| Yang, SC | 1 |
| Chen, CL | 1 |
| Huang, CJ | 1 |
| Wang, CH | 1 |
| Jawan, B | 1 |
| Cheng, KW | 1 |
| Yang, CH | 1 |
| Toppin, PJ | 1 |
| Chandy, TT | 1 |
| Ghanekar, A | 1 |
| Beattie, WS | 1 |
| Corvetto, MA | 2 |
| Taekman, JM | 1 |
| Setzer-Saade, N | 1 |
| Susa, T | 1 |
| Oda, T | 1 |
| Doi, M | 1 |
| Rueffert, H | 1 |
| Chen, MS | 1 |
| Young, MC | 1 |
| Kugler, Y | 1 |
| Russell, WJ | 1 |
| Schütte, JK | 2 |
| Becker, S | 2 |
| Burmester, S | 1 |
| Starosse, A | 2 |
| Lenz, D | 1 |
| Kröner, L | 1 |
| Lichtor, JL | 1 |
| Parness, J | 4 |
| Woehlck, H | 1 |
| Block, FE | 1 |
| Sugiyama, K | 1 |
| Toya, A | 1 |
| Shimomatsu, K | 1 |
| Saitoh, Y | 1 |
| Manabe, Y | 1 |
| Kohjitani, A | 1 |
| Patil, PM | 1 |
| Dirksen, SJ | 1 |
| Metz, KM | 1 |
| Policastro, MA | 1 |
| Valedon, A | 1 |
| Watson, CB | 2 |
| Migita, T | 3 |
| Kobayashi, M | 2 |
| Hamada, H | 2 |
| Kawamoto, M | 3 |
| Russell, T | 1 |
| Steel, A | 1 |
| Huang, C | 1 |
| Ahn, W | 1 |
| Guo, Q | 1 |
| Johns, CD | 1 |
| Stoudt, RS | 1 |
| Scholtis, MP | 1 |
| Gavel, T | 1 |
| Montaña, R | 1 |
| Bravo, MP | 1 |
| Altermatt, FR | 1 |
| Kamitani, K | 1 |
| Yoshida, H | 1 |
| Arai, R | 1 |
| Matsuura, K | 1 |
| Kuroda, Y | 1 |
| Schäfer, U | 1 |
| Oldewurtel, C | 1 |
| Singler, P | 1 |
| Richard, A | 1 |
| Haslego, SS | 1 |
| Heggie, JE | 1 |
| Hoenemann, CW | 1 |
| Halene-Holtgraeve, TB | 1 |
| Booke, M | 1 |
| Hinder, F | 1 |
| Daudel, F | 1 |
| Reich, A | 1 |
| Van Aken, H | 1 |
| Chartrand, D | 1 |
| Bouhajja, B | 1 |
| Haddad, F | 1 |
| Ben Ammar, MS | 1 |
| Harrison, G | 1 |
| Fiege, M | 5 |
| Krause, T | 2 |
| Agarwal, K | 1 |
| Green, G | 1 |
| Glahn, KP | 1 |
| Hollander, AS | 1 |
| Olney, RC | 1 |
| Blackett, PR | 1 |
| Marshall, BA | 1 |
| Halliday, NJ | 1 |
| Zimprich, F | 1 |
| Kress, HG | 2 |
| Zeitlhofer, J | 1 |
| Weisshorn, R | 2 |
| Menge, M | 1 |
| Schulte Am Esch, J | 6 |
| Ali, SZ | 1 |
| Taguchi, A | 2 |
| Arakawa, Y | 1 |
| Kuroiwa, M | 1 |
| Anzai, T | 1 |
| Kanai, A | 1 |
| Okamoto, H | 1 |
| Hoka, S | 1 |
| Rusyniak, DE | 1 |
| Banks, ML | 1 |
| Mills, EM | 1 |
| Sprague, JE | 1 |
| Linazasoro, G | 1 |
| Van Blercom, N | 1 |
| Castro, A | 1 |
| Dapena, MD | 1 |
| Jonassen, AA | 1 |
| Petersen, AJ | 1 |
| Mohr, S | 1 |
| Andersson, C | 1 |
| Skattum, J | 1 |
| Kvernebo, K | 1 |
| Paulsen, OG | 1 |
| Stokland, O | 1 |
| Kirkebøen, KA | 1 |
| Sun, WZ | 1 |
| Yeh, HM | 1 |
| Yip, WH | 1 |
| Mingi, CL | 1 |
| Ooi, SJ | 1 |
| Chen, SC | 1 |
| Chiang, YY | 1 |
| Muldoon, S | 1 |
| Deuster, P | 1 |
| Bunger, R | 1 |
| Bannister, ML | 1 |
| Gangopadhyay, JP | 1 |
| Hamada, T | 1 |
| Chang, KY | 1 |
| Ting, CK | 1 |
| Chan, KH | 1 |
| Tsai, SK | 1 |
| Hausfater, P | 1 |
| Murakawa, T | 1 |
| Sakai, I | 1 |
| Matsuki, A | 1 |
| Inada, H | 1 |
| Jinno, S | 1 |
| Kohase, H | 1 |
| Fukayama, H | 1 |
| Umino, M | 1 |
| Fukami, MC | 1 |
| Ganzberg, SI | 1 |
| Carter-Templeton, H | 1 |
| Haugen, T | 1 |
| Toft, M | 1 |
| Müller, CR | 1 |
| Aasly, J | 1 |
| Podranski, T | 1 |
| Bouillon, T | 1 |
| Schumacher, PM | 1 |
| Sessler, DI | 2 |
| Kurz, A | 1 |
| Hommertzheim, R | 1 |
| Steinke, EE | 1 |
| Kilbane, BJ | 1 |
| Mehta, S | 1 |
| Backeljauw, PF | 1 |
| Shanley, TP | 1 |
| Crimmins, NA | 1 |
| Guruli, ZV | 1 |
| Ramadhyani, U | 1 |
| Adamson, PA | 1 |
| Dahiya, R | 1 |
| Litner, JA | 1 |
| Vosu, H | 1 |
| Harrison, TK | 1 |
| Manser, T | 1 |
| Howard, SK | 1 |
| Gaba, DM | 1 |
| Yoganathan, T | 1 |
| Casthely, PA | 1 |
| Lamprou, M | 1 |
| Burkman, JM | 1 |
| Posner, KL | 1 |
| Domino, KB | 1 |
| Yuge, O | 2 |
| Baker, KR | 1 |
| Landriscina, D | 1 |
| Kartchner, H | 1 |
| Mirkes, DM | 1 |
| Picard, J | 1 |
| Ward, S | 1 |
| Meek, T | 1 |
| Morota, T | 1 |
| Endo, K | 1 |
| Furuta, S | 1 |
| Obara, S | 1 |
| Ohmuzo, H | 1 |
| Kaneko, T | 1 |
| Onuma, T | 1 |
| Watanabe, K | 1 |
| Newmark, JL | 1 |
| Voelkel, M | 1 |
| Wu, J | 1 |
| Noble, KA | 1 |
| Sudo, RT | 3 |
| Carmo, PL | 1 |
| Trachez, MM | 1 |
| Zapata-Sudo, G | 2 |
| Ichihara, Y | 1 |
| Kikuchi, H | 1 |
| Fernandes, CR | 1 |
| Azevedo, DM | 1 |
| Gomes, JM | 1 |
| Gonçalves, BP | 1 |
| Coelho, GR | 1 |
| Vasconcelos, JB | 1 |
| Garcia, JH | 1 |
| Cherednichenko, G | 1 |
| Ward, CW | 1 |
| Feng, W | 1 |
| Cabrales, E | 1 |
| Michaelson, L | 1 |
| Samso, M | 1 |
| López, JR | 10 |
| Allen, PD | 5 |
| Pessah, IN | 2 |
| Jiang, D | 1 |
| Xiao, J | 1 |
| Kong, H | 1 |
| Jones, PP | 1 |
| Zhang, L | 1 |
| Fruen, B | 1 |
| Chen, SR | 1 |
| Boles, JM | 1 |
| Lecam, B | 1 |
| Mialon, P | 1 |
| Pennec, Y | 1 |
| Garre, M | 1 |
| Goekoop, JG | 1 |
| Carbaat, PA | 1 |
| Daoudai, P | 1 |
| Delacour, JL | 1 |
| Coons, DJ | 1 |
| Hillman, FJ | 1 |
| Marshall, RW | 1 |
| Pera, J | 1 |
| Decoux, M | 1 |
| Guyon, M | 1 |
| Sage, M | 1 |
| Henderson, VW | 1 |
| French, MM | 1 |
| Phillips, KF | 1 |
| White, MD | 2 |
| Collins, JG | 1 |
| Denborough, MA | 13 |
| Di Prospero, S | 1 |
| Bianchi, S | 1 |
| Di Lazzaro, M | 1 |
| Camilli-Giammei, T | 1 |
| Nissen, RL | 1 |
| Yonkers, AJ | 1 |
| Byrd, JP | 1 |
| Flewellen, EH | 7 |
| Schulte-Sasse, U | 8 |
| Eberlein, HJ | 9 |
| Blanck, TJ | 1 |
| Gruener, RP | 1 |
| Gallant, EM | 3 |
| Ahern, CP | 2 |
| Britt, BA | 4 |
| Willner, J | 1 |
| Baudendistel, L | 1 |
| Goudsouzian, N | 1 |
| Cote', C | 1 |
| Strafford, M | 1 |
| Cupryn, JP | 1 |
| Kennedy, A | 1 |
| Byrick, RJ | 1 |
| Ellis, FR | 4 |
| Nagase, M | 1 |
| Naganuma, Y | 1 |
| Ryo, K | 1 |
| Kawashima, Y | 1 |
| Eliet, B | 1 |
| Carmes, C | 1 |
| Rochet, D | 1 |
| Eustratiades, N | 1 |
| Quesnel, J | 1 |
| Fuerst, DL | 1 |
| Toth, AJ | 1 |
| Adriani, J | 1 |
| Sundin, R | 1 |
| Jones, WP | 1 |
| Arens, JF | 1 |
| Wagner, DL | 1 |
| Haber, J | 1 |
| Hammer, DJ | 1 |
| Butler, B | 1 |
| Hess, W | 1 |
| Cooper, JM | 1 |
| Jones, HR | 1 |
| Williamson, JW | 1 |
| Wagner, W | 1 |
| Feldmann, E | 1 |
| Ruhland, G | 1 |
| Hinkle, AJ | 1 |
| Scott, E | 1 |
| Frodis, W | 1 |
| Clements, MJ | 1 |
| Endrenyi, L | 1 |
| Verburg, MP | 2 |
| Oerlemans, FT | 1 |
| van Bennekom, CA | 1 |
| Gielen, MJ | 2 |
| de Bruyn, CH | 1 |
| Crul, JF | 1 |
| Stadhouders, AM | 1 |
| Viering, WA | 1 |
| Ruitenbeek, W | 1 |
| Sengers, RC | 1 |
| Younker, D | 1 |
| DeVore, M | 1 |
| Hartlage, P | 1 |
| Heffron, JJ | 2 |
| Rommelsheim, K | 1 |
| Lauven, P | 1 |
| Westhofen, P | 1 |
| Stenger, I | 1 |
| Stoeckel, H | 1 |
| Brownell, AK | 1 |
| Paasuke, RT | 1 |
| Elash, A | 1 |
| Fowlow, SB | 1 |
| Seagram, CG | 1 |
| Diewold, RJ | 1 |
| Friesen, C | 1 |
| Wingard, DW | 2 |
| Kelfer, HM | 1 |
| Singer, WD | 1 |
| Reynolds, RN | 1 |
| Johnson, GC | 1 |
| Santos, AB | 1 |
| Manley, SV | 1 |
| Kelly, AB | 1 |
| Hodgson, D | 1 |
| Halsall, PJ | 2 |
| Plötz, J | 2 |
| Ohnishi, ST | 3 |
| Taylor, S | 1 |
| Tarnow, J | 1 |
| Gever, LN | 1 |
| Rosenburg, H | 1 |
| Gallagher, DM | 2 |
| Hyer, RL | 1 |
| Anderson, IL | 2 |
| Rawstron, RE | 1 |
| Dunlop, DJ | 1 |
| Hall, GM | 6 |
| Lucke, JN | 5 |
| Lister, D | 5 |
| Mozley, PD | 1 |
| Mayzner-Zawadzka, E | 2 |
| Kolb, ME | 1 |
| Horne, ML | 1 |
| Martz, R | 1 |
| Forrest, WH | 1 |
| Gohil, P | 1 |
| Forman, WM | 1 |
| de Rohan Chabot, P | 1 |
| Elkharrat, D | 1 |
| Conso, F | 1 |
| Bismuth, C | 1 |
| Goulon, M | 1 |
| Franks, RD | 1 |
| Aoueille, B | 1 |
| Mahowald, MC | 2 |
| Masson, N | 1 |
| Grote, B | 2 |
| Schuh, FT | 2 |
| Maier, C | 1 |
| Bernhardt, D | 1 |
| Dolan, PF | 1 |
| Harrison, GG | 7 |
| Chapman, DC | 1 |
| Hoffmann-Lundgren, B | 1 |
| Kühn, K | 1 |
| Hausdörfer, J | 1 |
| Sullivan, JS | 1 |
| Galloway, GJ | 1 |
| Fletcher, R | 1 |
| Blennow, G | 1 |
| Olsson, AK | 1 |
| Ranklev, E | 1 |
| Törnebrandt, K | 1 |
| Orchard, C | 1 |
| Lovell, R | 1 |
| Thompson, RL | 1 |
| Onofrio, BM | 1 |
| Bloom, DA | 1 |
| Iwamoto, K | 1 |
| Reynolds, RC | 1 |
| Ehrlich, RM | 1 |
| Schvaneveldt, JA | 1 |
| Stankiewicz, JA | 1 |
| Drechsler, H | 1 |
| Bagshaw, RJ | 1 |
| Cox, RH | 1 |
| Felice-Johnson, J | 1 |
| Sudds, T | 1 |
| Bennett, G | 1 |
| Harvengt, C | 1 |
| Waterman, PM | 1 |
| Ording, HO | 1 |
| Anderson, TE | 1 |
| Drummond, DS | 1 |
| Breed, AL | 1 |
| Taylor, CA | 1 |
| Waldron-Mease, E | 1 |
| Klein, LV | 1 |
| Leitch, M | 1 |
| Aldrete, JA | 1 |
| Bee, DE | 1 |
| Korczyn, AD | 1 |
| Shavit, S | 1 |
| Shlosberg, I | 1 |
| Okumura, F | 1 |
| Crocker, BD | 1 |
| Lambert, W | 1 |
| Fairhurst, AS | 1 |
| Hamamoto, V | 1 |
| Macri, J | 1 |
| Hoff, B | 1 |
| Taylor, C | 1 |
| Kruel, J | 1 |
| Junger, H | 1 |
| Kuhnle, P | 1 |
| Schorer, R | 1 |
| Fitzgibbons, DC | 1 |
| Landauer, B | 1 |
| Boshoff, L | 1 |
| Tonner, PH | 1 |
| Scholz, J | 3 |
| Richter, A | 2 |
| Löscher, W | 2 |
| Steinfath, M | 2 |
| Wlaz, P | 1 |
| Hadji, B | 1 |
| Roewer, N | 4 |
| Steele, AP | 1 |
| Imrie, MM | 1 |
| Rutherford, AM | 1 |
| Bradley, WN | 1 |
| Young, MS | 1 |
| Kindred, D | 1 |
| Fletcher, JE | 1 |
| Bello, N | 1 |
| Adnet, P | 6 |
| Saulnier, F | 1 |
| Lestavel, P | 1 |
| Adnet-Bonte, C | 1 |
| Reyford, H | 1 |
| Etchrivi, T | 1 |
| Tavernier, B | 1 |
| Krivosic-Horber, R | 7 |
| Carr, AS | 1 |
| Lerman, J | 2 |
| Cunliffe, M | 1 |
| McLeod, ME | 2 |
| Lenzen, C | 1 |
| Köchling, A | 2 |
| Stranix, ND | 1 |
| Hutchinson, R | 1 |
| Liversidge, P | 1 |
| Ssenoga, A | 1 |
| Clark, NJ | 1 |
| Gerdes, C | 1 |
| Poulsen, TD | 1 |
| Knudsen, F | 1 |
| Nielsen, J | 1 |
| Ording, H | 3 |
| Wedel, DJ | 3 |
| Quinlan, JG | 3 |
| Iaizzo, PA | 4 |
| Ebert, RJ | 1 |
| Lucy, SJ | 1 |
| DeRuyter, ML | 1 |
| Berge, KH | 1 |
| Klont, RE | 1 |
| Lambooy, E | 1 |
| van Logtestijn, JG | 1 |
| Sümpelmann, R | 1 |
| Bötel, C | 1 |
| Zimmermann, M | 1 |
| Krohn, S | 1 |
| Strauss, JM | 1 |
| Paul, T | 1 |
| Logi, G | 1 |
| Tanteri, M | 1 |
| Lucchesi, AM | 1 |
| Pellegrini, F | 1 |
| Roncucci, P | 1 |
| Heiman-Patterson, TD | 2 |
| Hassall, PJ | 1 |
| Semmler, A | 1 |
| Rieger, C | 1 |
| Lesinski, R | 1 |
| Bichel, T | 1 |
| Canivet, JL | 1 |
| Damas, P | 1 |
| Lamy, M | 1 |
| Stemp, LI | 1 |
| Kochs, E | 1 |
| Hoffman, WE | 1 |
| Strazis, KP | 1 |
| Fox, AW | 1 |
| Abballe, C | 1 |
| Primieri, P | 1 |
| De Cosmo, G | 1 |
| Ecker-Schlipf, B | 1 |
| Goto, S | 1 |
| Ogata, K | 1 |
| Fujie, T | 1 |
| Fujigaki, T | 1 |
| Nakamura, H | 2 |
| Yukinari, T | 1 |
| Shibata, O | 1 |
| Pérez, C | 1 |
| Linares, N | 2 |
| Allen, P | 4 |
| Terzic, A | 1 |
| Wackym, PA | 1 |
| Blackwell, KE | 1 |
| Karan, SM | 1 |
| Lojeski, EW | 1 |
| Haynes, DH | 1 |
| Bina, S | 1 |
| Wesche, DL | 1 |
| Boedeker, BH | 1 |
| Muldoon, SM | 1 |
| Rivera, PH | 1 |
| Worley, C | 1 |
| Goss, JA | 1 |
| Brennan, DC | 1 |
| Miller, BT | 1 |
| Shenoy, S | 1 |
| McClure, S | 1 |
| Howard, TK | 1 |
| Flye, MW | 1 |
| Lynch, C | 1 |
| Lin, M | 1 |
| Guyton, D | 1 |
| Muiños, PA | 1 |
| Ortells, MA | 1 |
| Sánchez, G | 1 |
| Carrasco, MS | 1 |
| Byrd, RP | 1 |
| Lukeman, RW | 1 |
| Mathai, M | 1 |
| Mathew, MK | 1 |
| Bjurström, S | 2 |
| Carlsten, J | 2 |
| Jönsson, L | 2 |
| Owen, VJ | 1 |
| Taske, NL | 1 |
| Lamb, GD | 1 |
| Hopkinson, KC | 3 |
| Ben Abraham, R | 2 |
| Cahana, A | 1 |
| Krivosic-Horber, RM | 1 |
| Perel, A | 3 |
| Konishi, K | 1 |
| Fujimoto, K | 1 |
| Kubota, M | 1 |
| Ogawa, H | 1 |
| Storella, RJ | 1 |
| Keykhah, MM | 1 |
| Smith, CA | 1 |
| Carvill, KA | 1 |
| Eckert, T | 1 |
| Michalek-Sauberer, A | 2 |
| Fricker, R | 1 |
| Gradwohl, I | 1 |
| Gilly, H | 2 |
| Palnitkar, SS | 1 |
| Mickelson, JR | 1 |
| Louis, CF | 2 |
| Neff, SP | 1 |
| Futter, ME | 1 |
| Anderson, BJ | 1 |
| Pollock, AN | 1 |
| McKenzie, AJ | 1 |
| Hodges, M | 2 |
| Plötz, FB | 1 |
| Waalkens, HJ | 1 |
| Verkade, HJ | 1 |
| von Richthofen, V | 1 |
| Lambrecht, W | 1 |
| Madi-Jebara, S | 1 |
| Yazbeck, P | 1 |
| Bou-Khalil, M | 1 |
| Cherfane, A | 1 |
| Antakly, MC | 1 |
| Wraith, A | 1 |
| Stolworthy, C | 1 |
| Haas, RE | 1 |
| Glauber, V | 2 |
| Kasamatsu, Y | 1 |
| Osada, M | 1 |
| Ashida, K | 1 |
| Azukari, K | 1 |
| Yoshioka, K | 1 |
| Ohsawa, A | 1 |
| Vermette, E | 1 |
| Tsujimoto, S | 1 |
| Maeda, K | 1 |
| Sugiyama, T | 1 |
| Yokochi, A | 1 |
| Chikusa, H | 1 |
| Maruyama, K | 1 |
| Chia, YY | 1 |
| Liu, YC | 1 |
| Lee, MC | 1 |
| Lo, Y | 1 |
| Liu, K | 1 |
| Brubaker, CL | 1 |
| Strecker, G | 1 |
| Forget, AP | 2 |
| Halle, I | 1 |
| Fricker, RM | 1 |
| Hoerauf, KH | 1 |
| Drewe, J | 1 |
| Denborough, M | 2 |
| Portel, L | 1 |
| Hilbert, G | 1 |
| Gruson, D | 1 |
| Favier, JC | 1 |
| Gbikpi-Benissan, G | 1 |
| Cardinaud, JP | 1 |
| Chastonay, P | 1 |
| Bracco, D | 1 |
| Freymond, D | 1 |
| Ravussin, P | 1 |
| Hall, LW | 1 |
| Martín i López, MA | 1 |
| Pérez i García, A | 1 |
| Sánchez i Pallarés, M | 1 |
| Oferil i Riera, F | 1 |
| Heggie, J | 1 |
| Short, JA | 1 |
| Cooper, CM | 1 |
| Antz, M | 1 |
| Couty, E | 1 |
| Abenhaim, L | 1 |
| Cordovez, G | 1 |
| Lane, JE | 1 |
| Brooks, AG | 1 |
| Logan, MS | 1 |
| Newman, WH | 1 |
| Castresana, MR | 1 |
| Nishioka, H | 1 |
| Kinuwaki, H | 1 |
| Shimoda, O | 1 |
| Terasaki, H | 1 |
| Sandlin, D | 1 |
| Kozack, JK | 1 |
| MacIntyre, DL | 1 |
| Nishiyama, K | 1 |
| Kitahara, A | 1 |
| Natsume, H | 1 |
| Matsushita, A | 1 |
| Nakano, K | 1 |
| Sasaki, S | 1 |
| Genma, R | 1 |
| Yamamoto, Y | 1 |
| Balog, EM | 1 |
| Fruen, BR | 1 |
| Kinouchi, K | 1 |
| Okawa, M | 1 |
| Fukumitsu, K | 1 |
| Tachibana, K | 1 |
| Kitamura, S | 1 |
| Taniguchi, A | 1 |
| Free, CW | 1 |
| Jaimon, MP | 1 |
| Bronstein, SL | 1 |
| Ryan, DE | 1 |
| Solomons, CC | 1 |
| Jardon, OM | 1 |
| Barak, AJ | 1 |
| Connolly, JF | 1 |
| Liebenschütz, F | 1 |
| Mai, C | 1 |
| Pickerodt, VW | 1 |
| Friesen, CM | 1 |
| Dillingham, MF | 1 |
| Relton, JE | 1 |
| Ryan, JF | 3 |
| Isaacs, H | 1 |
| Fisk, GC | 1 |
| Austin, KL | 1 |
| Milde, JH | 3 |
| Theye, RA | 2 |
| Krawczyńska-Wichrzycka, R | 1 |
| Kwiatkowski, H | 1 |
| Kamiński, B | 1 |
| Jones, EW | 1 |
| el-Hayek, R | 1 |
| Valdivia, HH | 1 |
| Coronado, R | 1 |
| Hogan, K | 1 |
| Holland, M | 1 |
| Williams, JH | 1 |
| Lee, JC | 1 |
| Pollock, N | 1 |
| Sendall, J | 1 |
| Katz, DN | 1 |
| Schwid, HA | 1 |
| O'Donnell, D | 1 |
| Yentis, SM | 1 |
| Levine, MF | 1 |
| Hartley, EJ | 1 |
| Gaillard, S | 1 |
| Rock, E | 1 |
| Vignon, X | 1 |
| Dufourc, EJ | 1 |
| Renou, JP | 1 |
| Johnson, C | 1 |
| Edleman, KJ | 1 |
| Moore, JL | 1 |
| Rice, EL | 1 |
| Gerardi, A | 1 |
| Lopez, MJ | 1 |
| Spirt, MJ | 1 |
| Chan, W | 1 |
| Thieberg, M | 1 |
| Sachar, DB | 1 |
| Hetherington, N | 1 |
| Larner, AJ | 1 |
| Broekema, AA | 1 |
| Boersma, GA | 1 |
| Hennis, PJ | 1 |
| Striebel, HW | 1 |
| Lechner, J | 1 |
| Wiegand, C | 1 |
| Hartung, E | 1 |
| Eldar, I | 1 |
| Goldberg, G | 1 |
| Foster, PS | 3 |
| Payne, N | 1 |
| Comunale, ME | 1 |
| DiNardo, JA | 1 |
| Schwartz, MJ | 1 |
| Sailer, R | 1 |
| Hinrichs, B | 1 |
| Mantel, K | 1 |
| Hard, C | 1 |
| Kentsch, M | 1 |
| Kunze, KP | 1 |
| Kuck, KH | 1 |
| Ezri, T | 1 |
| Soroker, D | 1 |
| López, M | 1 |
| McSweeney, DM | 1 |
| Grillo, PP | 1 |
| Valverde, A | 1 |
| Boyd, CJ | 1 |
| Dyson, DH | 1 |
| Pascoe, PJ | 1 |
| Hackl, W | 1 |
| Mauritz, W | 1 |
| Winkler, M | 1 |
| Sporn, P | 1 |
| Steinbereithner, K | 1 |
| Wajon, P | 1 |
| Kaukonen, L | 1 |
| Hoffman, RS | 1 |
| Girard, JF | 1 |
| Funel, MT | 1 |
| Vincent, G | 1 |
| Sanchez, V | 1 |
| Lopez, I | 1 |
| Mendoza, M | 1 |
| Sreter, FA | 2 |
| Ashby, D | 1 |
| Lascault, G | 1 |
| Waxman, MB | 1 |
| Grosgogeat, Y | 1 |
| Waring, AJ | 1 |
| Fang, SR | 1 |
| Horiuchi, K | 1 |
| Flick, JL | 1 |
| Sadanaga, KK | 1 |
| Ohnishi, T | 1 |
| Spiess-Kiefer, C | 1 |
| Hippius, H | 1 |
| Cain, AG | 1 |
| Bell, AD | 1 |
| Jacquot, C | 3 |
| Stieglitz, P | 4 |
| Amiel, I | 1 |
| Nivoche, Y | 2 |
| Lehmann-Horn, F | 1 |
| Taylor, SR | 2 |
| Turpin, IM | 1 |
| Manino, J | 1 |
| Harioka, T | 1 |
| Sone, T | 1 |
| Toda, H | 1 |
| Miyake, C | 1 |
| Driessen, JJ | 2 |
| Wuis, EW | 2 |
| Jenkins, LC | 1 |
| Scoates, PJ | 1 |
| Levenson, JL | 1 |
| Gibb, WR | 1 |
| Lees, AJ | 1 |
| Tuman, KJ | 1 |
| Spiess, BD | 1 |
| Ivankovich, AD | 1 |
| Wergowske, GL | 1 |
| Carmody, TJ | 1 |
| Sorosky, JI | 1 |
| Ingardia, CJ | 1 |
| Botti, JJ | 1 |
| Cattran, CB | 2 |
| Bennett, MH | 1 |
| Wainwright, AP | 1 |
| Strong, HA | 1 |
| Larach, DR | 1 |
| High, KM | 1 |
| Hensley, FA | 1 |
| Martin, DE | 1 |
| Williams, DR | 1 |
| Radwan, HE | 1 |
| Juneja, M | 1 |
| Joseph, M | 1 |
| Peterson, RG | 1 |
| Lalande, M | 1 |
| Hayakawa, A | 1 |
| Shimonaka, H | 1 |
| Uematsu, H | 1 |
| Yamamoto, M | 1 |
| Materson, BJ | 1 |
| Preston, RA | 1 |
| Shime, J | 1 |
| Gare, D | 1 |
| Andrews, J | 1 |
| Britt, B | 1 |
| Kemp, DR | 1 |
| Choong, LS | 1 |
| Häggendal, J | 1 |
| Johansson, G | 1 |
| Houvenaeghel, M | 1 |
| Achilli-Cornesse, E | 1 |
| Jullian-Papouin, H | 1 |
| Martin-Meyssonier, A | 1 |
| Manelli, JC | 1 |
| Welfringer, P | 1 |
| Cornet, C | 1 |
| Kozak-Reiss, G | 1 |
| Laxenaire, MC | 1 |
| Lienhart, A | 1 |
| Shindoh, M | 1 |
| Enomoto, K | 1 |
| Tatekawa, S | 1 |
| Yukioka, H | 1 |
| Yoshimoto, N | 1 |
| Fujimori, M | 1 |
| Eichhorn, JH | 1 |
| Tomarken, JL | 1 |
| Alamo, L | 3 |
| Jones, D | 2 |
| Taskalos, I | 1 |
| Hargrove, JC | 1 |
| San Juan, AC | 1 |
| Wong, KC | 1 |
| Port, JD | 1 |
| Hara, Y | 1 |
| Kato, A | 1 |
| Horikawa, H | 1 |
| Kato, Y | 1 |
| Ichiyanagi, K | 1 |
| Jones, DE | 1 |
| Sreter, F | 1 |
| Landymore, RW | 1 |
| Allen, C | 1 |
| Johnstone, D | 1 |
| Wood, J | 1 |
| Ward, A | 1 |
| Chaffman, MO | 1 |
| Sorkin, EM | 1 |
| Haddad, FS | 1 |
| Medina, P | 1 |
| Mora, CT | 2 |
| Eisenkraft, JB | 2 |
| Oikkonen, M | 1 |
| Rosenberg, PH | 1 |
| Björkenheim, JM | 1 |
| Paetau, A | 1 |
| Huopaniemi, T | 1 |
| Jantzen, JP | 2 |
| Erdmann, K | 1 |
| Kleemann, PP | 1 |
| Greany, D | 1 |
| Brown, MM | 1 |
| Jordan, LM | 1 |
| Thomas, DW | 1 |
| Dev, VJ | 1 |
| Whitehead, MJ | 1 |
| Souza, MR | 1 |
| Zapata, G | 1 |
| Suarez-Kurtz, G | 1 |
| Douglas, MJ | 1 |
| McMorland, GH | 1 |
| Rutberg, H | 1 |
| Håkanson, E | 1 |
| MacGillivray, RG | 1 |
| Jann, H | 1 |
| Vanker, E | 1 |
| Gemmell, L | 1 |
| Mahomedy, AE | 1 |
| Reierson, N | 1 |
| Norfleet, EA | 1 |
| Evers, J | 1 |
| Vree, TB | 1 |
| van der Kleyn, E | 1 |
| Guevart, E | 1 |
| Theunynck, D | 2 |
| Vincent, A | 1 |
| Rubin, AS | 1 |
| Zablocki, AD | 1 |
| Gravenstein, MA | 1 |
| Lydon, JC | 1 |
| Uttech, K | 1 |
| Weingarten, AE | 1 |
| Korsh, JI | 1 |
| Neuman, GG | 1 |
| Stern, SB | 1 |
| Hein, HA | 1 |
| Waite, PD | 1 |
| Ballard, JB | 1 |
| Yonfa, A | 1 |
| Guzé, BH | 1 |
| Baxter, LR | 1 |
| Papatestas, AE | 1 |
| Souliere, CR | 1 |
| Weintraub, SJ | 1 |
| Kirchner, JC | 1 |
| Thiagarajah, S | 1 |
| Komar, K | 1 |
| Martin, ML | 1 |
| Lucid, EJ | 1 |
| Walker, RW | 1 |
| Renfordt, E | 1 |
| Wardin, B | 1 |
| Scholtes, JL | 1 |
| Gribomont, BF | 1 |
| Ehler, WJ | 1 |
| Mack, JW | 1 |
| Brown, DL | 1 |
| Davis, RF | 1 |
| Foldes, FF | 1 |
| Rempel, WE | 1 |
| Duncan, PG | 1 |
| Lee, DS | 1 |
| Adams, JP | 1 |
| Zimmerman, JE | 1 |
| Keilani, MR | 1 |
| Al-Shanableh, JS | 1 |
| Kaplan, RF | 1 |
| Kellner, KR | 1 |
| Alibeu, JP | 1 |
| Gelas, P | 1 |
| Noda, B | 1 |
| Higa, K | 1 |
| Naitoh, H | 1 |
| Dan, K | 1 |
| Kiwitt, A | 1 |
| Pingel, E | 1 |
| Solera, J | 1 |
| Rallo, B | 1 |
| Alamo, LA | 1 |
| Papp, L | 1 |
| Gergely, J | 1 |
| Streter, F | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Cognitive Aids for the Management of Deteriorating Surgical Patients[NCT03812861] | 50 participants (Actual) | Interventional | 2017-02-07 | Completed | |||
| Perioperative Accuracy of the Raiing Wireless Axillary Thermometer[NCT02756910] | 80 participants (Actual) | Observational | 2016-05-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
"Accuracy, defined as the true difference between reference and iThermonitor temperature. The esophageal temperature will be the core temperature reference during surgery.~The primary outcome measure is the proportion of iThermonitor measurements for a patient that are within 0.5° C of the reference will be calculated, and this proportion (median, quartiles, 95% CI) will be summarized across patients.~The Secondary outcome measure are bias and 95% CIs determined by repeated-measures Bland-Altman analysis.~For each patient the average difference between the iThermometer and the reference temperature will be calculated. Patient iThermonitor measurements will be regressed on patient reference measurements to assess the Pearson correlation and 95% CI between iThermonitor and reference and to estimate the bias (slope) of device versus reference." (NCT02756910)
Timeframe: From 1 to 3 hours after induction of anesthesia
| Intervention | celsius (Mean) |
|---|---|
| Surgery Patients >1.5 Hrs | 0.14 |
75 reviews available for dantrolene and Anesthesia Related Hyperthermia
| Article | Year |
|---|---|
Malignant hyperthermia in maxillofacial surgery: Literature review supported by case presentation.
Topics: Adolescent; Adult; Child; Dantrolene; Humans; Hyperthermia, Induced; Male; Malignant Hyperthermia; M | 2023 |
Malignant Hyperthermia: A Clinical Review.
Topics: Calcium Channels, L-Type; Calcium-Binding Proteins; Calsequestrin; Comorbidity; Dantrolene; Genetic | 2019 |
Overlapping Mechanisms of Exertional Heat Stroke and Malignant Hyperthermia: Evidence vs. Conjecture.
Topics: Anesthetics; Calcium; Calcium Channel Blockers; Dantrolene; Heat Stroke; Humans; Malignant Hyperther | 2020 |
[Comments on the guidelines of the European Malignant Hyperthermia Group on the availability of dantrolene for the management of malignant hyperthermia crises].
Topics: Dantrolene; Humans; Hyperthermia; Malignant Hyperthermia; Muscle Relaxants, Central | 2020 |
Dantrolene : From Malignant Hyperthermia to Alzheimer's Disease.
Topics: Alzheimer Disease; Animals; Calcium; Dantrolene; Humans; Malignant Hyperthermia; Muscle, Skeletal; R | 2019 |
[S1 guidelines on malignant hyperthermia : Update 2018].
Topics: Dantrolene; Guidelines as Topic; Humans; Malignant Hyperthermia | 2018 |
[Inhalational analgosedation in the intensive care unit : Risk of malignant hyperthermia].
Topics: Anesthetics; Dantrolene; Humans; Intensive Care Units; Malignant Hyperthermia; Pharmacogenetics | 2020 |
Succinylcholine Use and Dantrolene Availability for Malignant Hyperthermia Treatment: Database Analyses and Systematic Review.
Topics: Dantrolene; Databases, Factual; Humans; Malignant Hyperthermia; Muscle Relaxants, Central; Neuromusc | 2019 |
Almost-certain malignant hyperthermia during cardiopulmonary bypass: a case report and literature review.
Topics: Cardiopulmonary Bypass; Dantrolene; Fatal Outcome; Humans; Male; Malignant Hyperthermia; Middle Aged | 2019 |
Overactivation of the sodium-calcium exchanger and transient receptor potential in anesthesia-induced malignant hyperthermia.
Topics: Anesthesia; Anesthetics; Calcium; Dantrolene; Humans; Malignant Hyperthermia; Muscle, Skeletal; Sodi | 2019 |
[Malignant hyperthermia].
Topics: Anesthesia; Calcium; Dantrolene; Humans; Malignant Hyperthermia; Muscle Relaxants, Central; Mutation | 2014 |
Ryanodex--A New Dantrolene Formulation for Malignant Hyperthermia.
Topics: Animals; Chemistry, Pharmaceutical; Dantrolene; Humans; Infusions, Intravenous; Malignant Hypertherm | 2015 |
Clinical protocol for the management of malignant hyperthermia.
Topics: Adolescent; Adult; Caffeine; Calcium Signaling; Child; Child, Preschool; Clinical Protocols; Critica | 2017 |
Malignant hyperthermia: a pharmacogenetic disorder.
Topics: Dantrolene; Genetic Predisposition to Disease; Humans; Malignant Hyperthermia; Muscle Relaxants, Cen | 2009 |
Malignant hyperthermia in the oral and maxillofacial surgery patient: an update.
Topics: Anesthesia, Dental; Anesthesia, General; Clinical Protocols; Contraindications; Dantrolene; Humans; | 2011 |
Malignant hyperthermia: considerations for the general surgeon.
Topics: Anesthetics, Inhalation; Biopsy; Dantrolene; General Surgery; Genetic Predisposition to Disease; Hum | 2002 |
[Malignant hyperthermia].
Topics: Anesthesia, General; Dantrolene; Diagnosis, Differential; Genetic Predisposition to Disease; Humans; | 2002 |
[Dantrolene. Pharmacological and therapeutic aspects].
Topics: Dantrolene; Drug Interactions; Hallucinogens; Humans; Malignant Hyperthermia; Muscle Relaxants, Cent | 2003 |
[Malignant hyperthermia].
Topics: Anesthetics, Inhalation; Dantrolene; Diagnosis, Differential; Genetic Predisposition to Disease; Hum | 2003 |
Fatal malignant hyperthermia-like syndrome with rhabdomyolysis complicating the presentation of diabetes mellitus in adolescent males.
Topics: Adolescent; Dantrolene; Diabetes Mellitus, Type 2; Fatal Outcome; Humans; Hyperglycemic Hyperosmolar | 2003 |
[Malignant hyperthermia].
Topics: Adult; Biopsy; Child; Dantrolene; Humans; Injections, Intravenous; Malignant Hyperthermia; Muscle Co | 2003 |
Malignant hyperthermia.
Topics: Anesthesia; Anesthetics, Inhalation; Dantrolene; Diagnosis, Differential; Humans; Malignant Hyperthe | 2003 |
Dantrolene--a review of its pharmacology, therapeutic use and new developments.
Topics: Dantrolene; Humans; Malignant Hyperthermia; Muscle Relaxants, Central; Neuroleptic Malignant Syndrom | 2004 |
Malignant hyperthermia--the perioperative nurse's role.
Topics: Algorithms; Anesthetics, General; Dantrolene; Decision Trees; Emergencies; Emergency Treatment; Huma | 2006 |
[Drug-induced malignant hyperthermia].
Topics: Anesthetics; Calcium; Dantrolene; Humans; Malignant Hyperthermia; Neuromuscular Depolarizing Agents; | 2007 |
Malignant hyperthermia.
Topics: Adult; Arrhythmias, Cardiac; Biopsy; Calcium; Child; Child, Preschool; Creatine Kinase; Dantrolene; | 1983 |
Current concepts. The malignant hyperthermia syndrome.
Topics: Animals; Dantrolene; Disease Models, Animal; Halothane; Humans; Malignant Hyperthermia; Muscles; Swi | 1983 |
[Malignant hyperthermia].
Topics: Acidosis; Anesthesia, Inhalation; Anesthetics; Body Temperature Regulation; Calcium; Cell Membrane P | 1983 |
Malignant hyperthermia.
Topics: Animals; Caffeine; Calcium; Cold Temperature; Creatine Kinase; Dantrolene; Disease Susceptibility; H | 1983 |
Malignant hyperthermia: responses of skeletal muscles to general anesthetics.
Topics: Animals; Calcium; Dantrolene; Disease Models, Animal; Humans; Malignant Hyperthermia; Muscles; Resea | 1983 |
Dantrolene.
Topics: Animals; Calcium; Dantrolene; Humans; In Vitro Techniques; Malignant Hyperthermia; Motor Neurons; Mu | 1984 |
Malignant hyperthermia.
Topics: Anesthesia, General; Anesthesia, Local; Dantrolene; Disease Susceptibility; Female; Humans; Male; Ma | 1984 |
Malignant hyperthermia--pearls out of swine?
Topics: Animals; Body Temperature; Dantrolene; Disease Models, Animal; Halothane; Magnesium Sulfate; Maligna | 1980 |
The pathopharmacology of malignant hyperpyrexia.
Topics: Adenylate Kinase; Anesthesia, General; Animals; Blood Platelets; Calcium; Catecholamines; Cats; Dant | 1980 |
Malignant hyperthermia following intravenous iodinated contrast media. Report of a fatal case.
Topics: Adult; Contrast Media; Dantrolene; Diatrizoate; Diatrizoate Meglumine; Drug Combinations; Female; Hu | 1981 |
[Experimental malignant hyperthermia].
Topics: Acidosis; Animals; Calcium; Cell Membrane Permeability; Dantrolene; Malignant Hyperthermia; Muscles; | 1980 |
An update on the malignant hyperthermia syndrome.
Topics: Anesthetics; Animals; Calcium; Calcium Channels; Child; Dantrolene; Disease Models, Animal; Disease | 1994 |
Neuroleptic malignant syndrome and malignant hyperthermia. Important issues for the medical consultant.
Topics: Dantrolene; Diagnosis, Differential; Dopamine Agents; Humans; Malignant Hyperthermia; Neuroleptic Ma | 1993 |
Malignant hyperthermia: a review of published cases.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Dantrolene; Female; Humans; Infant; Infant, Newbor | 1993 |
Malignant hyperthermia susceptibility: anaesthetic implications and risk stratification.
Topics: Adolescent; Anesthesia; Anesthesia, Obstetrical; Cesarean Section; Child; Child, Preschool; Contrain | 1997 |
Malignant hyperthermia: a potentially fatal complication of anesthesia.
Topics: Anesthesia, General; Dantrolene; Humans; Malignant Hyperthermia; Muscle Relaxants, Central; Operatin | 1998 |
Malignant hyperthermia.
Topics: Anesthesia; Anesthetics, Inhalation; Caffeine; Central Nervous System Stimulants; Dantrolene; Haloth | 1998 |
[Malignant anesthesia hyperthermia].
Topics: Biopsy; Critical Care; Dantrolene; Diagnosis, Differential; Humans; Malignant Hyperthermia; Muscle R | 1998 |
Malignant hyperthermia.
Topics: Adult; Aged; Anesthetics; Animals; Child; Creatine Kinase; Dantrolene; Disease Susceptibility; Exerc | 1998 |
[Malignant hyperthermia].
Topics: Biopsy; Child, Preschool; Dantrolene; Disease Models, Animal; Humans; Male; Malignant Hyperthermia; | 1999 |
Malignant hyperthermia.
Topics: Adult; Anesthesia; Child; Dantrolene; Exercise; Health Education; Heat Stroke; Humans; Malignant Hyp | 2001 |
Malignant hyperthermia: an inherited disorder of skeletal muscle Ca+ regulation.
Topics: Animals; Calcium; Dantrolene; Humans; Malignant Hyperthermia; Models, Biological; Muscle Relaxants, | 2001 |
[Malignant hyperthermia].
Topics: Age Factors; Anesthetics, Inhalation; Cause of Death; Dantrolene; Databases, Factual; Female; Humans | 2002 |
Treatment of porcine malignant hyperthermia. A review based on experimental studies.
Topics: Animals; Blood Glucose; Body Temperature; Carbon Dioxide; Catecholamines; Chlorpromazine; Dantrolene | 1975 |
Anaesthesia of pigs sensitive to malignant hyperthermia.
Topics: Anesthesia; Animals; Barbiturates; Body Temperature; Cardiac Output; Dantrolene; Halothane; Heart Ra | 1977 |
Etiology and pathophysiology of malignant hyperthermia.
Topics: Anesthesia, Inhalation; Animals; Calcium; Cell Membrane; Dantrolene; Humans; Islets of Langerhans; M | 1979 |
Porcine malignant hyperthermia.
Topics: Anesthesia, Inhalation; Animals; Body Temperature Regulation; Calcium; Cell Membrane; Dantrolene; Di | 1979 |
[Malignant hyperthermia].
Topics: Calcium; Calcium Channels; Chromosomes, Human, Pair 19; Critical Care; Dantrolene; Energy Metabolism | 1992 |
Current understanding of malignant hyperthermia: genesis, prevention, and treatment.
Topics: Child; Child, Preschool; Dantrolene; Humans; Infant; Malignant Hyperthermia; Monitoring, Physiologic | 1992 |
Malignant hyperthermia: a review.
Topics: Dantrolene; Female; Humans; Male; Malignant Hyperthermia | 1992 |
Malignant hyperthermia.
Topics: Adult; Biopsy; Dantrolene; Female; Hotlines; Humans; Malignant Hyperthermia | 1992 |
[An attempt to reconcile differences of opinion in the field of malignant hyperthermia].
Topics: Dantrolene; Disease Susceptibility; Humans; Malignant Hyperthermia; Preoperative Care | 1991 |
Malignant hyperthermia.
Topics: Dantrolene; Humans; Malignant Hyperthermia; Neuromuscular Diseases | 1991 |
Malignant hyperthermia. Treatment of the acute episode.
Topics: Clinical Protocols; Combined Modality Therapy; Dantrolene; Humans; Malignant Hyperthermia | 1990 |
Pathophysiology of malignant hyperthermia.
Topics: Animals; Calcium; Creatine Kinase; Dantrolene; Disease Susceptibility; Halothane; Humans; Lymphocyte | 1989 |
[Management of a patient with malignant hyperthermia susceptibility during anesthesia and daily living].
Topics: Activities of Daily Living; Anesthesia; Anesthesia Recovery Period; Anesthetics; Dantrolene; Disease | 1989 |
[Treatment of malignant hyperthermia crisis during anesthesia].
Topics: Anesthesia, General; Arrhythmias, Cardiac; Dantrolene; Humans; Hyperkalemia; Malignant Hyperthermia; | 1989 |
Anaesthetic implications of calcium channel blockers.
Topics: Adrenergic beta-Antagonists; Anesthesia; Anesthetics; Animals; Asthma; Calcium; Calcium Channel Bloc | 1985 |
Neuroleptic malignant syndrome.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Bromocriptine; Child; Dantrol | 1985 |
The neuroleptic malignant syndrome--a review.
Topics: Animals; Antipsychotic Agents; Catatonia; Dantrolene; Diagnosis, Differential; Heat Exhaustion; Huma | 1985 |
Neuroleptic malignant syndrome.
Topics: Antipsychotic Agents; Dantrolene; Dopamine; Humans; Malignant Hyperthermia; Neuroleptic Malignant Sy | 1987 |
[New findings and experiences in the field of malignant hyperthermia].
Topics: Anesthesia; Animals; Calcium Channel Blockers; Catatonia; Dantrolene; Diagnosis, Differential; Human | 1986 |
Plasma levels of dantrolene following oral administration in malignant hyperthermia-susceptible patients.
Topics: Administration, Oral; Adolescent; Adult; Dantrolene; Disease Susceptibility; Female; Humans; Male; M | 1988 |
[Non-rigid type malignant hyperthermia and dantrolene sodium].
Topics: Dantrolene; Female; Humans; Malignant Hyperthermia; Middle Aged | 1988 |
Malignant hyperthermia. Dantrolene--dynamics and kinetics.
Topics: Calcium; Child; Dantrolene; Drug Interactions; Female; Humans; Malignant Hyperthermia; Muscles | 1988 |
Malignant hyperthermia.
Topics: Body Temperature; Dantrolene; Humans; Malignant Hyperthermia; Prognosis | 1987 |
Malignant hyperthermia.
Topics: Action Potentials; Adult; Animals; Child; Counseling; Dantrolene; Humans; Malignant Hyperthermia; Mu | 1986 |
Dantrolene. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity.
Topics: Animals; Calcium; Central Nervous System; Dantrolene; Endocrine Glands; Heat Exhaustion; Humans; Kin | 1986 |
Malignant hyperthermia--a clinical review.
Topics: Calcium; Cell Membrane; Dantrolene; Genetic Predisposition to Disease; Humans; Malignant Hyperthermi | 1986 |
Current concepts. Neuroleptic malignant syndrome.
Topics: Amantadine; Basal Ganglia Diseases; Bromocriptine; Catatonia; Dantrolene; Diagnosis, Differential; D | 1985 |
1 trial available for dantrolene and Anesthesia Related Hyperthermia
| Article | Year |
|---|---|
Dantrolene in human malignant hyperthermia.
Topics: Adolescent; Adult; Child; Child, Preschool; Clinical Trials as Topic; Dantrolene; Female; Humans; In | 1982 |
446 other studies available for dantrolene and Anesthesia Related Hyperthermia
| Article | Year |
|---|---|
Delayed-onset malignant hyperthermia in the postanesthetic care unit: a case report.
Topics: Aged; Anesthesia; Body Temperature; Dantrolene; Humans; Hyperthermia; Male; Malignant Hyperthermia | 2021 |
The effects of dantrolene in the presence or absence of ryanodine receptor type 1 variants in individuals predisposed to malignant hyperthermia.
Topics: Caffeine; Calcium; Dantrolene; Humans; Malignant Hyperthermia; Mutation; Ryanodine Receptor Calcium | 2022 |
Malignant hyperthermia in Mazovia Province - are we adequately prepared?
Topics: Anesthetics, Inhalation; Dantrolene; Humans; Malignant Hyperthermia; Operating Rooms; Succinylcholin | 2022 |
Donating Dantrolene: Development and Implementation of a Malignant Hyperthermia Program in a Scarce Resource Setting.
Topics: Anesthesia; Child; Dantrolene; Humans; Malignant Hyperthermia; United States | 2022 |
Intravenous dantrolene in hypermetabolic syndromes: a survey of the U.S. Veterans Health Administration database.
Topics: Creatine Kinase; Dantrolene; Humans; Malignant Hyperthermia; Retrospective Studies; Sepsis; Veterans | 2022 |
Oral Dantrolene for Myopathic Symptoms in Malignant Hyperthermia-Susceptible Patients: A 25-Year Retrospective Cohort Study of Adverse Effects and Tolerability.
Topics: Dantrolene; Drug-Related Side Effects and Adverse Reactions; Fatigue; Halothane; Humans; Malignant H | 2023 |
Gene Panel Sequencing Identifies a Novel
Topics: Adolescent; Caffeine; Calcium; Dantrolene; Humans; Isoflurane; Male; Malignant Hyperthermia; Ryanodi | 2022 |
A Case Report of an Incidental Ultrasound Finding in a Suspected Malignant Hyperthermia Patient.
Topics: Anesthetics, Inhalation; Dantrolene; Female; Halothane; Humans; Malignant Hyperthermia; Middle Aged; | 2022 |
Rapid Dantrolene Administration with Body Temperature Monitoring Is Associated with Decreased Mortality in Japanese Malignant Hyperthermia Events.
Topics: Body Temperature; Dantrolene; East Asian People; Humans; Malignant Hyperthermia; Rare Diseases; Retr | 2023 |
Malignant hyperthermia in Poland: A survey study.
Topics: Anesthetics, Inhalation; Dantrolene; Humans; Malignant Hyperthermia; Poland; Surveys and Questionnai | 2023 |
Suspected malignant hyperthermia in a young Chinese patient undergoing a micro varicocelectomy surgery.
Topics: Abdomen; Dantrolene; East Asian People; Humans; Malignant Hyperthermia | 2023 |
Molecular Aspects Implicated in Dantrolene Selectivity with Respect to Ryanodine Receptor Isoforms.
Topics: Animals; Calcium; Dantrolene; Humans; Malignant Hyperthermia; Mammals; Muscle, Skeletal; Protein Iso | 2023 |
Pediatric fulminant malignant hyperthermia with severe electroencephalographic abnormality and brain damage: a case report.
Topics: Brain; Brain Injuries; Child; Dantrolene; Electroencephalography; Humans; Infant; Male; Malignant Hy | 2023 |
Suspected Malignant Hyperthermia in a Brain-Dead Donor During Anesthesia for Organ Procurement Surgery: A Case Report.
Topics: Adolescent; Anesthesia, General; Brain; Brain Death; Dantrolene; Humans; Liver Transplantation; Livi | 2023 |
Succinylcholine Use and Dantrolene Availability: Reply.
Topics: Anesthesia; Dantrolene; Humans; Malignant Hyperthermia; Neuromuscular Depolarizing Agents; Succinylc | 2019 |
Dantrolene Should Be Readily Available Wherever Malignant Hyperthermia Triggering Drugs Are Stocked.
Topics: Ambulatory Surgical Procedures; Anesthesia; Anesthesiologists; Dantrolene; Humans; Malignant Hyperth | 2019 |
[Malignant Hyperthermia - Update on Pathophysiology, Diagnostics and Treatment].
Topics: Anesthetics, Inhalation; Dantrolene; Humans; Malignant Hyperthermia; Succinylcholine | 2019 |
[Pharmacological Treatment of Malignant Hyperthermia: Update 2019].
Topics: Anesthetics; Dantrolene; Humans; Malignant Hyperthermia; Neuromuscular Depolarizing Agents; Succinyl | 2019 |
Pennywise and a Pound Foolish: The Advantage of Dantrolene Nanosuspension (Ryanodex) in the Treatment of Malignant Hyperthermia.
Topics: Adult; Ambulatory Surgical Procedures; Anesthesia; Anesthesiologists; Dantrolene; Humans; Malignant | 2019 |
A Prospective Repurposing of Dantrolene as a Multitarget Agent for Alzheimer's Disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Calcium; Calcium Channel Blockers; Carnitine; Cell Line; Ch | 2019 |
Letter to the Editor Regarding "Intraarterial Dantrolene for Refractory Cerebral Vasospasm in Patients with Aneurysmal Subarachnoid Hemorrhage": Is Malignant Hyperthermia a Model for Showing Dantrolene Efficacy in Limiting Brain Damage?
Topics: Brain; Dantrolene; Humans; Malignant Hyperthermia; Subarachnoid Hemorrhage; Vasospasm, Intracranial | 2020 |
MALIGNANT HYPERTHERMIA IN A CHILD AFTER MAGNETIC RESONANCE IMAGING: A CASE REPORT.
Topics: Acyclovir; Anesthetics, Inhalation; Anesthetics, Intravenous; Antiviral Agents; Child, Preschool; Da | 2020 |
Drawing up dantrolene for the treatment of malignant hyperthermia: use of a drawing up spike to make the process easier and quicker.
Topics: Dantrolene; Drug Compounding; Humans; Malignant Hyperthermia; Muscle Relaxants, Central | 2020 |
Availability of dantrolene for the management of malignant hyperthermia crises: European Malignant Hyperthermia Group guidelines.
Topics: Anesthesia Department, Hospital; Dantrolene; Drug Storage; Emergencies; Emergency Medical Services; | 2020 |
Malignant hyperthermia syndrome: A rare entity.
Topics: Adenoidectomy; Anesthetics, Inhalation; Child; Dantrolene; Female; Humans; Malignant Hyperthermia; S | 2020 |
The Use of Continuous Blood Purification for the Treatment of Malignant Hyperthermia in an Infant.
Topics: Adult; Anesthesia, General; Child; Dantrolene; Humans; Hyperthermia; Infant; Male; Malignant Hyperth | 2021 |
[Rhabdomyolysis during Perioperative Period after Cardiac Surgery].
Topics: Cardiac Surgical Procedures; Dantrolene; Humans; Male; Malignant Hyperthermia; Middle Aged; Perioper | 2020 |
Malignant hyperthermia 2020: Guideline from the Association of Anaesthetists.
Topics: Acidosis; Body Temperature; Calcium; Carbon Dioxide; Compartment Syndromes; Dantrolene; Disseminated | 2021 |
Beneficial effects of dantrolene in the treatment of rhabdomyolysis as a potential late complication associated with COVID-19: a case report.
Topics: Adult; COVID-19; Dantrolene; Humans; Male; Malignant Hyperthermia; Muscle Relaxants, Central; Rhabdo | 2021 |
Malignant hyperthermia in a 16-day-old infant with congenital diaphragmatic hernia: a case report.
Topics: Child; Dantrolene; Hernias, Diaphragmatic, Congenital; Humans; Hyperthermia; Infant; Malignant Hyper | 2021 |
Malignant hyperthermia when dantrolene is not readily available.
Topics: Adolescent; Adult; Aged; Arterial Pressure; Blood Coagulation Disorders; Carbon Dioxide; Child; Chil | 2021 |
Postoperative malignant hyperthermia confirmed by calcium-induced calcium release rate after breast cancer surgery, in which prompt recognition and immediate dantrolene administration were life-saving: a case report.
Topics: Anesthesia, General; Anesthetics, Inhalation; Breast Neoplasms; Calcium; Dantrolene; Female; Humans; | 2021 |
A case report of malignant hyperthermia in a patient with myotonic dystrophy type I: A CARE-compliant article.
Topics: Adolescent; Anesthesia, General; Dantrolene; Genetic Predisposition to Disease; Genetic Testing; Hum | 2021 |
Dantrolene requires Mg
Topics: Adult; Animals; Calcium Signaling; Dantrolene; Female; Halothane; Humans; Magnesium; Male; Malignant | 2017 |
Mind the magnesium, in dantrolene suppression of malignant hyperthermia.
Topics: Dantrolene; Humans; Magnesium; Malignant Hyperthermia; Time Factors | 2017 |
Reduced threshold for store overload-induced Ca
Topics: Adrenergic beta-Antagonists; Amino Acid Substitution; Animals; Calcium Signaling; Carbazoles; Carved | 2017 |
Malignant Hyperthermia in a Morbidly Obese Patient Depletes Community Dantrolene Resources: A Case Report.
Topics: Adult; Carcinoid Tumor; Dantrolene; Duodenal Neoplasms; Female; Humans; Malignant Hyperthermia; Musc | 2017 |
Delayed Development of Malignant Hyperthermia Following Cardiopulmonary Bypass.
Topics: Androstanols; Anesthesia, General; Anesthetics, Inhalation; Anesthetics, Intravenous; Cardiopulmonar | 2018 |
Malignant Hyperthermia and Ryanodine Receptor Type 1 Gene (RyR1) Mutation in a Family in Singapore.
Topics: Adult; Dantrolene; Female; Genetic Predisposition to Disease; Humans; Male; Malignant Hyperthermia; | 2017 |
Perioperative Cardiac Arrest: Focus on Malignant Hyperthermia (MH).
Topics: Dantrolene; Heart Arrest; Humans; Malignant Hyperthermia; Medical Illustration; Muscle Relaxants, Ce | 2018 |
[Abortive course of malignant hyperthermia following preclinical induction of general anesthesia using succinylcholine].
Topics: Anesthesia, General; Anesthetics, Intravenous; Dantrolene; Female; Fentanyl; Humans; Malignant Hyper | 2018 |
Management of a Patient With a History of Nonanesthesia-Related Malignant Hyperthermia Undergoing Laparoscopic Cholecystectomy: A Case Report.
Topics: Adult; Cholecystectomy, Laparoscopic; Dantrolene; Humans; Male; Malignant Hyperthermia; Muscle Relax | 2018 |
Cost-benefit Analysis of Maintaining a Fully Stocked Malignant Hyperthermia Cart versus an Initial Dantrolene Treatment Dose for Maternity Units.
Topics: Cost-Benefit Analysis; Dantrolene; Decision Trees; Dose-Response Relationship, Drug; Female; Humans; | 2018 |
Dantrolene and Malignant Hyperthermia Carts: Do We Need Them on Maternity Units?
Topics: Cost-Benefit Analysis; Dantrolene; Diagnostic Tests, Routine; Humans; Malignant Hyperthermia | 2018 |
Malignant hyperthermia and dantrolene sodium.
Topics: Dantrolene; Humans; Malignant Hyperthermia | 2019 |
Malignant Hyperthermia: From the OR to the Sidelines.
Topics: Anesthesia; Animals; Caffeine; Dantrolene; Humans; Malignant Hyperthermia; Muscle Contraction; Ryano | 2018 |
Malignant Hyperthermia: A Case Report in a Trauma Patient.
Topics: Anesthesia, General; Dantrolene; Desflurane; Humans; Male; Malignant Hyperthermia; Mandibular Fractu | 2019 |
Presumed Malignant Hyperthermia Treated During Cardiopulmonary Bypass in a Pediatric Patient Undergoing Aortic Valve Replacement: A Case Report.
Topics: Aortic Valve; Cardiopulmonary Bypass; Child; Dantrolene; Heart Valve Prosthesis Implantation; Humans | 2019 |
Succinylcholine and Dantrolene: Inseparable in the Emergency Cupboard?
Topics: Anesthesia; Dantrolene; Humans; Malignant Hyperthermia; Succinylcholine | 2019 |
The importance of a prepared and ready malignant hyperthermia response team.
Topics: Dantrolene; Female; Hospital Rapid Response Team; Humans; Intubation, Intratracheal; Malignant Hyper | 2019 |
Consensus Statement of the Malignant Hyperthermia Association of the United States on Unresolved Clinical Questions Concerning the Management of Patients With Malignant Hyperthermia.
Topics: Consensus; Dantrolene; Drug Administration Schedule; Evidence-Based Medicine; Exercise; Humans; Mali | 2019 |
Magnesium sulfate - An effective agent could delay the progression of fulminant malignant hyperthermia.
Topics: Anesthesia, General; Anesthetics; Calcium; Catecholamines; Dantrolene; Disease Progression; Fever; H | 2019 |
Malignant Hyperthermia and Cerebral Venous Sinus Thrombosis After Ventriculoperitoneal Shunt in Infant with Schizencephaly and COL4A1 Mutation.
Topics: Collagen Type IV; Dantrolene; Fluid Therapy; Germ-Line Mutation; Humans; Hydrocephalus; Infant; Male | 2019 |
Malignant Hyperthermia-Susceptible Adult Patient and Ambulatory Surgery Center: Society for Ambulatory Anesthesia and Ambulatory Surgical Care Committee of the American Society of Anesthesiologists Position Statement.
Topics: Ambulatory Surgical Procedures; Anesthesia; Dantrolene; Early Diagnosis; Hospitalization; Humans; Ma | 2019 |
Upper extremity deep vein thrombosis in a patient treated for malignant hyperthermia.
Topics: Adult; Dantrolene; Humans; Male; Malignant Hyperthermia; Muscle Relaxants, Central; Upper Extremity | 2013 |
Malignant hyperthermia in Canada: characteristics of index anesthetics in 129 malignant hyperthermia susceptible probands.
Topics: Adolescent; Adult; Aged; Anesthetics; Caffeine; Canada; Child; Child, Preschool; Dantrolene; Female; | 2014 |
A malignant hyperthermialike episode in a liver transplant recipient.
Topics: Carcinoma, Hepatocellular; Comorbidity; Dantrolene; Hepatitis C; Humans; Intraoperative Complication | 2013 |
Malignant hyperthermia in the ambulatory surgery center: how should we prepare?
Topics: Ambulatory Surgical Procedures; Anesthetics; Dantrolene; Humans; Malignant Hyperthermia | 2014 |
Cost-effectiveness analysis of stocking dantrolene in ambulatory surgery centers for the treatment of malignant hyperthermia.
Topics: Ambulatory Surgical Procedures; Anesthesia, General; Cost-Benefit Analysis; Dantrolene; Decision Tre | 2014 |
Low-cost, easy-to-make simulated dantrolene for malignant hyperthermia scenarios.
Topics: Anesthesiology; Dantrolene; Drug Compounding; Humans; Malignant Hyperthermia; Muscle Relaxants, Cent | 2014 |
Accuracy of malignant hyperthermia diagnoses in hospital discharge records.
Topics: Adolescent; Adult; Aged; Anesthesia, General; Canada; Child; Child, Preschool; Dantrolene; Female; H | 2015 |
[Suspected case of postoperative malignant hyperthermia treated with dantrolene one week after neurosurgery].
Topics: Administration, Oral; Adolescent; Anesthesia, General; Cerebral Hemorrhage; Dantrolene; Humans; Infu | 2014 |
[Malignant hyperthermia syndrome: case report].
Topics: Child; Dantrolene; Humans; Male; Malignant Hyperthermia | 2015 |
Do we foresee new emerging drugs to treat malignant hyperthermia?
Topics: Anesthesia, Inhalation; Dantrolene; Drug Approval; Humans; Malignant Hyperthermia; Nanoparticles; Ne | 2015 |
Essential Role of Calmodulin in RyR Inhibition by Dantrolene.
Topics: Animals; Calcium; Calmodulin; Dantrolene; Malignant Hyperthermia; Mice; Mice, Inbred C57BL; Muscle, | 2015 |
Malignant hyperthermia testing in probands without adverse anesthetic reaction.
Topics: Adolescent; Adult; Aged; Anesthetics, Inhalation; Caffeine; Dantrolene; Drug-Related Side Effects an | 2015 |
A Case of Malignant Hyperthermia Captured by Neuromonitoring During a Lumbar Endoscopic Discectomy.
Topics: Anesthetics, Intravenous; Dantrolene; Diskectomy; Electromyography; Endoscopy; Fentanyl; Fluid Thera | 2016 |
Neuromuscular conditions associated with malignant hyperthermia in paediatric patients: A 25-year retrospective study.
Topics: Adolescent; Anesthesia; Child; Child, Preschool; Dantrolene; Female; Humans; Infant; Male; Malignant | 2016 |
Implementation of a new dantrolene formulation across a multifacility health system.
Topics: Community Health Planning; Dantrolene; Drug Compounding; Humans; Malignant Hyperthermia; Muscle Rela | 2016 |
Readiness for malignant hyperthermia can be survey stumbling block.
Topics: Centers for Medicare and Medicaid Services, U.S.; Dantrolene; Equipment and Supplies, Hospital; Huma | 2016 |
An RYR1 mutation associated with malignant hyperthermia is also associated with bleeding abnormalities.
Topics: Amino Acid Substitution; Animals; Blood Coagulation Disorders; Calcium Signaling; Dantrolene; Female | 2016 |
A rare genetic variant of the ryanodine receptor in a suspected malignant hyperthermia susceptible patient.
Topics: Adolescent; Anesthesia, Intravenous; Blood Gas Analysis; Dantrolene; Genetic Predisposition to Disea | 2016 |
Repeated nonanesthetic malignant hyperthermia reactions in a child.
Topics: Administration, Intravenous; Dantrolene; Female; Humans; Infant; Malignant Hyperthermia; Muscle Rela | 2016 |
Long term oral Dantrolene Improved Muscular Symptoms in a Malignant Hyperthermia Susceptible Individual.
Topics: Adult; Chronic Pain; Creatine Kinase; Dantrolene; Female; Humans; Malignant Hyperthermia; Muscle Cra | 2016 |
Succinylcholine for Emergency Airway Rescue in Class B Ambulatory Facilities: The Society for Ambulatory Anesthesia Position Statement.
Topics: Airway Management; Ambulatory Care; Ambulatory Care Facilities; Anesthesia; Dantrolene; Emergency Me | 2017 |
Suspected Malignant Hyperthermia in the Setting of Hypothermic Circulatory Arrest for Type A Aortic Dissection Repair: A Case Report.
Topics: Aortic Aneurysm; Aortic Dissection; Cardiopulmonary Bypass; Circulatory Arrest, Deep Hypothermia Ind | 2017 |
JSA guideline for the management of malignant hyperthermia crisis 2016.
Topics: Acidosis; Anesthetics, Inhalation; Body Temperature; Calcium; Carbon Dioxide; Dantrolene; Humans; Hy | 2017 |
Treatment of Malignant Hyperthermia without Dantrolene in a 14-year-old Boy.
Topics: Adolescent; Carbon Dioxide; Dantrolene; Humans; Male; Malignant Hyperthermia | 2017 |
Successful management of malignant hyperthermia during orthognathic surgery: a case report.
Topics: Adult; Anesthetics, Inhalation; Cryotherapy; Dantrolene; Female; Humans; Isoflurane; Malignant Hyper | 2008 |
Be prepared: malignant hyperthermia.
Topics: Anesthetics; Dantrolene; Elective Surgical Procedures; Humans; Malignant Hyperthermia; Muscle Relaxa | 2008 |
A case of malignant hyperthermia in a child encountered during a humanitarian assistance mission to the Philippines.
Topics: Altruism; Anesthetics, Inhalation; Cleft Lip; Cleft Palate; Dantrolene; Female; Humans; Infant; Mali | 2008 |
Malignant hyperthermia developing during esophageal resection in an 82-year-old man.
Topics: Aged, 80 and over; Anesthesia, General; Blood Gas Analysis; Body Temperature; Carbon Dioxide; Dantro | 2008 |
[A 17-year-old woman with acute abdomen].
Topics: Abdomen, Acute; Acute Disease; Adolescent; Anesthesia, Inhalation; Appendectomy; Appendicitis; Dantr | 2009 |
Anesthetic- and heat-induced sudden death in calsequestrin-1-knockout mice.
Topics: Anesthetics; Animals; Caffeine; Calcium; Calcium-Binding Proteins; Calsequestrin; Central Nervous Sy | 2009 |
Dantrolene, a therapeutic agent for malignant hyperthermia, markedly improves the function of failing cardiomyocytes by stabilizing interdomain interactions within the ryanodine receptor.
Topics: Animals; Calcium; Dantrolene; Disease Models, Animal; Dogs; Heart Failure; Malignant Hyperthermia; M | 2009 |
Hyperthermia in the pediatric intensive care unit--is it malignant hyperthermia?
Topics: Adolescent; Child; Child, Preschool; Cohort Studies; Dantrolene; Diagnosis, Differential; Female; Fe | 2009 |
Clinical presentation, treatment, and complications of malignant hyperthermia in North America from 1987 to 2006.
Topics: Adolescent; Adult; Aged; Anesthetics; Child; Child, Preschool; Dantrolene; Female; Humans; Infant; M | 2010 |
Low-dose dantrolene is effective in treating hyperthermia and hypercapnia, and seems not to affect recovery of the allograft after liver transplantation: case report.
Topics: Adult; Dantrolene; Hepatitis B, Chronic; Humans; Hypercapnia; Liver Transplantation; Living Donors; | 2010 |
A report of fulminant malignant hyperthermia in a patient with a novel mutation of the CACNA1S gene.
Topics: Adult; Anesthesia; Blood Gas Analysis; Calcium Channels; Calcium Channels, L-Type; Dantrolene; DNA; | 2010 |
Recognizing and treating malignant hyperthermia.
Topics: Dantrolene; Humans; Male; Malignant Hyperthermia; Muscle Relaxants, Central; Neuromuscular Depolariz | 2010 |
Malignant hyperthermia in the absence of triggering agents.
Topics: Anesthesia; Anesthetics; Body Temperature; Child, Preschool; Dantrolene; Female; Humans; Malignant H | 2010 |
Dantrolene, a therapeutic agent for malignant hyperthermia, inhibits catecholaminergic polymorphic ventricular tachycardia in a RyR2(R2474S/+) knock-in mouse model.
Topics: Adrenergic alpha-Agonists; Animals; Anti-Arrhythmia Agents; Calcium; Dantrolene; Disease Models, Ani | 2010 |
Clinical utility gene card for: malignant hyperthermia.
Topics: Age Factors; Biopsy; Calcium Channels; Calcium Channels, L-Type; Dantrolene; Diagnosis, Differential | 2011 |
Complications associated with the administration of dantrolene 1987 to 2006: a report from the North American Malignant Hyperthermia Registry of the Malignant Hyperthermia Association of the United States.
Topics: Adolescent; Adult; Aged; Body Weight; Chi-Square Distribution; Child; Child, Preschool; Dantrolene; | 2011 |
Speeding dantrolene preparation for treating malignant hyperthermia.
Topics: Dantrolene; Drug Compounding; Hot Temperature; Malignant Hyperthermia; Muscle Relaxants, Central; So | 2011 |
Malignant hyperthermia: presymptomatic screening and treatment 2011.
Topics: Anesthetics, Inhalation; Animals; Dantrolene; Halothane; Humans; Malignant Hyperthermia; Muscle Cont | 2011 |
Comparison of the therapeutic effectiveness of a dantrolene sodium solution and a novel nanocrystalline suspension of dantrolene sodium in malignant hyperthermia normal and susceptible pigs.
Topics: Animals; Biomarkers; Chemistry, Pharmaceutical; Dantrolene; Disease Models, Animal; Halothane; Hemod | 2011 |
Put out the fire (with apologies to Queen).
Topics: Dantrolene; Female; Humans; Male; Malignant Hyperthermia; Muscle Relaxants, Central | 2011 |
Is a formal statistical analysis always necessary?
Topics: Adsorption; Algorithms; Anesthesia, General; Anesthetics; Bayes Theorem; Charcoal; Dantrolene; Data | 2011 |
Malignant hyperthermia and charcoal absorbent: too hot to handle.
Topics: Adsorption; Anesthesia; Anesthesia, Inhalation; Charcoal; Dantrolene; Filtration; Humans; Intraopera | 2011 |
[Case of fulminant-malignant hyperthermia occurring on sixth sevoflurane anesthesia].
Topics: Anesthesia, General; Child; Dantrolene; Female; Humans; Malignant Hyperthermia; Methyl Ethers; Oral | 2011 |
Special article: Creation of a guide for the transfer of care of the malignant hyperthermia patient from ambulatory surgery centers to receiving hospital facilities.
Topics: Ambulatory Care Facilities; Ambulatory Surgical Procedures; Dantrolene; Emergency Medical Services; | 2012 |
The severity of sevoflurane-induced malignant hyperthermia.
Topics: Adolescent; Adult; Anesthesia, Inhalation; Anesthetics, Inhalation; Body Temperature; Child, Prescho | 2012 |
Dantrolene preparation.
Topics: Dantrolene; Drug Compounding; Hot Temperature; Malignant Hyperthermia; Muscle Relaxants, Central | 2011 |
Calcium channel blockers are inadequate for malignant hyperthermia crisis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy; Calcium; Calcium Channel Blockers; Calcium Chann | 2012 |
Current state of malignant hyperthermia in China mainland: a less optimistic reality.
Topics: China; Dantrolene; Humans; Malignant Hyperthermia; Muscle Relaxants, Central | 2012 |
Malignant hyperthermia: a crisis response plan.
Topics: Dantrolene; Emergency Treatment; Humans; Intubation, Gastrointestinal; Malignant Hyperthermia; Muscl | 2012 |
Mixing and using dantrolene for simulated malignant hyperthermia crisis.
Topics: Dantrolene; Drug Compounding; Humans; Malignant Hyperthermia; Manikins; Muscle Relaxants, Central; P | 2012 |
[Case of suspected malignant hyperthermia following local infiltration anesthesia].
Topics: Anesthesia, Intravenous; Anesthesia, Local; Biopsy; Dantrolene; Hernia, Inguinal; Herniorrhaphy; Hum | 2012 |
3,4-Methylenedioxymethamphetamine induces a hyperthermic and hypermetabolic crisis in pigs with and without a genetic disposition for malignant hyperthermia.
Topics: Acidosis; Animals; Dantrolene; Fatty Acids, Nonesterified; Fever; Genetic Predisposition to Disease; | 2013 |
Malignant hyperthermia: how to spot it early.
Topics: Anesthetics, Inhalation; Dantrolene; Humans; Male; Malignant Hyperthermia; Middle Aged; Monitoring, | 2002 |
Delayed onset of malignant hyperthermia in desflurane anesthesia.
Topics: Adolescent; Anesthesia, Inhalation; Anesthetics, Inhalation; Biopsy; Dantrolene; Desflurane; Female; | 2003 |
Rapid intervention for an episode of malignant hyperthermia.
Topics: Dantrolene; Drug Compounding; Humans; Infusions, Intravenous; Malignant Hyperthermia; Muscle Relaxan | 2003 |
Dosage of dantrolene--"empiric" please!
Topics: Dantrolene; Humans; Malignant Hyperthermia; Semantics | 2003 |
A fatal case of malignant hyperthermia complicated by generalized compartment syndrome and rhabdomyolysis.
Topics: Adult; Anesthetics, Intravenous; Compartment Syndromes; Dantrolene; Fatal Outcome; Hemorrhage; Human | 2003 |
Malignant hyperthermia.
Topics: Anesthesia, General; Anesthetics, Inhalation; Caffeine; Calcium; Central Nervous System Stimulants; | 2003 |
Induction of malignant hyperthermia in susceptible swine by 3,4-methylenedioxymethamphetamine ("ecstasy").
Topics: Animals; Blood Gas Analysis; Body Temperature; Carbon Dioxide; Dantrolene; Dose-Response Relationshi | 2003 |
[Masseter muscle rigidity after suxamethonium during induction and postoperative abortive malignant hyperthermia in a patient with esophageal achalasia].
Topics: Adult; Anesthesia, Epidural; Anesthesia, Intravenous; Dantrolene; Esophageal Achalasia; Humans; Infu | 2004 |
Dantrolene use in 3,4-methylenedioxymethamphetamine (ecstasy)-mediated hyperthermia.
Topics: Animals; Body Temperature; Dantrolene; Disease Models, Animal; Hallucinogens; Malignant Hyperthermia | 2004 |
Subthalamic deep brain stimulation masking possible malignant syndrome in Parkinson disease.
Topics: Analgesics, Non-Narcotic; Anti-Infective Agents; Antiparkinson Agents; Combined Modality Therapy; Co | 2004 |
Sevoflurane-induced malignant hyperthermia during cardiopulmonary bypass and moderate hypothermia.
Topics: Anesthetics, Inhalation; Angina Pectoris; Blood Gas Analysis; Cardiac Surgical Procedures; Cardiopul | 2004 |
Oral dantrolene.
Topics: Administration, Oral; Dantrolene; Humans; Malignant Hyperthermia; Muscle Relaxants, Central | 2004 |
When economy meets medicine--malignant hyperthermia in Taiwan.
Topics: Cost-Benefit Analysis; Dantrolene; Genetic Predisposition to Disease; Health Care Costs; Humans; Mal | 2004 |
A survey for prevention and treatment of malignant hyperthermia in Taiwan.
Topics: Dantrolene; Health Care Costs; Humans; Malignant Hyperthermia; Surveys and Questionnaires | 2004 |
Is there a link between malignant hyperthermia and exertional heat illness?
Topics: Acidosis; Adolescent; Child; Dantrolene; Fatal Outcome; Genetic Predisposition to Disease; Heat Exha | 2004 |
Dantrolene stabilizes domain interactions within the ryanodine receptor.
Topics: Animals; Calcium; Calmodulin; Dantrolene; Fluorescent Dyes; Malignant Hyperthermia; Microsomes; Musc | 2005 |
Malignant hyperthermia with excellent response to small dose of dantrolene.
Topics: Adult; Aged; Dantrolene; Humans; Male; Malignant Hyperthermia | 2004 |
Dantrolene and heatstroke: a good molecule applied in an unsuitable situation.
Topics: Dantrolene; Environment; France; Heat Stroke; Humans; Hypothermia, Induced; Malignant Hyperthermia; | 2005 |
[Central hyperthermia suspected of malignant hyperthermia in a patient undergoing radical neck clipping for cerebral aneurysm].
Topics: Anesthesia, General; Creatine Kinase; Dantrolene; Diagnosis, Differential; Female; Fever; Humans; Hy | 2005 |
Postoperative hyperthermia of unknown origin treated with dantrolene sodium.
Topics: Alveolar Process; Alveoloplasty; Anti-Inflammatory Agents, Non-Steroidal; Body Temperature; Bone Tra | 2005 |
A case report of malignant hyperthermia in a dental clinic operating room.
Topics: Anesthetics, Inhalation; Child, Preschool; Dantrolene; Follow-Up Studies; Halothane; Humans; Jaw Fix | 2005 |
Malignant hyperthermia.
Topics: Adult; Dantrolene; Emergencies; Humans; Male; Malignant Hyperthermia; Muscle Relaxants, Central; Nur | 2005 |
[Malignant hyperthermia--a hereditary and potentially life-threatening condition].
Topics: Adult; Dantrolene; Female; Genetic Predisposition to Disease; Genetic Testing; Humans; Male; Maligna | 2005 |
Compartmental pharmacokinetics of dantrolene in adults: do malignant hyperthermia association dosing guidelines work?
Topics: Adult; Computer Simulation; Dantrolene; Female; Guidelines as Topic; Humans; Male; Malignant Hyperth | 2005 |
Approach to management of malignant hyperthermia-like syndrome in pediatric diabetes mellitus.
Topics: Adolescent; Black or African American; Butyryl-CoA Dehydrogenase; Child; Dantrolene; Diabetes Mellit | 2006 |
Suspected malignant hyperthermia in a child with laminin alpha2 (merosin) deficiency in the absence of a triggering agent.
Topics: Anesthesia, Intravenous; Child; Dantrolene; Dexmedetomidine; Humans; Laminin; Male; Malignant Hypert | 2006 |
Malignant hyperthermia: successful management in a private surgery centre.
Topics: Adult; Cryotherapy; Dantrolene; Female; Humans; Malignant Hyperthermia; Muscle Relaxants, Central; O | 2006 |
Use of cognitive aids in a simulated anesthetic crisis.
Topics: Anesthesiology; Anesthetics; Cohort Studies; Dantrolene; Decision Support Techniques; Female; Humans | 2006 |
Dantrolene-induced hyperkalemia in a patient treated with diltiazem and metoprolol.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Calcium Channel Blockers; Cardiac Output; Corona | 1988 |
Analysis of the clinical variables associated with recrudescence after malignant hyperthermia reactions.
Topics: Adolescent; Adult; Aged; Body Temperature; Case-Control Studies; Child; Child, Preschool; Dantrolene | 2007 |
Fulminant-type malignant hyperthermia in Japan: cumulative analysis of 383 cases.
Topics: Anesthetics; Dantrolene; Female; Humans; Incidence; Japan; Male; Malignant Hyperthermia; Recurrence | 2007 |
The Icarus effect: the influence of diluent warming on dantrolene sodium mixing time.
Topics: Dantrolene; Drug Compounding; Hot Temperature; Humans; Injections, Intravenous; Malignant Hypertherm | 2007 |
Antidotes to anesthetic catastrophe: lipid emulsion and dantrolene.
Topics: Anesthetics; Antidotes; Dantrolene; Fat Emulsions, Intravenous; Humans; Malignant Hyperthermia | 2007 |
[Case of malignant hyperthermia in which treatment was carried out smoothly].
Topics: Adolescent; Anesthesia, General; Anesthetics, Inhalation; Dantrolene; Female; Humans; Intraoperative | 2007 |
Delayed onset of malignant hyperthermia without creatine kinase elevation in a geriatric, ryanodine receptor type 1 gene compound heterozygous patient.
Topics: Aged; Anesthesia, General; Anesthetics, Inhalation; Antihypertensive Agents; Blood Pressure; Colosto | 2007 |
Malignant hyperthermia: hot stuff!
Topics: Adult; Anesthesia, General; Appendectomy; Clinical Protocols; Dantrolene; Humans; Hypothermia, Induc | 2007 |
Effects of azumolene on normal and malignant hyperthermia-susceptible skeletal muscle.
Topics: Animals; Dantrolene; Dose-Response Relationship, Drug; Guinea Pigs; Humans; Imidazoles; In Vitro Tec | 2008 |
Malignant hyperthermia in a liver transplant patient: a case report.
Topics: Anesthetics, Inhalation; Bilirubin; Dantrolene; Humans; Intraoperative Complications; Isoflurane; Li | 2007 |
Enhanced excitation-coupled calcium entry in myotubes expressing malignant hyperthermia mutation R163C is attenuated by dantrolene.
Topics: Amino Acid Substitution; Animals; Animals, Newborn; Arginine; Calcium; Calcium Signaling; Cysteine; | 2008 |
Reduced threshold for luminal Ca2+ activation of RyR1 underlies a causal mechanism of porcine malignant hyperthermia.
Topics: Anesthetics, Inhalation; Animals; Calcium; Cell Line; Cytosol; Dantrolene; Fever; Halothane; Humans; | 2008 |
[Malignant hyperthermia induced by neuroleptics. Rapid cure with dantrolene].
Topics: Aged; Antipsychotic Agents; Dantrolene; Female; Humans; Malignant Hyperthermia | 1982 |
Treatment of neuroleptic malignant syndrome with dantrolene.
Topics: Adult; Bipolar Disorder; Dantrolene; Haloperidol; Humans; Male; Malignant Hyperthermia; Muscle Rigid | 1982 |
Treatment of neuroleptic malignant syndrome with dantrolene.
Topics: Central Nervous System Diseases; Dantrolene; Diagnosis, Differential; Humans; Malignant Hyperthermia | 1982 |
Treatment of neuroleptic malignant syndrome with dantrolene sodium: a case report.
Topics: Adult; Antipsychotic Agents; Body Temperature; Dantrolene; Dose-Response Relationship, Drug; Dyskine | 1982 |
[Reflections on the malignant neuroleptic].
Topics: Adult; Antipsychotic Agents; Dantrolene; Humans; Male; Malignant Hyperthermia | 1982 |
Questions about dantrolene for neuroleptic malignant syndrome.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Dantrolene; Fever; Humans; Malignant Hyperthermia | 1983 |
When seconds count: treating malignant hyperthermia.
Topics: Adult; Cryotherapy; Dantrolene; Education, Nursing, Continuing; Humans; Male; Malignant Hyperthermia | 1984 |
The effect of dantrolene on skeletal-muscle sarcoplasmic-reticulum function in malignant hyperpyrexia in pigs.
Topics: Animals; Calcium; Calcium-Transporting ATPases; Dantrolene; Electrophoresis, Polyacrylamide Gel; Mal | 1983 |
Dantrolene and calcium uptake by the sarcoplasmic reticulum of malignant hyperpyrexia-susceptible pigs.
Topics: Adenosine Triphosphatases; Adenosine Triphosphate; Animals; Biological Transport; Calcium; Dantrolen | 1984 |
[Malignant hyperthermia: biochemico-metabolic aspects and personal experiences].
Topics: Adult; Dantrolene; Female; Halothane; Humans; Male; Malignant Hyperthermia; Succinylcholine | 1984 |
Malignant hyperthermia.
Topics: Acidosis; Bicarbonates; Calcium; Creatine Kinase; Dantrolene; Diuretics; Fever; Humans; Malignant Hy | 1982 |
Dantrolene does not block calcium pulse-induced calcium release from a putative calcium channel in sarcoplasmic reticulum from malignant hyperthermia and normal pig muscle.
Topics: Animals; Caffeine; Calcium; Dantrolene; Halothane; Ion Channels; Malignant Hyperthermia; Muscle Cont | 1984 |
End-tidal CO2 monitoring. Its use in the diagnosis and management of malignant hyperthermia.
Topics: Carbon Dioxide; Child; Dantrolene; Humans; Infant; Male; Malignant Hyperthermia; Monitoring, Physiol | 1984 |
Malignant hyperthermia in pregnancy.
Topics: Administration, Oral; Anesthesia, Obstetrical; Cesarean Section; Dantrolene; Female; Humans; Infant, | 1984 |
Prophylactic and therapeutic doses of dantrolene for malignant hyperthermia.
Topics: Adult; Child; Dantrolene; Humans; Malignant Hyperthermia | 1984 |
Malignant hyperpyrexia.
Topics: Adult; Anesthesia, General; Animals; Calcium; Child; Dantrolene; Heat Exhaustion; Humans; Malignant | 1984 |
[Treatment of malignant hyperthermia by dantrolene sodium administered through a nasogastric tube].
Topics: Adult; Anesthesia, General; Dantrolene; Dosage Forms; Humans; Intraoperative Complications; Intubati | 1984 |
[Malignant hyperthermia].
Topics: Child; Cysts; Dantrolene; Humans; Hypothermia, Induced; Male; Malignant Hyperthermia; Mandibular Dis | 1984 |
Dantrolene sodium and management of malignant hyperthermia.
Topics: Adult; Aged; Dantrolene; Humans; Malignant Hyperthermia; Middle Aged; Prognosis | 1983 |
Malignant hyperthermia in dental patients.
Topics: Adolescent; Anesthesia, Dental; Dantrolene; Electrocardiography; Electroencephalography; Epinephrine | 1984 |
Dantrolene dose response in awake man: implications for management of malignant hyperthermia.
Topics: Adult; Central Nervous System; Dantrolene; Female; Hand; Hemodynamics; Humans; Kinetics; Male; Malig | 1983 |
Malignant hyperthermia. A review and case report.
Topics: Adult; Anesthesia, Intravenous; Dantrolene; Humans; Male; Malignant Hyperthermia; Succinylcholine; T | 1983 |
Postoperative malignant hyperthermia and dantrolene therapy.
Topics: Child, Preschool; Dantrolene; Female; Humans; Infusions, Parenteral; Malignant Hyperthermia; Postope | 1983 |
Treatment of malignant hyperthermia with dantrolene.
Topics: Child; Dantrolene; Female; Humans; Malignant Hyperthermia | 1983 |
[Malignant hyperthermia - therapy results with dantrolene. A case report].
Topics: Anesthesia, Inhalation; Appendectomy; Child, Preschool; Dantrolene; Female; Humans; Infusions, Paren | 1983 |
Malignant hyperthermia after oral and intravenous pretreatment with dantrolene in a patient susceptible to malignant hyperthermia.
Topics: Administration, Oral; Anesthesia; Child; Dantrolene; Humans; Injections, Intravenous; Male; Malignan | 1984 |
Dantrolene--in vitro studies in malignant hyperthermia susceptible (MHS) and normal skeletal muscle.
Topics: Animals; Caffeine; Calcium; Dantrolene; Dose-Response Relationship, Drug; Drug Interactions; Humans; | 1984 |
In vivo induced malignant hyperthermia in pigs. I. Physiological and biochemical changes and the influence of dantrolene sodium.
Topics: Adenosine; Adenosine Triphosphate; Adenylate Kinase; Animals; Creatine; Dantrolene; Inosine Monophos | 1984 |
In vivo induced malignant hyperthermia in pigs. III. Localization of calcium in skeletal muscle mitochondria by means of electronmicroscopy and microprobe analysis.
Topics: Animals; Biopsy; Calcium; Cytosol; Dantrolene; Electron Probe Microanalysis; Extracellular Space; Ma | 1984 |
Malignant hyperthermia and glucose-6-phosphate dehydrogenase deficiency.
Topics: Dantrolene; Glucosephosphate Dehydrogenase Deficiency; Humans; Infant; Male; Malignant Hyperthermia | 1984 |
Mitochondrial and plasma membrane changes in skeletal muscle in the malignant hyperthermia syndrome.
Topics: Calcium; Cell Membrane; Dantrolene; Humans; Malignant Hyperthermia; Membrane Potentials; Mitochondri | 1984 |
[Dantrolen solution of high active substance concentration. Preliminary communication (author's transl)].
Topics: Animals; Carbon Dioxide; Dantrolene; Dose-Response Relationship, Drug; Infusions, Parenteral; Malign | 1980 |
Malignant hyperthermia in Duchenne muscular dystrophy.
Topics: Biopsy; Child, Preschool; Creatine Kinase; Dantrolene; Humans; Male; Malignant Hyperthermia; Muscles | 1983 |
Controversies regarding the prophylactic use of dantrolene for malignant hyperthermia.
Topics: Animals; Dantrolene; Humans; Malignant Hyperthermia; Premedication; Swine | 1983 |
Malignant hyperthermia in a child with Duchenne muscular dystrophy.
Topics: Child, Preschool; Dantrolene; Humans; Male; Malignant Hyperthermia; Muscular Dystrophies; Preanesthe | 1983 |
More on ECT and malignant hyperthermia.
Topics: Dantrolene; Electroconvulsive Therapy; Humans; Malignant Hyperthermia; Succinylcholine | 1983 |
Malignant hyperthermia-like reactions in three anesthetized horses.
Topics: Anesthesia, General; Animals; Dantrolene; Female; Halothane; Horse Diseases; Horses; Male; Malignant | 1983 |
The control of muscle contracture by the action of dantrolene on the sarcolemma.
Topics: Animals; Caffeine; Dantrolene; Diaphragm; Dinitrophenols; Dose-Response Relationship, Drug; Halothan | 1983 |
[Malignant hyperthermia. III. Progress report on serum CK activity, questionable screening test, effect of dantrolene in family members with a hereditary disposition].
Topics: Adolescent; Adult; Aged; Child; Cholesterol; Cholinesterases; Creatine Kinase; Dantrolene; Erythrocy | 1983 |
Calcium-induced Ca2+ release from sarcoplasmic reticulum of pigs susceptible to malignant hyperthermia. The effects of halothane and dantrolene.
Topics: Animals; Calcium; Dantrolene; Halothane; Kinetics; Malignant Hyperthermia; Sarcoplasmic Reticulum; S | 1983 |
[Successful treatment of malignant hyperthermia with dantrolene-sodium and uneventful re-anaesthesia after oral dantrolene-prophylaxis (author's transl)].
Topics: Adult; Anesthesia, General; Dantrolene; Humans; Male; Malignant Hyperthermia; Menisci, Tibial; Micro | 1982 |
Dantrium: the approved drug to control malignant hyperthermia.
Topics: Dantrolene; Humans; Malignant Hyperthermia; Nursing Assessment | 1980 |
Malignant hyperpyrexia.
Topics: Adult; Anesthetics; Animals; Cryotherapy; Dantrolene; Female; Humans; Male; Malignant Hyperthermia; | 1981 |
Effective use of dantrolene in a patient susceptible to malignant hyperthermia.
Topics: Adolescent; Anesthesia, General; Dantrolene; Facial Bones; Fractures, Bone; Humans; Male; Malignant | 1980 |
Screening for malignant hyperthermia susceptibility.
Topics: Caffeine; Dantrolene; Halothane; Humans; Malignant Hyperthermia; Mass Screening; Muscle Contraction; | 1980 |
A collaborative clinical trial on trial.
Topics: Clinical Trials as Topic; Dantrolene; Humans; Malignant Hyperthermia; Research Design | 1982 |
Malignant hyperthermia: description and case report.
Topics: Adolescent; Anesthesia, Inhalation; Dantrolene; Humans; Male; Malignant Hyperthermia; Muscle Relaxan | 1982 |
[Neuroleptic malignant syndrome. Beneficial effects of dantrolene on hyperthermia and hypertonia (author's transl)].
Topics: Adolescent; Basal Ganglia Diseases; Calcium; Dantrolene; Fever; Haloperidol; Humans; Male; Malignant | 1982 |
Malignant hyperthermia.
Topics: Dantrolene; Humans; Lidocaine; Malignant Hyperthermia; Succinylcholine; Tachycardia | 1982 |
Heat stroke and malignant hyperpyrexia.
Topics: Adult; Dantrolene; Heat Exhaustion; Humans; Male; Malignant Hyperthermia | 1982 |
ECT use for a patient with malignant hyperthermia.
Topics: Adult; Dantrolene; Depressive Disorder; Electroconvulsive Therapy; Female; Humans; Malignant Hyperth | 1982 |
[Dantrolene and malignant hyperthermia].
Topics: Dantrolene; Humans; Malignant Hyperthermia | 1982 |
[Anaesthesia in a patient susceptible to malignant hyperthermia (author's transl)].
Topics: Adolescent; Anesthesia, General; Body Temperature Regulation; Dantrolene; Epiphyses, Slipped; Female | 1982 |
[Transient normalisation of CK blood levels in patients susceptible to malignant hyperthermia by oral administration of dantrolene (author's transl)].
Topics: Administration, Oral; Adult; Creatine Kinase; Dantrolene; Female; Humans; Male; Malignant Hypertherm | 1982 |
Dantrolene and malignant hyperthermia.
Topics: Dantrolene; Humans; Malignant Hyperthermia | 1982 |
Dantrolene sodium in the treatment of malignant hypertension.
Topics: Child; Dantrolene; Female; Humans; Malignant Hyperthermia | 1982 |
[Malignant hyperthermia. Current aspects of dantrolene treatment of 2 cases of hyperthermia maligna incipiens].
Topics: Child; Dantrolene; Humans; Hypospadias; Male; Malignant Hyperthermia; Testis | 1982 |
Clodanolene sodium and malignant hyperpyrexia.
Topics: Animals; Dantrolene; Imidazoles; In Vitro Techniques; Malignant Hyperthermia; Muscle Contraction; Mu | 1982 |
Malignant hyperthermia in a myopathic child. Prolonged postoperative course requiring dantrolene.
Topics: Dantrolene; Humans; Infant; Malignant Hyperthermia; Muscular Dystrophies; Postoperative Complication | 1982 |
Effect of dantrolene on leg metabolism in porcine malignant hyperthermia.
Topics: Animals; Dantrolene; Hindlimb; Malignant Hyperthermia; Muscles; Swine | 1982 |
Human malignant hyperthermia: awake episodes and correction by dantrolene.
Topics: Adenosine Triphosphate; Adult; Caffeine; Dantrolene; Fatigue; Female; Halothane; Humans; In Vitro Te | 1980 |
Management of malignant hyperthermia.
Topics: Abnormalities, Multiple; Anesthesia, General; Child, Preschool; Dantrolene; Female; Humans; Malignan | 1981 |
Malignant hyperpyrexia: an update for the otolaryngologist.
Topics: Adolescent; Adult; Aged; Animals; Child; Child, Preschool; Dantrolene; Disease Susceptibility; Diure | 1981 |
[On the treatment of malignant hyperthermia. A simple method of preparing a dantrolene sodium solution (author's transl)].
Topics: Dantrolene; Drug Compounding; Malignant Hyperthermia; Solutions | 1981 |
Dantrolene treatment of malignant hyperthermia.
Topics: Animals; Dantrolene; Dog Diseases; Dogs; Malignant Hyperthermia | 1981 |
Malignant hyperthermia: current perspectives.
Topics: Creatine Kinase; Dantrolene; Humans; Malignant Hyperthermia; Muscle Contraction | 1981 |
[Malignant hyperthermia--now a controllable potentially lethal anesthesia complication].
Topics: Age Factors; Child; Dantrolene; Female; Humans; Male; Malignant Hyperthermia; Sex Factors | 1981 |
[Malignant hyperthermia. Immediate treatment and procedure in another anesthesia].
Topics: Anesthesia; Dantrolene; Humans; Malignant Hyperthermia; Oxygen Inhalation Therapy; Respiration, Arti | 1981 |
[Recently registered drugs in Belgium].
Topics: Bacteroides Infections; Dantrolene; Humans; Malignant Hyperthermia; Metronidazole | 1981 |
Malignant hyperthermia syndrome.
Topics: Calcium; Calcium Channel Blockers; Child, Preschool; Dantrolene; Female; Humans; Injections, Intrave | 1981 |
Dantrolene sodium in the treatment of malignant hyperthermia. A case report.
Topics: Child; Dantrolene; Female; Humans; Malignant Hyperthermia | 1981 |
[Sodium dantrolene in the treatment of malignant hyperthermia].
Topics: Animals; Dantrolene; Female; Humans; Male; Malignant Hyperthermia | 1981 |
Malignant hyperthermia in myelomeningocele: a previously unreported association.
Topics: Child, Preschool; Dantrolene; Female; Humans; Male; Malignant Hyperthermia; Meningomyelocele; Premed | 1981 |
Malignant hyperthermia in a halothane-anesthetized horse.
Topics: Anesthesia, Inhalation; Animals; Dantrolene; Fluid Therapy; Halothane; Horse Diseases; Horses; Male; | 1981 |
Advances in the diagnosis and treatment of malignant hyperthermia.
Topics: Dantrolene; Female; Humans; Male; Malignant Hyperthermia | 1981 |
Porcine malignant hyperthermia--failure of dantrolene dose response to diagnose susceptibility (halothane effect).
Topics: Animals; Dantrolene; Dose-Response Relationship, Drug; Drug Synergism; Female; Halothane; Male; Mali | 1980 |
The chick as a model for malignant hyperpyrexia.
Topics: Animals; Calcium; Chickens; Dantrolene; Disease Models, Animal; Drug Evaluation, Preclinical; Malign | 1980 |
Dantrolene dose response in malignant hyperthermia-susceptible (MHS) swine: method to obtain prophylaxis and therapeusis.
Topics: Animals; Dantrolene; Dose-Response Relationship, Drug; Female; Hydrogen-Ion Concentration; Lactates; | 1980 |
[Malignant hyperthermia].
Topics: Adolescent; Adult; Aged; Anesthesia, General; Calcium; Child; Child, Preschool; Dantrolene; Forensic | 1980 |
[Malignant hyperthermia. II. Investigation of the patient's family (author's transl)].
Topics: Child, Preschool; Creatine Kinase; Dantrolene; Electromyography; Female; Humans; Isoenzymes; Maligna | 1980 |
Site of the muscle cell abnormality in swine susceptible to malignant hyperpyrexia.
Topics: Acetylcholine; Animals; Caffeine; Dantrolene; Halothane; In Vitro Techniques; Malignant Hyperthermia | 1980 |
Dantrolene and caffeine contracture test.
Topics: Adult; Caffeine; Dantrolene; Female; Humans; Malignant Hyperthermia; Muscle Contraction | 1980 |
Dantrolene and caffeine contracture test.
Topics: Adult; Caffeine; Dantrolene; Female; Humans; Malignant Hyperthermia; Muscle Contraction | 1980 |
Dantrolene for malignant hyperthermia during anesthesia.
Topics: Anesthesia; Dantrolene; Humans; Malignant Hyperthermia | 1980 |
Modification of ryanodine toxicity by dantrolene and halothane in a model of malignant hyperthermia.
Topics: Alkaloids; Animals; Dantrolene; Diaphragm; Disease Models, Animal; Halothane; In Vitro Techniques; M | 1980 |
Dantrolene therapy for malignant hyperthermia.
Topics: Adult; Child, Preschool; Dantrolene; Female; Humans; Malignant Hyperthermia | 1980 |
Dantrolene and the treatment of malignant hyperthermia.
Topics: Dantrolene; Humans; Malignant Hyperthermia | 1980 |
[New aspects in the clinical picture of malignant hyperthermia (author's transl)].
Topics: Adenosine Triphosphate; Adenylate Kinase; Adult; Calcium; Child; Creatine Kinase; Dantrolene; Female | 1980 |
Puzzles in malignant hyperthermia.
Topics: Anesthesia; Dantrolene; Humans; Malignant Hyperthermia | 1981 |
Malignant hyperthermia following preoperative oral administration of dantrolene.
Topics: Adjuvants, Anesthesia; Anesthetics; Child; Creatine Kinase; Dantrolene; Humans; Male; Malignant Hype | 1981 |
[Treatment of malignant hyperthermia with dantrolene].
Topics: Dantrolene; Humans; Malignant Hyperthermia | 1980 |
Malignant hyperthermia--still around.
Topics: Cerebral Palsy; Dantrolene; Hernia, Inguinal; Humans; Infant; Malignant Hyperthermia | 1995 |
Alterations of inositol polyphosphates in skeletal muscle during porcine malignant hyperthermia.
Topics: Anesthetics, Inhalation; Animals; Chromatography, High Pressure Liquid; Dantrolene; Disease Suscepti | 1995 |
Malignant hyperthermia and compartment syndrome.
Topics: Adult; Compartment Syndromes; Dantrolene; Humans; Male; Malignant Hyperthermia; Muscle Relaxants, Ce | 1995 |
Malignant hyperthermia: not just an operating room emergency.
Topics: Adult; Dantrolene; Humans; Male; Malignant Hyperthermia; Nursing Assessment; Perioperative Nursing | 1993 |
[Lack of sensitivity to per-anesthetic malignant hyperthermia in 32 patients who developed neuroleptic malignant syndrome].
Topics: Adolescent; Adult; Aged; Anesthesia, General; Caffeine; Contracture; Creatine Kinase; Dantrolene; Di | 1994 |
Incidence of malignant hyperthermia reactions in 2,214 patients undergoing muscle biopsy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anesthesia Recovery Period; Anesthesia, Conduction; Anes | 1995 |
Modulation of ryanodine-induced contractures in human skeletal muscle pretreated with dantrolene.
Topics: Adolescent; Adult; Calcium; Child; Dantrolene; Dose-Response Relationship, Drug; Female; Humans; Mal | 1995 |
Malignant hyperthermia treated without dantrolene.
Topics: Child; Child, Preschool; Cryotherapy; Dantrolene; Humans; Intraoperative Complications; Male; Malign | 1994 |
Lack of prophylactic or therapeutic efficacy of 5-HT2A receptor antagonists in halothane-induced porcine malignant hyperthermia.
Topics: Animals; Blood Pressure; Body Temperature; Dantrolene; Female; Halothane; Heart Rate; Ketanserin; Ma | 1994 |
Clinical variability of possible malignant hyperthermia as revealed by two cases.
Topics: Adolescent; Adult; Appendicitis; Combined Modality Therapy; Critical Care; Dantrolene; Heart Arrest; | 1994 |
Clinical effects of intravenously administered dantrolene.
Topics: Adult; Dantrolene; Dizziness; Fatigue; Female; Humans; Infusions, Intravenous; Male; Malignant Hyper | 1995 |
Dantrolene and thyroid crisis.
Topics: Dantrolene; Diagnosis, Differential; Humans; Malignant Hyperthermia; Thyroid Crisis | 1994 |
Anaesthesia for caesarean delivery of a malignant hyperthermia susceptible parturient.
Topics: Adult; Anesthesia, Inhalation; Anesthesia, Obstetrical; Anesthesia, Spinal; Bupivacaine; Cesarean Se | 1994 |
Hyperthermia requiring prolonged administration of high-dose dantrolene in the postoperative period.
Topics: Adult; Dantrolene; Humans; Male; Malignant Hyperthermia; Postoperative Complications | 1995 |
Effect of dantrolene treatment on muscle metabolism and meat quality of anesthetized pigs of different halothane genotypes.
Topics: Anesthesia; Animals; Biopsy, Needle; Calcium; Creatine; Dantrolene; Genotype; Glycogen; Halothane; H | 1994 |
[Malignant hyperthermia in swine during isoflurane anesthesia].
Topics: Anesthesia, Inhalation; Animals; Carbon Dioxide; Dantrolene; Isoflurane; Malignant Hyperthermia; Swi | 1994 |
[Malignant hyperthermia in Tuscany: a study of a five year period from 1986 to 1990].
Topics: Adolescent; Adult; Child; Dantrolene; Female; Humans; Italy; Male; Malignant Hyperthermia; Surveys a | 1994 |
Malignant hyperthermia.
Topics: Anesthetics; Carbon Dioxide; Dantrolene; Disease Susceptibility; Humans; Malignant Hyperthermia; Ris | 1993 |
[A case report of malignant hyperthermia in a 14-month-old boy].
Topics: Dantrolene; Humans; Infant; Intraoperative Complications; Male; Malignant Hyperthermia; Mastoiditis | 1994 |
Malignant hyperthermia and severe hypoglycemia after reexposure to halothane.
Topics: Child, Preschool; Dantrolene; Female; Halothane; Humans; Hypoglycemia; Liver; Malignant Hyperthermia | 1994 |
Management of lethal catatonia with dantrolene sodium.
Topics: Catatonia; Dantrolene; Electroconvulsive Therapy; Humans; Malignant Hyperthermia; Neuroleptic Malign | 1993 |
Improvement of brain electrical activity during treatment of porcine malignant hyperthermia with dantrolene.
Topics: Animals; Blood Pressure; Brain; Carbon Dioxide; Dantrolene; Electroencephalography; Halothane; Malig | 1993 |
[The use of subarachnoid bupivacaine analgesia in malignant hyperthermia-susceptible subjects. A clinical case report].
Topics: Adult; Anesthesia, Spinal; Bupivacaine; Dantrolene; Female; Humans; Intraoperative Complications; Ma | 1993 |
[Malignant hyperthermia. Physiologic and genetic principles].
Topics: Animals; Calcium; Dantrolene; Energy Metabolism; Humans; Malignant Hyperthermia; Muscle Contraction; | 1993 |
[Caesarean section in a patient with past history of fulminant malignant hyperthermia].
Topics: Adult; Anesthesia, Obstetrical; Anesthesia, Spinal; Cesarean Section; Dantrolene; Disease Susceptibi | 1993 |
Hypersensitive response of malignant hyperthermia-susceptible skeletal muscle to inositol 1,4,5-triphosphate induced release of calcium.
Topics: Calcium; Dantrolene; Humans; In Vitro Techniques; Inositol 1,4,5-Trisphosphate; Malignant Hypertherm | 1995 |
Malignant hyperthermia in the otology patient: the UCLA experience.
Topics: Administration, Inhalation; Adult; Anesthetics; Caffeine; Child; Child, Preschool; Dantrolene; Femal | 1994 |
Intravenous lecithin-coated microcrystals of dantrolene are effective in the treatment of malignant hyperthermia: an investigation in rats, dogs, and swine.
Topics: Animals; Crystallization; Dantrolene; Dogs; Dose-Response Relationship, Drug; Malignant Hyperthermia | 1996 |
This looks like malignant hyperthermia!
Topics: Dantrolene; Education, Nursing, Continuing; Emergencies; Humans; Malignant Hyperthermia; Muscle Rela | 1995 |
Successful treatment of intraoperative malignant hyperthermia during renal transplantation.
Topics: Adult; Anesthesia, General; Dantrolene; Humans; Intraoperative Complications; Ischemia; Kidney; Kidn | 1996 |
Complex pharmacology of malignant hyperthermia.
Topics: Calcium; Calcium Channels; Dantrolene; Humans; Malignant Hyperthermia; Muscle Proteins; Ryanodine Re | 1996 |
Dantrolene sodium can increase or attenuate activity of skeletal muscle ryanodine receptor calcium release channel. Clinical implications.
Topics: Animals; Calcium Channels; Dantrolene; Dogs; Humans; In Vitro Techniques; Malignant Hyperthermia; Mu | 1996 |
IARS annual meeting includes safety topics.
Topics: Anesthesia, Conduction; Anesthesia, General; Anesthesiology; Anesthetics; Congresses as Topic; Dantr | 1996 |
[A case of malignant hyperthermia without hyperthermia].
Topics: Adolescent; Carbon Dioxide; Creatine Kinase; Dantrolene; Drug Eruptions; Fasciculation; Female; Huma | 1995 |
Catheter-associated central venous thrombosis.
Topics: Adult; Bipolar Disorder; Catheterization, Central Venous; Dantrolene; Female; Fluid Therapy; Haloper | 1996 |
The reduction of skeletal muscle lesions after experimental stress in stress-susceptible pigs protected with dantrolene.
Topics: Animals; Dantrolene; Female; Male; Malignant Hyperthermia; Muscle Relaxants, Central; Muscle, Skelet | 1995 |
Reduced Mg2+ inhibition of Ca2+ release in muscle fibers of pigs susceptible to malignant hyperthermia.
Topics: Animals; Caffeine; Calcium; Calcium Channel Blockers; Dantrolene; Genetic Predisposition to Disease; | 1997 |
Dantrolene and "ecstasy".
Topics: Calcium; Dantrolene; Hallucinogens; Humans; In Vitro Techniques; Malignant Hyperthermia; Muscle Cont | 1997 |
[A case of malignant syndrome triggered by the use of haloperidol and chrorpromazine].
Topics: Adult; Antipsychotic Agents; Anxiety; Autonomic Nervous System Diseases; Basal Ganglia Diseases; Chl | 1997 |
Antagonism of suxamethonium-induced jaw muscle contracture in rats.
Topics: Animals; Dantrolene; Male; Malignant Hyperthermia; Masseter Muscle; Muscle Relaxants, Central; Muscl | 1997 |
Suspected malignant hyperthermia in a 13-month-old: today's "typical" episode--a case report.
Topics: Age Factors; Biopsy; Dantrolene; Female; Humans; Infant; Malignant Hyperthermia; Muscle Relaxants, C | 1997 |
A case of suspected malignant hyperthermia during desflurane administration.
Topics: Adolescent; Anesthesia, Closed-Circuit; Anesthetics, Inhalation; Carbon Dioxide; Cerebral Angiograph | 1997 |
Pharmacological distinction between dantrolene and ryanodine binding sites: evidence from normal and malignant hyperthermia-susceptible porcine skeletal muscle.
Topics: Animals; Binding Sites; Cell Membrane; Dantrolene; Malignant Hyperthermia; Muscle Relaxants, Central | 1997 |
Fatal outcome after propofol sedation in children.
Topics: Acidosis; Arrhythmias, Cardiac; Cardiac Output, Low; Cause of Death; Child; Creatine Kinase; Dantrol | 1997 |
Propofol and malignant hyperthermia susceptibility.
Topics: Acidosis; Adolescent; Adult; Aged; Anesthetics, Intravenous; Arrhythmias, Cardiac; Cause of Death; C | 1997 |
Fatal outcome after propofol sedation in children.
Topics: Anesthetics, Intravenous; Cause of Death; Child; Dantrolene; Disease Susceptibility; Humans; Hypnoti | 1997 |
Attenuation of serotonin-induced contractures in skeletal muscle from malignant hyperthermia-susceptible patients with dantrolene.
Topics: Adolescent; Adult; Amphetamines; Child; Child, Preschool; Dantrolene; Humans; Malignant Hyperthermia | 1997 |
[Intraoperative malignant hyperthermia: apropos of a case].
Topics: Dantrolene; Diagnosis, Differential; Female; Humans; Malignant Hyperthermia; Middle Aged; Muscle Rel | 1997 |
Malignant hyperthermia. It could happen to you.
Topics: Adult; Anesthesia; Dantrolene; Emergencies; Female; Humans; Male; Malignant Hyperthermia; Muscle Rel | 1996 |
Prophylactic use of dantrolene in a patient with central core disease.
Topics: Cardiomyopathy, Dilated; Chemoprevention; Dantrolene; Disease Susceptibility; Heart Transplantation; | 1998 |
Rhabdomyolysis after infection and taking a cold medicine in a patient who was susceptible to malignant hyperthermia.
Topics: Adult; Caffeine; Chlorpheniramine; Common Cold; Dantrolene; Halothane; Humans; In Vitro Techniques; | 1998 |
Emergency! Malignant hyperthermia.
Topics: Child; Dantrolene; Emergencies; Humans; Male; Malignant Hyperthermia; Muscle Relaxants, Central | 1998 |
Efficacy of prolonged large-dose dantrolene for severe neuroleptic malignant syndrome.
Topics: Adult; Antipsychotic Agents; Dantrolene; Humans; Male; Malignant Hyperthermia | 1998 |
Elimination of hypercapnia may postpone the clinical presentation of malignant hyperthermia: a case report.
Topics: Adult; Dantrolene; Humans; Hypercapnia; Male; Malignant Hyperthermia | 1998 |
Human malignant hyperthermia associated with desflurane anesthesia.
Topics: Adolescent; Adult; Aged; Anesthetics, Inhalation; Child; Child, Preschool; Dantrolene; Databases as | 1998 |
[Malignant hyperthermia and appendicular sepsis. Can they be differentiated during surgical procedure?].
Topics: Adolescent; Adult; Appendicitis; Child; Dantrolene; Diagnosis, Differential; Female; Fever; Humans; | 1997 |
Secretion of dantrolene into breast milk after acute therapy of a suspected malignant hyperthermia crisis during cesarean section.
Topics: Adult; Cesarean Section; Dantrolene; Female; Humans; Lactation; Malignant Hyperthermia; Milk, Human; | 1998 |
Control of the malignant hyperpyrexic syndrome in MHS swine by dantrolene sodium. 1975.
Topics: Animals; Dantrolene; History, 20th Century; Malignant Hyperthermia; Muscle Relaxants, Central; South | 1998 |
Malignant hyperthermia and neuroleptic malignant syndrome in a patient during treatment for acute asthma.
Topics: Acute Disease; Adjuvants, Anesthesia; Adult; Anesthetics, Inhalation; Asthma; Bronchodilator Agents; | 1999 |
Malignant hyperpyrexic syndrome.
Topics: Animals; Dantrolene; History, 20th Century; Humans; Malignant Hyperthermia; Muscle Relaxants, Centra | 1999 |
[Importance of capnography in the early clinical diagnosis of malignant hyperthermia syndrome].
Topics: Blood Gas Monitoring, Transcutaneous; Child; Dantrolene; Humans; Male; Malignant Hyperthermia; Muscl | 1999 |
Malignant hyperthermia.
Topics: Dantrolene; Humans; Malignant Hyperthermia; Muscle Relaxants, Central; Operating Rooms | 1999 |
Suspected recurrence of malignant hyperthermia after post-extubation shivering in the intensive care unit, 18 h after tonsillectomy.
Topics: Adult; Dantrolene; Disease Susceptibility; Humans; Male; Malignant Hyperthermia; Muscle Relaxants, C | 1999 |
Hemodynamic and metabolic alterations in response to graded exercise in a patient susceptible to malignant hyperthermia.
Topics: Adult; Dantrolene; Exercise; Genetic Predisposition to Disease; Hemodynamics; Humans; Male; Malignan | 2000 |
[Letter DGS/DH dated November 18, 1999 on the treatment of paranesthetic malignant hyperthermia (MH)].
Topics: Anesthesia, General; Anesthesiology; Dantrolene; France; Humans; Malignant Hyperthermia; Muscle Rela | 2000 |
Cyclic ADP-ribose induces a larger than normal calcium release in malignant hyperthermia-susceptible skeletal muscle fibers.
Topics: Adenosine Diphosphate Ribose; Animals; Calcium; Calcium Channel Blockers; Cyclic ADP-Ribose; Dantrol | 2000 |
Dantrolene in malignant hyperthermia (MH)-susceptible patients with exaggerated exercise stress.
Topics: Dantrolene; Exercise; Humans; Malignant Hyperthermia | 2000 |
An unusual case of malignant hyperthermia during desflurane anesthesia in an African-American patient.
Topics: Adult; Androstanols; Anesthesia, Inhalation; Anesthetics, Inhalation; Anesthetics, Intravenous; Blac | 2000 |
[A case of high dose administration of propofol].
Topics: Adult; Anesthesia, General; Cholesterol; Dantrolene; Humans; Male; Malignant Hyperthermia; Postopera | 2000 |
Product review: refrigerated malignant hyperthermia cart.
Topics: Dantrolene; Drug Storage; Emergency Treatment; Equipment Design; Fluid Therapy; Humans; Malignant Hy | 2001 |
Malignant hyperthermia in a patient with Graves' disease during subtotal thyroidectomy.
Topics: Acidosis, Respiratory; Adult; Anesthetics; Antithyroid Agents; Carbon Dioxide; Creatine Kinase; Dant | 2001 |
[Two pediatric cases of malignant hyperthermia caused by sevoflurane].
Topics: Anesthetics, Inhalation; Child; Dantrolene; Female; Humans; Infant; Male; Malignant Hyperthermia; Me | 2001 |
Pre-anaesthetic administration of dantrolene sodium to a patient at risk from malignant hyperthermia: case report.
Topics: Child; Dantrolene; Diarrhea; Humans; Hydantoins; Male; Malignant Hyperthermia; Preanesthetic Medicat | 1978 |
Dantrolene sodium in the management of patients at risk from malignant hyperthermia.
Topics: Adult; Anesthesia, Dental; Creatine Kinase; Dantrolene; Female; Humans; Malignant Hyperthermia; Risk | 1979 |
Malignant hyperthermia.
Topics: Anesthesia, Dental; Dantrolene; Humans; Malignant Hyperthermia | 1979 |
Rationale for dantrolene vs. procainamide for treatment of malignant hyperthermia.
Topics: Animals; Dantrolene; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Halothane; Hy | 1979 |
[Therapy of malignant hyperthermia, preliminary report].
Topics: Dantrolene; Drug Compounding; Humans; Malignant Hyperthermia; Solutions | 1979 |
Malignant hyperthermia. A potentially fatal syndrome in orthopaedic patients.
Topics: Adult; Animals; Child, Preschool; Dantrolene; Female; Genes, Dominant; Humans; Male; Malignant Hyper | 1979 |
A screening test for the malignant hyperpyrexia phenotype using suxamethonium-induced contracture of muscle treated with caffeine and its inhibition by dantrolene.
Topics: Adolescent; Adult; Caffeine; Child; Dantrolene; Drug Synergism; Humans; Malignant Hyperthermia; Midd | 1979 |
Increased carbon dioxide production in two patients with malignant hyperpyrexia and its control by dantolene.
Topics: Adult; Carbon Dioxide; Dantrolene; Dopamine; Female; Humans; Male; Malignant Hyperthermia | 1979 |
Successful use of dantrolene sodium in human malignant hyperthermia syndrome: a case report.
Topics: Adult; Anesthesia, Spinal; Dantrolene; Humans; Male; Malignant Hyperthermia | 1979 |
Dantrolene sodium approved for malignant hyperthermia.
Topics: Dantrolene; Humans; Malignant Hyperthermia; United States; United States Food and Drug Administratio | 1979 |
Anesthesia for elective surgery in patients susceptible to malignant hyperthermia.
Topics: Anesthesia, General; Anesthesia, Inhalation; Anesthesia, Local; Dantrolene; Disease Susceptibility; | 1979 |
Treatment of acute hyperthermia crises.
Topics: Acute Disease; Adult; Aged; Dantrolene; Humans; Male; Malignant Hyperthermia; Procainamide | 1979 |
Does prior dantrolene affect the in vitro diagnosis of malignant hyperthermia susceptibility?
Topics: Animals; Biopsy; Caffeine; Dantrolene; Drug Interactions; Halothane; In Vitro Techniques; Malignant | 1979 |
Malignant hyperpyrexia.
Topics: Adult; Anesthesia, General; Animals; Child; Dantrolene; Humans; Male; Malignant Hyperthermia; Swine | 1977 |
Treatment of porcine malignant hyperpyrexia. The successful use of dantrolene in the Pietrain pig.
Topics: Animals; Dantrolene; Hydantoins; Malignant Hyperthermia; Swine; Swine Diseases | 1977 |
The prophylaxis of malignant hyperthermia by oral dantrolene sodium in swine.
Topics: Administration, Oral; Anesthesia, General; Anesthesia, Inhalation; Animals; Dantrolene; Halothane; H | 1977 |
Malignant hyperpyrexia.
Topics: Dantrolene; Humans; Malignant Hyperthermia | 1977 |
Malignant hyperpyrexia.
Topics: Animals; Dantrolene; Humans; Male; Malignant Hyperthermia; Swine | 1977 |
Drug treatment of malignant hyperpyrexia.
Topics: Caffeine; Calcium; Dantrolene; Humans; Hydantoins; Malignant Hyperthermia; Muscle Contraction; Muscl | 1977 |
Role of sympathetic activity in porcine malignant hyperthermia.
Topics: Acidosis; Acidosis, Respiratory; Anesthesia, Conduction; Anesthesia, Spinal; Animals; Catecholamines | 1977 |
[Present-day views on the diagnosis of intraoperative malignant hyperthermia syndrome].
Topics: Dantrolene; Diagnostic Techniques, Surgical; Humans; Malignant Hyperthermia; Procainamide | 1977 |
Control of the malignant hyperpyrexic syndrome in MHS swine by dantrolene sodium.
Topics: Anesthesia, General; Animals; Dantrolene; Halothane; Hydantoins; Malignant Hyperthermia; Mannitol; S | 1975 |
Porcine malignant hyperthermia: effect of dantrolene sodium on in-vitro halothane-induced contraction of susceptible muscle.
Topics: Animals; Caffeine; Calcium; Contracture; Dantrolene; Halothane; Hydantoins; In Vitro Techniques; Mal | 1976 |
Dantrolene in porcine malignant hyperthermia.
Topics: Animals; Dantrolene; Halothane; Hydantoins; Malignant Hyperthermia; Succinylcholine; Swine | 1976 |
Dantrolene and azumolene inhibit [3H]PN200-110 binding to porcine skeletal muscle dihydropyridine receptors.
Topics: Animals; Caffeine; Calcium Channels; Dantrolene; Dihydropyridines; Imidazoles; Isradipine; Malignant | 1992 |
W-7, a calmodulin antagonist, and contracture of malignant hyperthermia susceptible skeletal muscle.
Topics: Animals; Caffeine; Calcium; Calmodulin; Dantrolene; Drug Synergism; Halothane; Intercellular Signali | 1992 |
Prolonged malignant hyperthermia in the absence of triggering agents.
Topics: Adolescent; Dantrolene; Disease Susceptibility; Humans; Intraoperative Complications; Male; Malignan | 1992 |
Educational computer simulation of malignant hyperthermia.
Topics: Adult; Body Temperature; Computer Simulation; Dantrolene; Education, Medical; Female; Halothane; Hum | 1992 |
Should all children with suspected or confirmed malignant hyperthermia susceptibility be admitted after surgery? A 10-year review.
Topics: Adolescent; Adult; Anesthesia; Child; Child, Preschool; Dantrolene; Female; Fever; Hospitalization; | 1992 |
31P NMR and freeze fracture studies of sarcoplasmic reticulum membranes from normal and malignant hyperthermic pigs: effect of halothane and dantrolene.
Topics: Animals; Dantrolene; Freeze Fracturing; Halothane; Magnetic Resonance Spectroscopy; Malignant Hypert | 1992 |
Effects of dantrolene on myoplasmic free [Ca2+] measured in vivo in patients susceptible to malignant hyperthermia.
Topics: Calcium; Dantrolene; Disease Susceptibility; Dose-Response Relationship, Drug; Electric Stimulation; | 1992 |
Neuroleptic malignant syndrome induced by domperidone.
Topics: Dantrolene; Diabetes Mellitus, Type 1; Domperidone; Female; Humans; Malignant Hyperthermia; Middle A | 1992 |
Dantrolene.
Topics: Dantrolene; Drug Interactions; Humans; Malignant Hyperthermia; Neuroleptic Malignant Syndrome; Spasm | 1992 |
Neuroleptic malignant syndrome.
Topics: Biomarkers; Dantrolene; Female; Humans; In Vitro Techniques; Male; Malignant Hyperthermia; Muscle Ri | 1992 |
A case of malignant hyperthermia?
Topics: Adult; Dantrolene; Humans; Isoflurane; Male; Malignant Hyperthermia; Muscles; Myoglobin; Succinylcho | 1991 |
[Fulminant malignant hyperthermia during the 6th general anesthesia using volatile anesthetics].
Topics: Adult; Anesthesia, Inhalation; Dantrolene; Female; Humans; Isoflurane; Kidney Transplantation; Malig | 1991 |
[In vitro diagnosis of malignant hyperpyrexia syndrome].
Topics: Adult; Caffeine; Dantrolene; Female; Halothane; Hernia, Inguinal; Humans; In Vitro Techniques; Male; | 1991 |
The effect of azumolene on hypercontractility and sarcoplasmic reticulum Ca(2+)-dependent ATPase activity of malignant hyperpyrexia-susceptible porcine skeletal muscle.
Topics: Animals; Caffeine; Calcium-Transporting ATPases; Dantrolene; Halothane; Imidazoles; Malignant Hypert | 1991 |
Pharmacokinetics of dantrolene in an adult patient undergoing cardiopulmonary bypass.
Topics: Aged; Blood Pressure; Cardiac Output; Cardiopulmonary Bypass; Central Venous Pressure; Dantrolene; H | 1991 |
[Malignant hyperthermia in a child with acute lymphatic leukemia].
Topics: Child, Preschool; Dantrolene; Humans; Male; Malignant Hyperthermia; Masseter Muscle; Precursor Cell | 1991 |
[Reasons for the persistent lethality of malignant hyperthermia and recommendations for its reduction].
Topics: Anesthesia; Dantrolene; Humans; Malignant Hyperthermia; Monitoring, Intraoperative | 1991 |
Neuroleptic malignant syndrome versus malignant hyperthermia.
Topics: Dantrolene; Diagnosis, Differential; Humans; Malignant Hyperthermia; Neuroleptic Malignant Syndrome | 1991 |
Intravenous dantrolene does not exhibit calcium channel blocking effects on the cardiac conduction system in humans.
Topics: Adult; Anti-Arrhythmia Agents; Calcium Channel Blockers; Dantrolene; Female; Heart Conduction System | 1991 |
Phaeochromocytoma presenting as MH.
Topics: Adrenal Gland Neoplasms; Carbon Dioxide; Dantrolene; Diagnosis, Differential; Humans; Malignant Hype | 1991 |
Malignant hyperthermia in dogs.
Topics: Animals; Biopsy; Caffeine; Crosses, Genetic; Dantrolene; Dog Diseases; Dogs; Female; Halothane; Hear | 1991 |
Dantrolene reduces myoplasmic free [Ca2+] in patients with malignant hyperthermia.
Topics: Calcium; Dantrolene; Humans; Malignant Hyperthermia; Muscles | 1990 |
Uptake and release of calcium ions by heavy sarcoplasmic reticulum fraction of normal and malignant hyperthermia-susceptible human skeletal muscle.
Topics: Azides; Biological Transport, Active; Calcium; Calcium-Transporting ATPases; Dantrolene; Halothane; | 1990 |
Malignant hyperthermia crisis. Planning a mock demonstration.
Topics: Clinical Protocols; Dantrolene; Emergencies; Humans; Inservice Training; Malignant Hyperthermia; Pat | 1990 |
Multiple-pulse stimulation and dantrolene in malignant hyperthermia.
Topics: Adult; Dantrolene; Disease Susceptibility; Electric Stimulation; Electromyography; Female; Humans; L | 1990 |
Prophylactic use of dantrolene associated with prolonged postanesthetic recumbency in a horse.
Topics: Animals; Dantrolene; Horse Diseases; Horses; Male; Malignant Hyperthermia; Muscular Diseases; Postop | 1990 |
Anaesthesia in malignant hyperthermia-susceptible patients without dantrolene prophylaxis: a report of 30 cases.
Topics: Adolescent; Adult; Aged; Anesthesia, General; Child; Dantrolene; Disease Susceptibility; Female; Hum | 1990 |
Phaeochromocytoma in a malignant hyperthermia patient under anaesthesia.
Topics: Adrenal Gland Neoplasms; Anesthesia, Intravenous; Critical Care; Dantrolene; Diagnosis, Differential | 1990 |
Cocaine.
Topics: Acidosis; Ammonium Chloride; Bicarbonates; Cocaine; Dantrolene; Humans; Malignant Hyperthermia; Rhab | 1990 |
[The treatment of malignant hyperthermia].
Topics: Dantrolene; Humans; Injections, Intravenous; Malignant Hyperthermia | 1990 |
The effects of extracellular magnesium on myoplasmic [Ca2+] in malignant hyperthermia susceptible swine.
Topics: Animals; Calcium; Dantrolene; Disease Susceptibility; Extracellular Space; Halothane; Magnesium Sulf | 1990 |
Malignant hyperthermia: a potential crisis in the postanesthesia care unit.
Topics: Dantrolene; Female; Humans; Malignant Hyperthermia; Patient Care Planning; Recovery Room | 1990 |
[In vitro electrophysiological effects of sodium dantrolene on isolated preparations of Purkinje fibers and ventricular myocardium of sheep].
Topics: Action Potentials; Animals; Atropine; Dantrolene; Heart; Heart Conduction System; Heart Ventricles; | 1985 |
Abnormal membrane properties of the sarcoplasmic reticulum of pigs susceptible to malignant hyperthermia: modes of action of halothane, caffeine, dantrolene, and two other drugs.
Topics: Animals; Caffeine; Calcium; Dantrolene; Electron Spin Resonance Spectroscopy; Halothane; Intracellul | 1986 |
[Malignant neuroleptic syndrome and malignant hyperthermia--a comparison].
Topics: Adult; Amantadine; Bromocriptine; Calcium; Cross-Sectional Studies; Dantrolene; Female; Humans; Ion | 1986 |
Effects of halothane, caffeine, dantrolene and tetracaine on the calcium permeability of skeletal sarcoplasmic reticulum of malignant hyperthermic pigs.
Topics: Animals; Caffeine; Calcium; Cell Membrane Permeability; Dantrolene; Halothane; Kinetics; Malignant H | 1987 |
How much dantrolene? A case of fulminant malignant hyperthermia.
Topics: Adolescent; Anesthesia, General; Dantrolene; Dose-Response Relationship, Drug; Humans; Male; Maligna | 1989 |
Effect of diltiazem, verapamil and dantrolene on the contractility of isolated malignant hyperpyrexia-susceptible human skeletal muscle.
Topics: Caffeine; Dantrolene; Diltiazem; Disease Susceptibility; Halothane; Humans; In Vitro Techniques; Mal | 1989 |
Fatal thermal injury.
Topics: Dantrolene; Heat Exhaustion; Humans; Malignant Hyperthermia; Neuroleptic Malignant Syndrome | 1989 |
Malignant hyperthermia: effects of halothane on the surface membrane.
Topics: Action Potentials; Animals; Dantrolene; Halothane; Malignant Hyperthermia; Membrane Potentials; Musc | 1989 |
Effect of diltiazem and dantrolene on the contractility of isolated malignant hyperpyrexia-susceptible porcine skeletal muscle.
Topics: Animals; Caffeine; Dantrolene; Diltiazem; Dose-Response Relationship, Drug; Halothane; In Vitro Tech | 1989 |
Malignant hyperthermia in an office surgery suite: a case report.
Topics: Adult; Ambulatory Surgical Procedures; Dantrolene; Female; Humans; Malignant Hyperthermia; Nasal Sep | 1989 |
Malignant hyperthermia in a hemodialysis patient.
Topics: Acidosis; Dantrolene; Female; Humans; Hyperkalemia; Intraoperative Complications; Malignant Hyperthe | 1989 |
Prolonged vecuronium neuromuscular blockade in a patient receiving orally administered dantrolene.
Topics: Dantrolene; Drug Interactions; Electromyography; Female; Humans; Malignant Hyperthermia; Middle Aged | 1985 |
Sufentanil-midazolam anesthesia in malignant hyperthermia.
Topics: Adolescent; Anesthesia, General; Dantrolene; Fentanyl; Humans; Male; Malignant Hyperthermia; Midazol | 1988 |
Diagnosis and management of susceptibility to malignant hyperthermia in pregnancy.
Topics: Adult; Anesthesia, Obstetrical; Biopsy; Dantrolene; Delivery, Obstetric; Disease Susceptibility; Fem | 1989 |
Rewarming following hypothermic cardiopulmonary bypass in the malignant hyperthermia-susceptible patient: implications for diagnosis and perioperative management.
Topics: Cardiopulmonary Bypass; Dantrolene; Disease Susceptibility; Hot Temperature; Humans; Hypothermia, In | 1989 |
Acute thyroid crisis on induction of anaesthesia.
Topics: Acute Disease; Adult; Anesthesia, General; Dantrolene; Diagnosis, Differential; Humans; Male; Malign | 1989 |
Pharmacokinetics of intravenous dantrolene in children.
Topics: Child; Child, Preschool; Chromatography, High Pressure Liquid; Dantrolene; Disease Susceptibility; H | 1989 |
Cardiopulmonary bypass interference with dantrolene prophylaxis of malignant hyperthermia.
Topics: Anesthesia, Inhalation; Anesthesia, Intravenous; Cardiopulmonary Bypass; Child, Preschool; Dantrolen | 1987 |
Malignant hyperthermia in a Saudi child.
Topics: Bicarbonates; Critical Care; Dantrolene; Humans; Infant; Male; Malignant Hyperthermia; Mannitol; Sod | 1985 |
Treatment of porcine malignant hyperthermia: lactate gradient from muscle to blood.
Topics: Animals; Bicarbonates; Carbon Dioxide; Dantrolene; Halothane; Lactates; Lactic Acid; Malignant Hyper | 1986 |
Myoglobinuria versus hemoglobinuria.
Topics: Acute Kidney Injury; Alcoholism; Biopsy; Creatine Kinase; Dantrolene; Diagnosis, Differential; Hemog | 1988 |
Optimal treatment for malignant hyperthermia today.
Topics: Anesthesia; Clinical Protocols; Critical Care; Dantrolene; Humans; Malignant Hyperthermia; Postopera | 1988 |
Dantrolene in pregnancy: lack of adverse effects on the fetus and newborn infant.
Topics: Administration, Oral; Apgar Score; Dantrolene; Female; Fetus; Heart Rate, Fetal; Humans; Infant, New | 1988 |
Malignant hyperthermia and the conscious patient.
Topics: Anesthesia, Spinal; Anesthetics; Bupivacaine; Consciousness; Dantrolene; Humans; Male; Malignant Hyp | 1988 |
Disordered catecholamine release in pigs susceptible to malignant hyperthermia.
Topics: Animals; Catecholamines; Dantrolene; Female; Male; Malignant Hyperthermia; Stress, Physiological; Su | 1988 |
[Peranesthetic malignant hyperthermia].
Topics: Dantrolene; France; Humans; Malignant Hyperthermia; Self-Help Groups; United States | 1988 |
[Oral dantrolene in a parturient with myotonic dystrophy and susceptibility to malignant hyperthermia].
Topics: Administration, Oral; Adult; Anesthesia, Epidural; Anesthesia, Obstetrical; Cesarean Section; Creati | 1988 |
[Is the prevention of peranesthetic malignant hyperthermia with dantrolene justified?].
Topics: Anesthesia, General; Dantrolene; Humans; Male; Malignant Hyperthermia; Middle Aged; Premedication | 1988 |
[Registration of peranesthetic cases of malignant hyperthermia in France. An update].
Topics: Adolescent; Adult; Anesthetics; Child; Child, Preschool; Dantrolene; Female; France; Humans; Infant; | 1988 |
[Prophylactic use of oral dantrolene for spinal anesthesia in a patient with susceptible malignant hyperthermia].
Topics: Administration, Oral; Adolescent; Anesthesia, Spinal; Dantrolene; Humans; Intraoperative Complicatio | 1988 |
Malignant hyperthermia revisited.
Topics: Biopsy; Dantrolene; Disease Susceptibility; Humans; Malignant Hyperthermia; Muscular Diseases; Surge | 1988 |
Myoplasmic free [Ca2+] during a malignant hyperthermia episode in swine.
Topics: Animals; Calcium; Dantrolene; Halothane; Malignant Hyperthermia; Membrane Potentials; Muscles; Osmol | 1988 |
A faster way to reconstitute dantrolene sodium for malignant hyperthermia.
Topics: Dantrolene; Humans; Malignant Hyperthermia; Solutions; Syringes; Time Factors | 1988 |
Are we really prepared for malignant hyperthermia: Part II.
Topics: Dantrolene; Humans; Malignant Hyperthermia; Methods | 1988 |
Hyperkalemia after dantrolene and verapamil-dantrolene administration in dogs.
Topics: Animals; Blood Pressure; Calcium; Cardiac Output; Dantrolene; Dogs; Drug Interactions; Heart Rate; H | 1988 |
[Postoperative respiratory depression thought to be due to oral dantrolene pretreatment in a malignant hyperthermia-susceptible patient].
Topics: Administration, Oral; Adult; Dantrolene; Female; Humans; Malignant Hyperthermia; Postoperative Compl | 1988 |
Dantrolene prevents the malignant hyperthermic syndrome by reducing free intracellular calcium concentration in skeletal muscle of susceptible swine.
Topics: Anesthetics; Animals; Calcium; Dantrolene; Disease Susceptibility; Female; Male; Malignant Hyperther | 1987 |
Malignant hyperthermia: a dilemma for the cardiac surgeon.
Topics: Aged; Calcium; Cardiac Surgical Procedures; Coronary Artery Bypass; Dantrolene; Female; Humans; Mali | 1987 |
Dantrolene sodium is able to reduce the resting ionic [Ca2+]i in muscle from humans with malignant hyperthermia.
Topics: Adult; Calcium; Dantrolene; Female; Humans; Malignant Hyperthermia; Muscles | 1987 |
Dantrolene prophylaxis and neuromuscular disorders.
Topics: Dantrolene; Humans; Malignant Hyperthermia; Neuromuscular Diseases | 1987 |
Spinal block, after dantrolene pretreatment, for resection of a thigh muscle herniation in a young malignant hyperthermia susceptible man.
Topics: Adolescent; Adult; Anesthesia, Spinal; Child; Dantrolene; Disease Susceptibility; Herniorrhaphy; Hum | 1987 |
Malignant hyperthermia susceptibility--successful management with a "stressfree" technique.
Topics: Administration, Oral; Adolescent; Anesthesia, Inhalation; Child; Dantrolene; Female; Humans; Infusio | 1987 |
Malignant hyperthermia--a concern for critical care nurses.
Topics: Critical Care; Dantrolene; Humans; Intraoperative Care; Male; Malignant Hyperthermia; Middle Aged | 1986 |
Malignant hyperthermia.
Topics: Adult; Child; Critical Care; Dantrolene; Humans; Malignant Hyperthermia; Operating Room Nursing | 1987 |
Malignant hyperpyrexia and isoflurane. A case report.
Topics: Anesthesia, Inhalation; Dantrolene; Humans; Intraoperative Complications; Isoflurane; Male; Malignan | 1987 |
Use of dantrolene plus multiple pulses to detect stress-susceptible porcine muscle.
Topics: Animals; Calcium; Dantrolene; Electric Stimulation; Malignant Hyperthermia; Muscle Contraction; Musc | 1986 |
Halothane-cooling contractures of mammalian muscles.
Topics: Anesthetics, Local; Animals; Caffeine; Calcium; Cold Temperature; Dantrolene; Dose-Response Relation | 1986 |
The anaesthetic management of the malignant hyperthermia susceptible parturient.
Topics: Analgesics; Anesthesia; Anesthesiology; Cesarean Section; Dantrolene; Female; Humans; Malignant Hype | 1986 |
Malignant hyperthermia: clinical course and metabolic changes in two patients.
Topics: Catecholamines; Child; Child, Preschool; Dantrolene; Female; Halothane; Humans; Hydrocortisone; Mali | 1986 |
Development of malignant hyperthermia obscured by cardiopulmonary bypass.
Topics: Cardiopulmonary Bypass; Child, Preschool; Dantrolene; Heart Septal Defects, Ventricular; Humans; Hyp | 1986 |
Clinically significant muscle weakness induced by oral dantrolene sodium prophylaxis for malignant hyperthermia.
Topics: Anesthesia, General; Child, Preschool; Dantrolene; Female; Humans; Intubation, Intratracheal; Malign | 1986 |
Dantrolene plasma and urine concentrations after oral pretreatment for malignant hyperthermia: report of a case.
Topics: Administration, Oral; Anesthesia; Creatinine; Dantrolene; Female; Humans; Malignant Hyperthermia; Mi | 1986 |
[Experimental study of dantrolene sodium in anesthetic malignant hyperthermia in the pietrain-strain pig].
Topics: Animals; Dantrolene; Malignant Hyperthermia; Swine; Swine Diseases | 1986 |
Hyperkalemia, verapamil, and dantrolene.
Topics: Colectomy; Colonic Neoplasms; Coronary Disease; Dantrolene; Drug Interactions; Humans; Hyperkalemia; | 1987 |
Mini-spike dispensing pin--an efficient way to prepare dantrolene.
Topics: Dantrolene; Emergencies; Equipment Design; Female; Humans; Malignant Hyperthermia | 1987 |
Postpartum uterine atony after intravenous dantrolene.
Topics: Adult; Cesarean Section; Dantrolene; Female; Humans; Injections, Intravenous; Malignant Hyperthermia | 1987 |
Malignant hyperthermia: are we really prepared?
Topics: Dantrolene; Humans; Malignant Hyperthermia; Operating Rooms | 1987 |
Malignant hyperthermia in a patient receiving nitrous oxide.
Topics: Adolescent; Anesthesia, Dental; Anesthesia, General; Dantrolene; Humans; Male; Malignant Hyperthermi | 1985 |
[Capnography and anesthetic-induced malignant hyperthermia].
Topics: Animals; Carbon Dioxide; Dantrolene; Halothane; Malignant Hyperthermia; Monitoring, Physiologic; Suc | 1985 |
Intravenous dantrolene in a patient with myasthenia gravis.
Topics: Adolescent; Anesthesia, General; Dantrolene; Disease Susceptibility; Drug Evaluation; Electromyograp | 1986 |
Markedly delayed postoperative malignant hyperthermia.
Topics: Adenoidectomy; Anesthesia, Inhalation; Child; Creatine Kinase; Dantrolene; Disease Susceptibility; H | 1986 |
Management of an unsuspected case of malignant hyperpyrexia.
Topics: Anesthesia; Child, Preschool; Dantrolene; Humans; Male; Malignant Hyperthermia | 1986 |
[Dantrolene in the treatment of life-threatening psychiatric disease pictures. A contribution to the therapy of the malignant neuroleptic syndrome and acute febrile catatonia].
Topics: Adult; Basal Ganglia Diseases; Dantrolene; Diagnosis, Differential; Fever; Humans; Male; Malignant H | 1985 |
Neuroleptic malignant syndrome.
Topics: Adult; Basal Ganglia Diseases; Bromocriptine; Dantrolene; Diagnosis, Differential; Haloperidol; Heat | 1985 |
[Electroconvulsive and dantrolene treatment of acute febrile catatonia. A case report].
Topics: Adult; Combined Modality Therapy; Dantrolene; Electroconvulsive Therapy; Fever; Humans; Male; Malign | 1985 |
[Anesthesiologic management of the patient threatened by malignant hyperthermia].
Topics: Anesthetics; Atropine; Dantrolene; Humans; Intraoperative Complications; Malignant Hyperthermia; Mon | 1985 |
Avoidance of malignant hyperthermia in a porcine model for experimental open heart surgery.
Topics: Anesthesia; Animals; Cardiac Surgical Procedures; Dantrolene; Hypothermia, Induced; Malignant Hypert | 1985 |
Verapamil is not a therapeutic adjunct to dantrolene in porcine malignant hyperthermia.
Topics: Anesthesia, Inhalation; Animals; Blood Gas Analysis; Blood Pressure; Dantrolene; Drug Synergism; Hal | 1985 |
Availability of dantrolene in Canadian hospitals.
Topics: Canada; Costs and Cost Analysis; Dantrolene; Humans; Malignant Hyperthermia; Medication Systems, Hos | 1985 |
Malignant hyperthermia: a possible new variant.
Topics: Adolescent; Creatine Kinase; Dantrolene; Humans; Male; Malignant Hyperthermia; Pedigree; Potassium | 1985 |
Verapamil and malignant hyperthermia--case reports.
Topics: Adult; Calcium; Child; Child, Preschool; Dantrolene; Drug Therapy, Combination; Female; Humans; Male | 1985 |
More on malignant hyperthermia during delivery.
Topics: Dantrolene; Female; Humans; Labor, Obstetric; Malignant Hyperthermia; Pregnancy | 1985 |
[Temporary registration of cases of peranesthetic malignant hyperthermia in France].
Topics: Adolescent; Adult; Anesthesia, General; Child; Creatine Kinase; Dantrolene; Epidemiologic Methods; F | 1985 |
[A case of malignant hyperthermia; successful treatment with intravenous dantrolene sodium].
Topics: Anesthesia, Inhalation; Child, Preschool; Dantrolene; Female; Halothane; Humans; Injections, Intrave | 1985 |
[A case of malignant hyperthermia in operative obstetrics].
Topics: Adult; Cesarean Section; Combined Modality Therapy; Dantrolene; Female; Humans; Infant, Newborn; Mal | 1985 |
[Malignant hyperthermia].
Topics: Dantrolene; Humans; Malignant Hyperthermia | 1985 |
[Determination of intracellular free calcium concentration, in vivo, in swine susceptible to malignant hyperthermia syndrome].
Topics: Animals; Calcium; Dantrolene; Halothane; Malignant Hyperthermia; Membrane Potentials; Muscle Contrac | 1985 |